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aan Aukje en Elke 
My heart leaps up when I behold 
A rainbow in the sky: 
So was it when my life began; 
So is it now I am a man; 
So be it when I shall grow old, 
Or let me die! 
The child is father of the man. 
William Wordsworth -
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When technology is master, 
we shall reach disaster faster. 
Piet Hein 
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VOORWOORD 
Met vee! plezier begin ik dit proefschrift met het uitspreken van mijn dank en 
waardering aan hen die aan mijn vorming tot kinderarts hebben bijgedragen. Met 
naam wil ik noemen mijn opleiders Prof. Dr. E.D.A.M. Schretlen en Prof. Dr. G.B.A. 
Stoelinga. Dr. A.J. van Vught heeft mij de kneepjes van de paediatrische intensive 
care bijgebracht en gewezen op de noodzaak om stoornissen in ""vitale funkties'' te 
vertalen naar de onderliggende pathophysiologische processen. 
Bij de voltooiing van dit manuscript hebben velen geholpen. 
Prof. Dr. J.C. Molenaar: Jan, vee! heb ik van je geleerd. Je benadering van 
klinische problemen en medisch-ethische vraagstukken hebben een grote invloed 
gehad op mijn "klinisch denken". Aan onze reis naar lndonesie bewaar ik de beste 
herinneringen. 
Prof. Dr. D. Tibboel: Dick, onze samenwerking op de Intensive Care 
Kinderheelkunde is heel intensief geweest. Dit proefschrift is een van de resultaten 
daarvan en zou er zonder jouw inzet niet zijn gekomen. Onze gesprekken over 
patient-gebonden problemen en vooral de "vertaling" daarvan naar processen op 
cellulair niveau, waren goed. 
Dr. W. Sluiter: Wim, de discussies over de verschillende facetten van het 
onderzoek heb ik als zeer stimulerend ervaren. Dank daarvoor. 
Drs. J. Hagoort: Ko, niet aileen je bijdrage aan het Engels maar vooral je 
inhoudelijke adviezen over de opbouw van het manuscript heb ik erg op prijs 
gesteld. 
De Leden van de Studiegroep "Congenitale Hernia Diaphragmatica" : Dankzij de 
inzet van met name Rob Tenbrinck en Thijs van Aken en de gastvrijheid van de 
afdeling van prof. dr. Burkhard Lachrnann heeft de ontwikkeling van het diermodel 
plaats kunnen vinden. 
De Collega's van de afdeling Kinderheelkunde: Aile "snijdende" kinderartsen 
bedank ik voor de morele ondersteuning, met name Frans Hazebroek zorgde voor 
positieve kritiek op de publikaties in wording. Bram Provoost had aile tijd voor 
statistische adviezen. 
De Collega' s uit Zwolle: Wim Baerts, Will em Fetter en Richard van Lingen gaven 
mij ruimte en tijd om het manuscript af te ronden. lneke Ribbers heeft aile versies 
van het manuscript gezien en toch haar goede hurneur bewaard. De rnedewerkers 
van de bibliotheek van het Sophia Ziekenhuis stonden altijd klaar om te helpen. 
lk vind het jammer dat mijn vader en moeder deze dag niet meer kunnen 
meemaken. 
Zander Boudien en de kinderen zou mijn Ieven niet zijn wat het is. 
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INTRODUCTION 
Congenital diaphragmatic hernias are classified according to the location of the 
defect: posterolateral hernia with or without a sac (Bochdalek-type), parasternal 
hernia through the foramen of Morgagni, central hernia, and diaphragmatic 
eventration. The so-called hiatal hernia has a different pathophysiology and a 
different clinical presentation. Posterolateral defects account for 85% of congenital 
diaphragmatic herniasY Left-sided posterolateral defects occur eight times more 
frequently than right-sided defects in the neonatal period. Bilateral defects are rare 
and estimated at 3 to 5%.3 
Children at the highest risk of dying are they who are symptomatic in the 
delivery room or within six hours after birth.' The mortality rate reported in this 
group ranges from 40 to 50%." Conversely, those who do not develop respiratory 
failure in the first 24 hours of life have an almost 100% chance of survival. 
In contrast to other major congenital anomalies the mortality due to congenital 
posterolateral diaphragmatic hernia remains high despite improvements in neonatal 
intensive care and pediatric surgery.'~ The main reason is that pulmonary 
hypoplasia and pulmonary hypertension form the pathophysiological basis for the 
clinical picture of respiratory distress and right-to-left shunting that frustrates so 
many clinicians responsible for newborns with a diaphragmatic defect. 
This thesis presents the research into clinical aspects of congenital posterolateral 
diaphragmatic hernia related to pulmonary hypoplasia and pulmonary hypertension; 
the pathophysiological background of these disorders was studied in an animal 
model. The clinical studies were all carried out in the Pediatric Surgical Intensive 
Care Unit of the Sophia Children's Hospital. The animal model was developed by 
TenBrinck and coworkers in the Laboratory of Experimental Surgery of the Erasmus 
University in Rotterdam.' In this model congenital diaphragmatic hernia is induced 
in fetal rats by means of administering a single dose of Nitrofen (2,4-dichlorophenyl-
p-nitrophenyl ether) on the lOth day of gestation. The model interferes with lung 
development in an early stage, thus providing the opportunity to study several 
aspects of lung development in relation to both ventilatory capacity and pulmonary 
vascular reactivity. 
The results of the conducted studies, as they have been reported and discussed 
in papers either published or accepted by international journals, form the core of 
this thesis. These papers are preceded by a review of the literature focussed on 
historical aspects, clinical picture and normal and abnormal lung development. They 
are followed by a concluding chapter in which changing concepts concerning 
pathogenesis and treatment are discussed. 
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1.1 HISTORY-----------------------------
REVIEW OF THE LITERATURE 
1.1 History 
Diaphragmatic defects caused by sword and knife were already known to 
Hippocrates of Cos, who thought that such wounds were inevitably "mortal'". 
Congenital diaphragmatic hernia was first recorded in 1679 by Lazarus Riverius as 
an incidental observation during the autopsy of a 24-year-old man.' ln 1701, Sir 
Charles Holt reported congenital diaphragmatic hernia in a two-month-old infant', 
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... when we had opened the abdomen ... part of the duodenum passed thro a foramen in the 
diaphragm, placed on the left side. 
ln 1769, Morgagni, a pupil of Valsalva, described the congenital anterior 
diaphragmatic defect named after him.' In 1824, Sir Astley Cooper published the 
case history of a 28 year-old woman who died after recurrent episodes of intestinal 
strangulation through a diaphragmatic defect. In the same treatise he mentioned two 
newborn infants who died within hours after birth due to congenital diaphragmatic 
hernia, and he already noted underdevelopment of the lung', 
.. .the left lobes of the lungs were not larger than a small nutmeg, and about two-thirds 
less than the right. 
In 1848, Vincent Alexander Bochdalek, professor of Anatomy at Prague, described 
herniation of the bowel through the posterior part of the diaphragm, a defect that 
now bears his name.' In this century, Bowditch reported the first series of congenital 
diaphragmatic hernia and gave a classic description of the clinical symptoms', 
... no respiration over whole of left chest. In its place a mixture of gurgling, whistling, 
and blowing sounds was heard, like those heard over the abdomen. 
Among his patients were twenty-six with a congenital diaphragmatic defect. Eleven 
of them died within hours after birth, six within two years, one at the age of seven, 
and eight during adult life. ln 1902, Heidenhain gave the first account of successful 
surgical repair; the patient was a nine-year-old boy.' Greenwald and Steiner 
published a report on 43 cases of diaphragmatic hernia in infancy and childhood in 
1929, and categorized the signs and symptoms by age groups. There were 13 
stillborns and 24 of the other 30 neonates died within 36 hours of birth. They 
concluded', 
.. .for the patient in whom the hernia makes its appearance at birth, little or nothing can 
be done from a surgical standpoint. 
8 
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Eleven years later Ladd. and Gross reported 16 children who underwent operation 
and advocated early surgical repair in the first 48 hours of life9, 
... the policy of waiting until the child gets older and stronger is apparently responsible for 
the loss of a great many lives that might have been saved by a timely operation. 
The use of endotracheal intubation and assisted ventilation became routine 
procedure during early surgical repair since 1950. Gross reported 63 cases of 
Bochdalek hernia, and he optimistically stated in 1953", 
... surgical therapy is highly satisfactory regardless of the extent of the herniation and the 
apparent critical condition of the child. 
In 1955, Campanale and Rowland described the presence of pulmonary hypoplasia 
in five newborn infants with a congenital diaphragmatic hernia, in whom they noted 
a marked reduction in number and differentiation of alveolar ducts and alveoli." 
These observations were confirmed by Butler and Claireaux who drew the attention 
to the presence of hypoplasia in the contralateral lung as well. They also noted an 
association with other major congenital anomalies and their contribution to 
mortality." Moore had already observed that the hypoplastic lungs are vulnerable to 
positive pressure ventilation13~ 
.. .the vigorous use of positive pressure through the endotracheal tube must be avoided. 
These lungs cannot be expanded by this type of effort and only harm can result. 
In 1964, Gross looked back at experiences of the Boston Children's Hospital and 
found it disturbing that over the years the cure rates of congenital diaphragmatic 
hernia had dropped. This is possibly explained by a much higher proportion of 
babies less than 24 hours of age corning for treatment." 
Areechon and Reid drew attention to the long-term growth and development of 
the hypoplastic lung and stated", 
... no correction of the bronchial and bronchiolar deficiency will occur; but that growth 
within the acini will be great enough to provide the lung with its normal complement of 
alveoli. 
They also pointed out that animal experiments were needed to study the normal 
growth of the lung as well as growth compensatory to disease. 
The problem of neonatal hypoxemia due to pulmonary hypertension, and 
subsequent right-to-left shunting of undersaturated blood through fetal channels 
such as the foramen ovale and the ductus arteriosus, was gradually recognized 
during the 1960s. Naeye and Letts studied infants with neonatal hypoxemia and 
found thickened smooth muscle in pulmonary arterial vessel walls. They also noted 
that the usual postnatal decrease in musculature and thickness of the pulmonary 
vascular bed did not occur." Kitagawa made a detailed study of the lungs of one 
child with congenital diaphragmatic hernia and found not only a reduced number of 
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alveoli, but also a pathological, excessive muscularization of pre-acinar arteries." 
Both Murdock" and Rowe19 reported large alveolar-to-arterial oxygen tension 
differences between radial artery and descending aorta during adequate alveolar 
ventilation. They both suggested venoarterial admixture in the lungs, or right-to-left 
shunting through the ductus arteriosus and foramen ovale. 
At the time it was normal pediatric surgical practice to treat congenital 
diaphragmatic hernia in newborns as an emergency condition. Many afflicted 
newborns were in a poor clinical condition, due to a combination of hypothermia, 
asphyxia, and low systemic blood pressure. Postoperatively some patients improved 
and survived, but others improved only temporarily: the so-called "honeymoon 
period"". 
9 
The observation that preoperative treatment aimed at correcting acidosis, hypoxia, 
and tissue perfusion improves survival, has led to the concept of delayed surgery." 
In several centers around the world this "new" approach has been evaluated. In a 
prospective pilot study Hazebroek et al concluded that ventilation parameters that 
are satisfactory on admission, will remain good during the stabilization phase, and 
that unsatisfactory ventilation parameters may improve." 
Extracorporeal membrane oxygenation (ECMO) has been developed in the United 
States as a treatment modality for neonates with severe respiratory failure. Bartlett 
published a survey of the initial ECMO-experiences in 100 neonates and concluded 
that the best survival results were achieved in persistent fetal circulation, and the 
second best in congenital diaphragmatic hernia." Nakayama studied a group of 
patients treated according to a delayed-surgery protocol in combination with ECMO. 
He found improved survival but concluded that further studies are needed to 
determine the benefits of preoperative stabilization." Compared with series from the 
1970s and 1980s the mortality rate remained unchanged at 40 to 50% when ECMO 
was applied.24,25,,,, Some patients may benefit from alternative ventilatory strategies 
such as high frequency oscillatory ventilation." The application of surfactant in these 
patients or the development of newer drugs to modulate pulmonary vascular tone, 
however, are only described in anecdotical reports."-" 
A completely different approach was made by the group of Harrison. They 
advocate repair before birth by means of fetal surgery. One of the disadvantages of 
this treatment modality is the impossibility to identify patients who really would 
benefit from such a risky surgical procedure." 
Despite all these new developments, congenital diaphragmatic hernia remains a 
serious congenital anomaly with a high mortality. There is growing awareness that 
it might be part of a more basic defect, the defect in the diaphragm probably being 
the least important. 
10-----------------------------------------------------~YITR 1 
12 Epidemiology 
Congenital diaphragmatic hernia is a common neonatal disorder. Epidemiological 
studies from around the world, most of which include stillborns, are summarized in 
Table 1. They show an incidence of one in 2 to 3000 newborns. A higher incidence 
was found in Avon (UK) in 198036; Sarda mentioned a much higher prevalence in 
stillbirths (one in 74) thsn in livebirths (one in 2450).37 In the northern part of 
Netherlands the prevalence is one in 5000 newborns", in the south-west of the 
country it is one in 3000. 
Diaphragmatic defects are associated with a number of chromosomal_ genetic, 
and nongenetic patterns of malformation. The types of abnormalities vary according 
to whether stillborns are included in the study or not. The original studies by Butler 
and Claireaux12, and David and lllingworth32 included stillborns and showed 
anomalies other thsn congenital diaphragmatic hernia in about 50% of cases (Table 
2). The central nervous system was affected most frequently (especially neural tube 
defects). 
Table 1. Reported incidence of congenital 
diaphragmatic hernia 
England, 1962 12 
England, 1976 32 
England (Avon), 1980 36 
USA, 1981 33 
Hungary, 1985 34 
France, 1991 36 
France, 1991 37 
Netherlands 38 
1 :2200 
1 : 1870 
1 : 1850 
1 :2644 
1 :2500 
1:2500 
1:2450 
1 :5000 
Table 2. Associated malformations 
System Ref. 12· 32 4Q• 
NeNous 35% 28 % 18% 
Cardiovascular 12% 13 % 42% 
Gastrointestinal 5% 19.6% 13% 
Genitourinary 10% 14.7% 42% 
Skeletal nr 11.7% 16% 
Others nr 13 % nr 
Incidence 47% 50 % 48% 
•autopsy findings; nr: not reported 
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Most American studies concentrated on liveborn infants and excluded autopsy 
data. In 1985, Adzick reported data from a questionnaire on 94 cases of fetal 
congenital diaphragmatic hernia: 16% of the fetuses had associated lethal anomalies, 
and isolated nonlethal anomalies presented in an additional 8%.39 A few years later 
Adzick published the experiences of the Boston Children's Hospital: 11 of the deaths 
were associated with other lethal anomalies, (almost 30%)." Cunni£ and coworkers 
reviewed the medical records of 102 liveborn children with congenital diaphragmatic 
hernia to establish patterns of malformation. They found associated anomalies in 40 
of them (39%). Eleven patients had previously recognized patterns of malformation, 
such as chromosomal disorders or Fryns' syndrome. In addition, 13 patients had 
multiple congenital anomalies that did not represent a recognized pattern of 
malformation. Thirteen children had only one defect in addition to the 
diaphragmatic hernia. Cardiac defects were present in 18 newborns, and this group 
showed a much higher mortality rate (72 vs 38%). It was therefore suggested that 
preoperative cardiac evaluation should be part of the preoperative workup." 
Congenital diaphragmatic hernia has been reported to present in association with 
chromosomal abnormalities. The abnormal fetal karyotypes most commonly observed 
are trisomies 18 and 21.39·" As the fetal karyotype is abnormal in more than 10% of 
cases, karyotyping should be part of the assessment of children with congenital 
diaphragmatic hernia and other anomalies." 
Diaphragmatic defects can also be part of other circumscript syndromes such as 
Fryns' syndrome", Cornelia de Lange syndrome, Apert syndrome", Goldenhar 
syndrome", Beckwith-Wiedemann syndrome", and Pierre Robin syndrome." Other 
phenotypes that may include diaphragmatic defects are, for instance, Cantrell's 
pentalogy (omphalocele, congenital diaphragmatic hernia, pericardia! defect, 
intracardiac defect, and sternal cleft)"', and rarely, the DiGeorge sequence. 
Familial occurrence of congenital diaphragmatic hernia was first described in 1916 
by Makela." Since that time it is known that congenital diaphragmatic hernia may 
occur in identical twins, siblings, maternal uncles of affected siblings, and cousins.50 
There is no doubt that t.l-te incidence in familial cases is much lower than in 
sporadic cases. The mode of inheritance in familial cases of congenital diaphragmatic 
hernia is unknown. In 1979, Crane analyzed twelve afflicted families and argued 
that multifactorial inheritance is probably a more likely way of transmission than 
autosomal recessive inheritance; because of (1) the absence of consanguinity, and (2) 
the absence of equal distribution of affected males and females." In 1980, Wolff 
reviewed the literature on familial congenital diaphragmatic defects and also 
concluded that familial congenital diaphragmatic hernia follows a multifactorial 
inheritance pattern, because of the heterogeneity of the anatomy of the defect, the 
male predominance in the sex ratio, and the observation of associated anomalies.52 
Norio also took this view, but added that multifactorial determination does not 
exclude other genetic causes in some familial cases." Some years later Hitch 
described a family that had a second, third, and fourth infant with congenital 
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Table 3. Causes of malformations in man 
Known genetic transmission 
Chromosomal aberration 
Environmental causes: 
- radiations 
- infections 
- maternal metabolic imbalance 
- drugs and environmental chemicals 
Unknown 
20 % 
3-5 % 
<1 % 
2-3 % 
1-2 % 
4-6 % 
65-70% 
diaphragmatic hernia after a first normal male infant. The latter two children were 
fraternal twins. There was no known consanguinity in three generations of this 
family. Chromosomal studies yielded normal results. The question arises indeed 
whether autosomal recessive inheritance had been the way of transmission in this 
family.'" 
13 Etiology and animal models 
The causes of birth defects are widely ranging, but the etiology of the majority of 
malformations is a maze of unknowns. This has been emphasized by Wilson (Table 
3).55 
The critical period of the diaphragm's organogenesis is estimated at day 40 of 
gestation, and the cause of absent closure of the diaphragm still is categorized as 
unknown."' Although a few drugs or groups of drugs have now been established as 
teratogenic agents in humans, none of these agents is associated with diaphragmatic 
hernia. 
Experimental models 
In animals, only a limited number of models has been developed to study 
pathogenic aspects of congenital diaphragmatic hernia. Harrison's group developed a 
model 
mimicking diaphragmatic hernia by implanting and inflating a balloon in the chest 
of fetal lambs.57 These lambs deteriorated soon after delivery, showing the clinical 
picture of respiratory distress. Deflation of the balloon in the neonatal period, 
mimicking correction of the defect, did not improve survival. However, deflation at 
day 120 of gestation (so-called simulated "correction"), resulted in catch-up lung 
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growth and development; after birth these lambs were easily resuscitated and all 
survived. They had significant increase in lung weight, air capacity, compliance, and 
area of the pulmonary vascular bed."-" In other words, this model established the 
pathophysiological efficacy of in utero repair. 
Direct surgical repair in animals has been done by Harrison's group and by 
Soper and coworkers. It was shown that intrauterine repair indeed results in 
improved survival after delivery."'" Others induced diaphragmatic hernia in fetal 
rabbits by rupturing the left diaphragm in utero during the pseudoglandular period 
of pulmonary histological development.'w 
In both animal models, studies into alveolar hypoplasia and characteristics of the 
pulmonary vascular bed showed a reduction in total lung weights in animals with a 
diaphragmatic defect. The ipsilateral lung was always more affected. The total size 
of the pulmonary vascular bed was decreased, the number of vessels per unit area 
lung was reduced~ and there was increased muscularization of the arterial tree.58.6z 
The defect of the diaphragm 
Since 1971 Nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether) has been recognized as 
a potent teratogenic agent in rodents.'"' When administered to the pregnant mother 
during organogenesis, the heart, kidneys, diaphragm, and lung will develop 
abnormally. The exact mechanism of teratogenesis is not known, but evidence is 
accumulating that the teratogenic effects are mediated via alterations in thyroid 
hormone status." The stereochemical configuration of Nitrofen greatly resembles that 
of triiodothyronine and thyroxine. 
lritani studied in mice whether hypoplasia of the lung bud might be responsible 
for the defect of the diaphragm."' He induced congenital diaphragmatic hernia in 
80% of the offspring and concluded that pulmonary hypoplasia is a causal factor in 
the origin of congenital diaphragmatic hernia. This is in contrast to the generally 
accepted theory that lung hypoplasia is secondary to compression of the migrated 
viscera into the thoracic cavity. In other words, lung hypoplasia might not be the 
result but the primary defect in congenital diaphragmatic hernia. 
The effect of Nitrofen on rat fetuses was further studied by Kluth and by 
Tenbrinck, who demonstrated the presence of lung hypoplasia in rats exposed to 
Nitrofen with or without a diaphragmatic defect."-"'"' This finding is in accordance 
with the concept that Nitrofen primarily interferes with lung development and not 
with development of the diaphragm alone."·" In this model Nitrofen interferes with 
the closing mechanism of the diaphragm during organogenesis and not in fetal life 
as in the lamb model. Other drugs that are able to induce congenital diaphragmatic 
hernia in animals are quinine and thalidomide, but they are not currently used in 
experiments." Thus Nitrofen is probably the most promising drug to study 
pathophysiological and developmental aspects in congenital diaphragmatic hernia 
and pulmonary hypop !asia. 
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1.4 Clinical picture 
1.4.1 Antenatal presentation 
Congenital diaphragmatic hernia can be detected in utero by prenatal ultrasono-
graphy when herniated abdominal viscera in the fetal chest, abnormal upper 
abdominal anatomy, and mediastinal shift away from the side of herniation can be 
visualized." Sometimes herniated viscera move in and out of the fetal chest, 
suggesting that fetal congenital diaphragmatic hernia is a dynamic process." It has 
been suggested that the presence of the stomach in the chest, especially if it is 
dilated, is predictive of poor outcome." 
In most cases, sonography is performed because the mother is large-for-date. 
Polyhydramnios usually develops after 24 weeks of gestation, suggesting that it is a 
relatively late manifestation of this disease." The cause of polyhydramnios is 
unknown, but it may be functional upper gastrointestinal obstruction or impaired 
fetal swallowing." Others have reported that congenital diaphragmatic hernia is 
associated with renal enlargement. They suggested that the kidneys produce a 
certain pulmonary growth factor and that due to compression the fetal lungs may 
be unable to respond. Pulmonary hypoplasia would maximally stimulate production 
of pulmonary-derived renotropin, resulting in continual stimulation of the kidneys, 
and renal enlargement. Subsequently, renal enlargement would lead to increased 
urine production by the fetus, and polyhydramnios." In a large, retrospective study, 
polyhydramnios was present in 76% of cases, and was also a predictor of poor 
clinical outcome." A recent report from England on fetal diaphragmatic hernia did 
not confirm this association; the incidence of hydramnios was only 29%." The same 
study showed that a reduced left-to-right ventricular size and a lower aorta-to-
pulmonary artery ratio is associated with poor prognosis. Sequential observations 
showed that changes occurred with advancing gestation. The cause of the 
underdevelopment of the left heart remains uncertain, although the evidence of right 
heart underdevelopment in right-sided hernia suggests that direct compression of 
cardiac structures may play a role." 
Once a congenital diaphragmatic hernia is diagnosed, it is possible to perform 
chromosomal analysis by amniocentesis or percutaneous umbilical blood sampling. 
Screening for other anatomical abnormalities, including structural cardiac defects, 
should be carried out by an experienced obstetrical sonographer. 
Prenatal diagnosis makes it possible to provide the best chances for survival for 
the yet unborn patient. It allows maternal transport to a specialized center, planned 
delivery, and immediate resuscitation. Ultrasonography may not detect small 
congenital diaphragmatic hernias in utero, but it apparently detects those fetuses that 
are most severely affected. Diagnostic errors may include cystic adenomatoid 
malformation of the lung, and cystic masses in the mediastinum." 
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1.4.2 Postnatal presentation 
The classic symptom triad of the common left-sided congenital diaphragmatic hernia 
consists of cyanosis, dyspnea, and cardiac dextroposition. Physical examination 
reveals a scaphoid abdomen, decreased breath sounds, and distant heart sounds. 
Auscultation of bowel sounds in the chest is an inconsistent finding. A chest 
roentgenogram shows a mediastinal shift, air-filled bowel loops located in the chest, 
and a relatively gasless abdomen. Right-sided hernias may be asymptomatic because 
of tamponade of the defect by the liver. The children at highest risk are 
symptomatic in the delivery room or within six hours after birth." The mortality 
rate reported in this patient group ranges from 40 to 50%.''-" The mortality rate has 
not decreased probably due to the fact that more patients with profound respiratory 
distress and circulatory collapse, who previously would have died, reach the 
specialized center earlier nowadays. It is this group of children that Harrison 
referred to as representing the '"hidden·· mortality."' 
Infants with congenital diaphragmatic hernia have abnormal pulmonary structure 
characterized by diverse degrees of hypoplasia of lung parenchyma and pulmonary 
blood vessels."·" As a consequence they present with the clinical symptoms of 
respiratory distress and persistent pulmonary hypertension. 
Nguyen and coworkers conducted a large study of 40 autopsied congenital 
diaphragmatic hernia patients and found hypoplasia in all cases. They concluded 
that the mortality was caused by a combination of factors, one of which certainly 
bilateral lung hypoplasia." A five-year study from the Boston Children's Hospital 
involved 50 neonates with a diaphragmatic defect, thirteen of whom underwent 
cardiac catheterization in the postoperative period." Analysis of the data suggested 
the presence of two separate physiological groups, "responders" and "nonresponders" 
to conventional therapy. "Responders" often had left-to-right shunting. Episodes of 
right-to-left shunting i...'l. the postoperative period were due to vasoconstriction of the 
pulmonary vascular bed after the so-called honeymoon period. Pulmonary 
vasoconstriction can be triggered by many events such as suctioning of the 
endotracheal tube, pain, and loud noises. Continued administration of anesthetics 
reduced the incidence and frequency of this episodes.87 "Nonresponders" had severe 
right-to-left shunting that was unresponsive to any attempts at pulmonary 
vasodilation. In a number of these children pulmonary arteriograms were made. 
Patients were grouped by the (in)ability to reach at least one postductal Pa02 > 100 
torr. Arteriograms in the group with PaO, values < 100 torr showed smaller 
ipsilateral and contralateral main pulmonary arteries, as well as smaller ipsilateral 
lungs with more severe peripheral vascular obstructive disease. The authors 
proposed the postductal PaO, as the clinical marker for identification of the degree 
of pulmonary perfusion." 
As the degrees of pulmonary hypoplasia and pulmonary hypertension are by no 
means uniform in this disease, attempts have been made to identify the patients 
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who run the highest risk. Early reports predicted survival on the basis of acid-base 
balances and alveolar-arterial oxygen differences {(A-a)DO,}."''" Later the site of the 
stomach was used as a prognostic sign: an abdominal site was associated with an 
excellent prognosis, an intrathoracic site with a high mortality." About the same 
time Touloukian described a scoring system based on the final preoperative thoracic 
X-ray. He scored the side of the diaphragmatic defect, the location of the stomach, 
presence of an ipsilateral or contralateral pneumothorax, the degree of mediastinal 
shift, amount of visceral distension, and relative volume of aerated ipsilateral and 
contralateral lung: high scores were associated with nonsurvival.92 Cloutier measured 
V /P values (expiratory tidal volume over inspiratory pressure) as an index of 
pulmonary expansion in newborns with congenital diaphragmatic hernia; he also 
recorded these values in lambs and correlated them with the amount of lung tissue 
found at post mortem. He found low V /P values in newborns and a significant 
correlation between V /P and fractional lung mass in lambs with a diaphragmatic 
defect, suggesting that this index of expansion could be an indicator of lung 
hypoplasia." Bohn recently emphasized the importance of hypoplasia, and asserted 
that a better estimation of survival can be made in the relationship of the PaCO, 
and ventilation parameters.'" He showed that the values measured 2 hours post 
surgery predicted outcome: if the PaCO, was less than or equal to 40 torr and the 
ventilation index was less than 1000, the chance of survival was excellent. The 
ventilation index is the product of the mean airway pressure and the respiratory 
rate. In another paper Bohn used these criteria both before and after surgical repair 
and confirmed his earlier report. He concluded that patients with elevated PaCO, 
levels, which cannot be reduced by hyperventilation, have bilateral lung hypoplasia 
associated with death." 
Other diagnoses that should be considered in neonates presenting with the triad 
of cyanosis, dyspnea or dextrocardia are space-occupying developmental anomalies 
such as congenital lobar emphysema and cystic adenomatoid malformation of the 
lung. In congenital lobar emphysema there is even distribution of air in the affected 
lobe. In cystic adenomatoid malformation of the lung, however, multiple air and 
fluid-filled cystic spaces can be seen that resemble the bowel loops in congenital 
diaphragmatic hernia. Tachypnea will result in air swallowing with dilated bowel 
loops within the abdomen. In contrast, congenital diaphragmatic hernia is associated 
with a scaphoid abdomen with less abdominal gas. 
In conclusion, alveolar hypoplasia and persistent pulmonary hypertension form the 
pathophysiologic background for the clinical picture in symptomatic newborns with 
congenital diaphragmatic hernia. 
1.4.3 "Delayed" or "acquired" presentation 
The late-presenting Bochdalek hernia often presents difficulties in diagnosis because 
its symptoms and signs are far from specific and resemble those of other disease 
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processes. Between 5 and 10% of congenital diaphragmatic hernia presents after the 
neonatal period-" 
Berman reported a 20-year review and suggested that there are two distinct 
groups. In one group the defect may be longstanding, but the viscera are confined 
by a hernial sac or obturated by the liver or spleen. The defect will present when 
the sac ruptures or the intra-abdominal pressure is raised, causing the viscera to 
herniate. This type of presentation is supported by previously normal chest X-rays 
and is called "acquired" hernia." The other group probably has long-standing 
congenital diaphragmatic hernia which presents when a complication of the 
herniated bowel loops, such as strangulation, occurs. Berman found a high incidence 
of respiratory tract infections and acute respiratory distress. In contrast other studies 
concerning late congenital diaphragmatic hernias and eventrations reported failure to 
thrive followed by abdominal pain and vomiting as the commonest symptom.97 On 
the basis of clinical presentation, there are two types of patients: those presenting 
early in childhood with respiratory symptoms and those with gastrointestinal 
symptoms presenting later in childhood." Mistaken diagnoses included pneumonia, 
congenital lung cysts, and tension pneumothorax." Right-sided hernias may present 
as a pleural effusion, the obstructed hepatic venous outflow from the herniated liver 
causing vascular transudation from the liver surface.' 00 Clinically, it may be difficult 
to distinguish between a hernia with a sac and an eventration, but an eventration is 
characterized by elevation of an attenuated, intact diaphragm.'" Group B 
streptococcal sepsis has been associated with congenital diaphragmatic hernia and 
has been thought to develop because of compression of the lung with resultant 
consolidation.102 
1.5 Normal developmental aspects 
1.5.1 Diaphragm 
The diaphragm has four developmental components: (1) anterior components from 
the septum transversum, (2) a posterior component from foregut mesentery, (3) a 
lateral component from body wall muscle, and (4) pleuroperitonea! canals. Two 
developmental phases can be identified: (1) development of the septum transversum 
and (2) closure of the pleuroperitonea! canals. The primary body cavity, or 
intraembryonic celom, is formed as early as the fourth week of gestation. The 
septum transversum is established between the pericardia! cavity cranially and the 
peritoneal cavity caudally; it is a mesodermal structure. Dorsal to the septum 
transversum the pleuroperitonea! canals develop. 
The septum transversum expands due to active growth of the developing heart 
and lungs. The pulmonary primordium appears at the caudal end of the 
laryngotracheal sulcus after two weeks.'" The dorsal part of the future diaphragm is 
formed from mesenchymal cells around the aorta, the lateral parts from muscular 
parts of the body waiL There are no arguments that point to a primary defective 
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development of the septum transversum as the cause of the diaphragmatic hernia. 
The pleuroperitonea! canals close at approximately 52 days of gestation."' There is 
no agreement on the exact mechanism of closure. The closure of the diaphragm is 
completed by the ninth week of gestation. 
1.5.2 Gas exchange area 
Recently, several authors have reviewed the structural development of the fetal 
lung."'·""·'" lt appears that the process of development can be subdivided into five 
stages. 
The first is the embryonic period (0 to 7 weeks), when a small diverticulum of the 
foregutdevelops. Two bronchial buds appear and form the right and left main-stem 
bronchi. Respiratory epithelium already develops in the endodermal foregut bud and 
interacts with the bronchial mesoderm, growing invasively into the surrounding 
mesenchyme. The pattern of branching is determined by the associated mesenchyme. 
The next stage is the pseudoglandular phase (8 to 16 weeks); in this phase, the 
primitive airways rapidly proliferate so that all airway divisions are completed by 
16 weeks. The extreme peripheral structures are the terminal bronchioles which 
undergo further differentiation into respiratory bronchioles and alveolar ducts. 
Differentiation of epithelial cells begins as early as 10 weeks. Mucous glands appear 
at 10 to 12 weeks, and ciliated cells at 13 weeks of gestation. 
The canalicular phase (17 to 27 weeks) shows further division and enlargement of 
distal airways. By 20 to 22 weeks the epithelium begins to differentiate into two cell 
types: type II cells containing lamellar bodies, and more flattened type I cells with 
large cytoplasmic extensions. 
Another important event at this stage, is the development of the distal 
pulmonary circulation, where capillaries come in close contact with the epithelial 
layer. In other words, the first steps are made to form a thin air-blood barrier and 
sufficient quantities of surfactant material to enable future gas exchange. 
The saccular phase (28 to 35 weeks) is characterized by large sack-like, peripheral 
airspaces. The sacculi are subdivided by ridges that protrude into the airspaces, 
taking part of the capillary bed with them, and forming a double capillary layer. In 
this way "primitive" alveoli are formed as early as 32 weeks of gestation. 
This stage gradually proceeds into the alveolar stage (36 weeks to Term). It is still 
unsolved whether alveolar formation actually starts in this period. Boyden stated 
that there are only "primitive sacculi" before birth.'" In 1984, Thurlbeck reported that 
alveoli started to appear as early as the 32nd or 34th week of gestation, and that 
there were 50 million alveoli at birth.'" This is far more than was estimated 
previously. '10 The volume of potential airspace, both within the airway lumen and 
within the future gas exchange area, increases with thinning of septal walls and 
attenuation of cuboidal cells. The postnatal growth of the lung results in a further 
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increase of lung volume (23-fold), number of alveoli (six-fold), alveolar surface area 
(21-fold), and lung weight (20-fold) into adulthood. 
Lynne Reid summarized the process of lung development and introduced the 
three laws of lung development' 11 : 
LAw I: the bronchial tree - bronchi and bronchioli - is developed by the 16th week of 
intrauterine life. Airway development is an intrauterine story. 
LAw !1: alveoli develop after birth, and at birth the "alveolar" spaces are more primitive 
than in the adult. The alveolar story is mainly postnatal. The fastest multiplication takes 
place during the first 4 years of life. As thoracic growth exceeds alveolar multiplication, 
alveoli increase in size and their density decreases. The radial alveolar count (the number 
of alveoli between the last respiratory bronchiole and the outside margin of the acinus) is 
a convenient way to assess alveolar multiplication.m. 
LAw Ill: the "vascular" law reflects the first two. The pre-acinar branches of the 
pulmonary artery appear at the same time as the accompanying airways. The intra-acinar 
vessels appear as alveoli grow. 
Professor Reid concluded: 
... that by using these laws as the timetable of development it is possible to decide at what 
stage in development a given anomaly has appeared. 
Lung growth is influenced by various hormones, such as glucocorticoids, sex 
hormones, thyroid hormones, and growth hormone. Glucocorticoids enhance lung 
maturation and increase surfactant production."' Thyroid hormones have been 
recognized as important agents in stimulating septation of alveoli and DNA 
synthesis in lung cells of newborn rats.114•115 
I .5 .3 Pulmonary vascular bed 
Recently, deMello and Reid emphasized the pre- and postnatal development of 
pulmonary circulation."' The acinus is the unit of the lung supplied by a terminal 
bronchiolus. The respiratory bronchioli, the alveolar ducts, and the distal alveoli are 
part of it. The pulmonary artery supplies the intra-acinar structures; the capillary 
bed begins only at the level of the respiratory bronchiolus. The bronchial artery 
supplies the capillary bed within the bronchial wall and the structures of the 
perihilar region. The intrapulmonary structures drain to the pulmonary vein, 
whereas the hilar structures drain to the bronchial veins and to the azygos system. 
The pulmonary arteries run together with the airways but give off more 
branches, so that ''conventional"' and "supernumerary" branches can be distinguished. 
The former are eventually distributed beyond the level of the terminal bronchiolus, 
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whereas the latter supply the capillary bed of alveoli immediately around the 
pulmonary artery. The process of pre-acinar branching follows branching of airways 
and is completed by 16 weeks of gestation. The intra-acinar arteries develop later in 
fetal life and continue to form after birth as the alveolar ducts and the alveoli 
develop. 
During fetal life, the walls of muscular and partially muscular pulmonary arteries 
are thick. The wall structure is related to the diameter of an artery, and relatively 
few intra-acinar arteries contain muscle. As new arteries are formed, they acquire a 
muscle coat corresponding with their diameter. The number of muscularized arteries 
increases, but the muscle coat of each individual artery does not thicken. The 
structure of the fetal pulmonary vascular bed reflects the high pulmonary vascular 
resistance and the low pulmonary blood flow characteristic of fetal life. 
The main features of adaptation to the postnatal period are concerned with 
maturation, adaptation to air breathing, and a major increase in pulmonary blood 
flow. After birth the pulmonary vascular bed is remodeled in order to effect an 
abrupt reduction in pulmonary vascular resistance. Postnatal adaptations can be 
classified into three different stages."' 
The first stage, from birth to the first three or four days of life reflects the 
adaptation to extrauterine life. The wall-thickness of the peripheral pulmonary 
arteries will decrease during the first weeks of life'"; more recent reports show that 
adaptation actually involves the entire arterial pathway, including the elastic and 
large muscular conducting arteries in addition to the arteries just proximal to the 
respiratory unit.'" Major roles seem to be reserved for the precapillary arteries. 
These vessels consist of endothelial cells surrounded by pericytes. They become 
thinner within minutes after birth, resulting in a thinner vessel wall and a larger 
lumen diameter.'" Similar structural changes occur in the small muscular arteries 
where smooth muscle cells show a significant reduction in diameter during the first 
month of life."' 
The second stage shows structural stabilization lasting until 3 to 4 weeks of age. 
Connective tissue is deposited, and the definitive elastic lamina is formed in the 
small muscular arteries. 
The third stage is growth continuing into adulthood. This stage is characterized by 
an increase in arterial diameter, which reflects cell multiplication. The main burst of 
growth is seen within the acinus. Smooth muscle cells in the respiratory unit 
arteries differentiate from precursor cells, and muscle cells extend all along the 
arterial pathway with growth. The prominent intra-acinar arteries increase in size, 
and new alveolar wall vessels grow to supply the increasing gas-exchange area. The 
process of adaptation and growth during these stages is also known as growth by 
"fits and starts".111 
At birth almost the entire pulmonary vasculature bed is innervated. Nerve trunks 
run in the adventitia of the large arteries and veins. Both noradrenergic and 
cholinergic nerves are identified, containing several transmitters such as vasoactive 
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intestinal peptide and calcitonin gene-related peptide in the extrapulmonary 
arteries. 122•123 
1.5.4 Surfactant 
The existence of lung surfactant and its function were reported in 1950.'" Surfactant 
has at least four important functions: (a) to stabilize the lung during deflation, (b) to 
prevent high surface-tension pulmonary edema, (c) to protect the lung against 
damage, and (d) to assist in the defense mechanisms of the lung. The alveolar 
surfaces are lined with extended, thin epithelial type I cells and with the more 
cuboidal type II cells. Autoradiography studies with various labeled precursors of 
surfactant have shown that surfactant is produced by the type ll cells.'" Surfactant 
consists of a number of lipids, primarily dipalrnitoylphosphatidylcholine, and a 
number of surfactant-specific proteins (SP-A, SP-B, SP-C). These proteins have both a 
surfactant function and a non-surfactant function; they are probably involved in the 
homeostatic control of surfactant in the alveolus, and they have a potential defense 
function.1::6 
At 24 weeks of gestation type II cells are able to take up metabolic precursors 
and to produce the lipid and protein components of surfactant. They are also able 
to package these components in lamellar bodies: their storage and secretory 
organelle. Saturated phosphatidylcholine is present early in whole lung extracts and 
increases in level after 24 weeks.127 
The process of development and accelerating synthesis is under control of 
hormones like glucocorticoids and thyroid hormones.'" Secretion of surfactant is 
regulated by several hormones and other agents."' The fetus releases large amounts 
of surfactant during labor and shortly after delivery.'"' During the last weeks of 
gestation there is an increase in adrenergic receptors in the lung, suggesting that the 
catecholarnines may play an important role in the control of secretion.'" 
The development of surfactant replacement therapy started in the late 1950s after 
the original observation of Avery and Mead that neonatal respiratory distress 
syndrome was associated with the absence or delayed appearance of pulmonary 
surfactant.'" This study initiated further research into the ontogeny of the surfactant 
system and into the possibilities of surfactant replacement therapy. Highlights were 
the reports of Enhorning and Robertson, who showed improvement of pulmonary 
mechanics in prematurely born rabbits after the application of whole surfactant."' In 
1980, Fujiwara published promising results of the treatment of newborns with an 
exogenous surfactant isolated from bovine lung.'" Since that time several studies 
have been undertaken to define the optimal composition and mode of application of 
surfactant in prematurely born infants.'"·'"' Surfactant replacement therapy may have 
other indications in the neonatal or pediatric intensive care unit, such as shock lung 
syndrome~ meconium aspiration syndrome, and pneumonia.137 
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155 Antioxidant defense 
Marx's statement that "breathing oxygen is, it seems, hazardous to your health", is 
certainly applicable to the newborn infant.'" At birth the fetus leaves the quite 
hypoxic in utero environment for the relatively hyperoxic environment of the outside 
world. It therefore seems necessary that the fetal lung develops sufficient antioxidant 
defenses to prepare against potential oxygen-induced cytotoxicity when breathing 
begins. 
An oxygen free radical is defined as any species capable of independent existence 
that possesses one or more unpaired electrons.'" Induction of oxidant stress can 
occur due to raising ambient oxygen concentrations, toxins that augment 
intracellular oxidant formation, and ischemia followed by tissue reoxygenation."0 
Normally there is a balance between the toxicity of oxidants such as superoxide 
radical (0,·-), hydrogen peroxide (H,O,), and hydroxyl radical (HO-), and the 
protective activities of antioxidant defense mechanisms. The cell can protect itself 
against free radicals by enzymatic conversion of free radicals to nontoxic products, 
nonenzymatic scavenging, and compartmentalization. The intracellular antioxidant 
enzyme system consists of superoxide dismutase (SOD), catalase, and the glutathione 
redox cycle (glutathione peroxidase, glutathione reductase, and glucose-6-phosphate 
dehydrogenase). Superoxide dismutase handles superoxide, catalase is involved in 
the elimination process of hydrogen peroxide, and glutathione reduces hydrogen 
peroxide to H,O. The nonenzymatic agents can be distinguished into water-soluble 
and lipid-soluble compounds. Vitamin E is the major lipid-soluble antioxidant, 
vitamin C the major water-soluble antioxidant. Compartmentalization is mainly 
related to the binding of iron and copper. Iron is bound to transferrin and 
lactoferrin outside the cell, and to ferritin within the cell. Copper is predominantly 
bound to ceruloplasmin."' 
The developmental course of the antioxidant enzyme system is remarkably 
similar to that of the surfactant system. The levels of the three antioxidant enzymes, 
- SOD, catalase, and glutathione reductase - increase during the last part of 
gestation. Tanswell found an increase with advancing gestational age in rats and 
concluded that maturation of the antioxidant enzyme system is virtually complete 
before delivery."' These observations have been confirmed by Gerdin and 
coworkers.143 
The first studies in fetal rats were followed by a demonstration of identical 
developmental patterns in other species. Frank found late gestational elevations of 
antioxidant enzyme levels in rats, hamsters, rabbits, and guinea pigs; he concluded 
that these changes represent a normal preparation for birth."' Frank also pointed out 
that investigation of the antioxidant enzyme system should not be aimed at baseline 
(normoxic) conditions only, but also at hyperoxic conditions. He found that term 
neonatal rats were able to induce antioxidant enzyme activity, whereas adult rats 
were not."' He also studied the ability of premature rabbits to induce antioxidant 
1.6 DISTURBED DEVELOPMENT 
________________________________ n 
enzyme activity in reaction to hyperoxia and found that unlike term rabbits, preterm 
rabbits were not able to increase the production of antioxidant enzymes.'"' Other 
studies revealed that intrauterine growth-retarded rats had decreased levels of 
glutathione peroxidase, and increased susceptibility to pulmonary oxygen toxicity.'" 
The late gestational developmental pattern of antioxidant enzyme activity may be 
"switched on" by the same hormonal regulation mechanisms that account for the 
surfactant system. In vitro this could be demonstrated in rats."" The question 
remains how to translate this advancement in knowledge to the newborn infant. 
1.6 Develapmental aspects in congenital diaphragmatic hernia 
!.6.1 Diaphragm 
Several theories have been described to explain the diaphragmatic defect. Grosser 
supported the theory of improper development of the pleuroperitonea! membrane.'" 
Holder suggested a failure of muscularization of the diaphragm resulting in a weak 
area.'50 A recent morphologic study, however, showed no pathological findings that 
favor these theories."' Infiltration of the intestinal organs is a theory described in 
1943."' Gattone and coworkers suggested that lung tissue could be present in the 
pleuroperitoneal canal at the moment of closure resulting in a diaphragmatic 
defect."' Kluth and coworkers proved that closure of the diaphragm in the normal 
Sprague-Dawley rat takes place in two layers.'" At the moment, the most exciting 
theory is the one proposed by lritani; he suggested that lung hypoplasia may be 
merely the cause of the diaphragmatic defect rather than the result."' 
.1.6.2 Gas exchange area 
Potter described pulmonary hypoplasia as a circumscript entity in anencephaly and 
renal anomalies.'" Soon thereafter, morphometrical studies were carried out to define 
the degree of lung hypoplasia in congenital diaphragmatic hernia patients. 
Campanale found an abnormality variable in size and configuration, with the 
ipsilateral lung showing the most pronounced degree of retardation." A classic, 
detailed study was reported by·Areechon and Reid." They found a reduction in the 
number of bronchial branches, more marked on the affected side, and a reduction in 
the volume of alveoli. This means that the diaphragmatic defect occurs early in 
gestation during the pseudoglandular period, the period of bronchial development. 
Because pulmonary hypoplasia is a poorly defined condition, several attempts 
have been made to establish reliable criteria for the diagnosis. Reale and coworkers 
reported a large study of 80 autopsy cases including 20 patients with congenital 
diaphragmatic hernia: they found decreased mean lung-body weight ratios and 
lower radial alveolar counts.'" Askenazi reported the morphometrical lung analysis 
of 111 patients who had pulmonary hypoplasia and suggested that a lung-body 
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weight ratio of < 0.012 in combination with a radial alveolar count of < 4.1 (75% of 
mean normal count) are reliable diagnostic criteria of pulmonary hypoplasia.'" 
Assessment of pulmonary hypoplasia by DNA estimation was carried out by 
Wigglesworth and coworkers in infants with pulmonary hypoplasia defined 
according to lung-body weight ratio. Lung hypoplasia was associated with lung 
DNA content low for gestation. In infants with hypoplastic lungs born at 34-39 
weeks of gestation DNA values were equivalent to those seen in normal fetuses at 
20-22 weeks of gestation.'" In another study, including two infants with congenital 
diaphragmatic hernia, the quantitative biochemical criteria for lung growth and 
maturation were compared with the histological appearances. The hypoplastic 
ipsilateral lung had an immature structure with low phospholipid concentrations, 
whereas the contralateral lung was structurally and biochemically more mature. '59 
The observation that the lungs of congenital diaphragmatic hernia survivors showed 
overdistension and emphysema, has drawn attention to the terminal lung unit in 
congenital diaphragmatic hernia.'" 
George and coworkers assessed the maturity of the lungs in 10 infants with 
congenital diaphragmatic hernia who died in the immediate perinatal period. They 
showed that the lungs were all immature, the ipsilateral lung being most affected. 
The radial alveolar count was reduced in all cases, and they stated that hypoplasia 
is not only characterized by deficient airway generation but also by acinar 
hypoplasia. In several patients they also found hyaline membranes, despite term 
gestation.'" These observations were confirmed by others, who also found absence 
of elastic fibers in alveolar septa of the ipsilateral lung."' This could be an 
important observation because elastic fibers might be involved in the process of 
septation of alveoli."" 
Mechanical factors that have been associated with late gestational lung growth 
include available space (fetal compression), amniotic and lung fluid volume, and 
fetal breathing movements. The classic theory of available space in congenital 
diaphragmatic hernia points at compression of the developing lung by the herniated 
viscera, beginning early in gestation. This situation has been mimicked in fetal 
lambs, after which pulmonary hypoplasia could be shown.59 Fetal breathing 
movements are important for lung development, probably by the mechanism of 
stretch.1~ 
In conclusion: there is evidence that the hypoplastic congenital diaphragmatic 
hernia lung is immature, both in structure and in function. 
1.6.3 Pulmonary vascular bed 
One of the major clinical problems in congenital diaphragmatic hernia is persistent 
pulmonary hypertension. The structural basis of persistent pulmonary hypertension 
has been emphasized by Geggel and Reid.'"' They distinguish between 
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maladaptation, excessive muscularization, and underdevelopment of the pulmonary 
vascular bed. 
In case of maladaptation there is a structurally normal vascular bed, but no 
normal, postnatal increase in compliance of the small muscular arteries. The neonatal 
pulmonary vascular bed is highly reactive, and acidosis, hypoxia, and hypercarbia 
may all contribute to pulmonary vasoconstriction and create a vicious circle of 
ongoing persistent pulmonary hypertension, which is thought to be caused by 
mediators such as the prostanoids, and is associated with acute perinatal stress."" 
Excessive muscularization is characterized by an increase of medial wall thickness 
of normally muscularized intra-acinar arteries and by extension of muscularization 
into nonmuscular arterioles. This form has been mentioned in chronic intrauterine 
hypoxia, and in in utero closure of the ductus arteriosus.167 
Underdevelopment of the pulmonary vascular bed may occur in several conditions 
associated with pulmonary hypoplasia, for instance congenital diaphragmatic hernia. 
Early reports on the pulmonary vascular bed in congenital diaphragmatic hernia 
mentioned increased mean wall thickness compared to normal newborns, but no 
extension of muscle into the intra-acinar arteries." In 1978, Levin reported a 
morphologic analysis of the pulmonary vascular bed in congenital diaphragmatic 
hernia and found: (a) a decrease in total size of the pulmonary vascular bed, (b) 
increased pulmonary smooth muscle, and (3) a decrease in the number of vessels 
per unit of lung.'"' In earlier studies he suggested the possibility that mechanical 
distortion of the fetal ductus arteriosus may cause partial constriction, resulting in 
fetal pulmonary hypertension due to excessive muscularization.'69 Geggel was able to 
demonstrate that abnormalities of the pulmonary vascular bed in patients who have 
persistent hypoxemia differ from those in patients who at first maintain normal 
blood gas values postoperatively, but after the so-called honeymoon period become 
hypoxemic. No-honeymoon patients have smaller lungs, increased muscularization of 
intra-acinar arteries; and decreased luminal area of pre-acinar and intra-acinar 
arteries due to reduced external diameter. Geggel concluded that clinical 
deterioration in the honeymoon group depends on a vasoconstrictive response of the 
hypoplastic vascular bed. Persistent hypoxemia in the no-honeymoon group is 
determined by the severity of pulmonary hypoplasia and by the structural 
remodeling of pulmonary arteries.'" The consequences for the clinical course in these 
patients and the significance of these observations in terms of mortality risk has 
been emphasized by Shochat."' 
Various animal models were developed to gain more insight in the 
developmental pathophysiology of abnormal pulmonary circulation associated with 
congenital diaphragmatic hernia. Changes of the pulmonary vascular bed have been 
demonstrated in fetal lambs. Fetal surgical repair of the hernia restored the 
pulmonary arterial bed, probably through compensatory lung growth." A major 
disadvantage of the lamb model is that interference takes place in a relatively late 
stage of otherwise normal lung development. Others found 'similar results in a fetal 
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rabbit modeL" Notwithstanding all this, our knowledge of the morphology of the 
pulmonary vascular bed and the pathophysiology of persistent pulmonary 
hypertension is still limited, especially on the cellular level. 
1.6.4 Surfactant and antioxidant defense 
Reports on biochemical maturation of the lung in congenital diaphragmatic hernia 
are scarce. Hisanaga and coworkers observed low lecithin/sphingomyelin ratios (056 
and 057 respectively) in two infants with a congenital diaphragmatic hernia. They 
argued that lung hypoplasia actually means a reduced number of type Il 
pneumocytes and reduced production of surfactant."' The lecithin-sphingomyelin 
ratio reflects to some extent the maturation of the fetal lung. The question remains, 
however, whether ratios are low because of the total reduction in lung tissue or 
because the type Il cell in congenital diaphragmatic hernia functions at a lower 
level. The . type II cell has been extensively studied, and reduced numbers of these 
cells as w~U as fewer lamellar bodies per cell have been associated with lung 
immaturity."' Hashimoto and Pringle investigated the morphologic characteristics of 
the type II cell in a fetal lamb model of congenital diaphragmatic hernia. 
Surprisingly, they found that type II cells were five to ten times more abundant in 
the lungs of animals with a diaphragmatic defect. No ultrastructural changes of 
immaturity were observed in type II cells."' 
Further studies into lung surfactant production in the fetal lamb with congenital 
diaphragmatic hernia showed: (1) a marked decrease in pulmonary compliance, (2) a 
reduction of the total amount of phospholipid in bronchoalveolar lavage fluid, and 
(3) a reduction in the synthesis rate of phosphatidylcholine by type II cells."' The 
authors concluded that congenital diaphragmatic hernia in the fetal lamb leads to 
profound lung hypoplasia and apparent immaturity of the surfactant system. 
In neonatal rats congenital diaphragmatic hernia was induced by feeding of 
Nitrofen to the mothers during gestation. Their lungs showed hypoplasia and lower 
content of disaturated phosphatidylcholine per jlg DNA and total disaturated 
phosphatidylcholine.'" 
To our knowledge there are no reports on the maturation of antioxidant enzyme 
activity in the presence of congenital diaphragmatic hernia neither in humans nor in 
animal models. 
1.7 Treatment 
Management of the fetus with congenital diaphragmatic hernia has been recently 
emphasized by Caplan and MacGregor." Antenatal management requires fetal 
karyotyping, assessing of the degree of herniation, locating of the stomach, and 
ultrasound evaluation for associated anomalies. The findings will determine 
antepartum and intrapartum management. In fetuses with a normal karyogram and 
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no additional lethal anomalies, follow-up sonograms are needed and maternal 
transport to a specialized tertiary center should be strongly considered. Some centers 
consider prenatal diagnosis of congenital diaphragmatic hernia before week 20 as an 
indication to advise the parents to terminate pregnancy, especially when other 
congenital anomalies have been detected as well. Only a multidisciplinary team 
approach can provide optimal information for the parents and adequate care for the 
yet unborn patient. 
Delivery is generally planned after 37 weeks' gestation, and vaginal delivery is 
usually preferred."' In patients symptomatic at birth, initial resuscitation in the 
delivery room should be aimed at stabilization while preparing for transport to the 
intensive care unit. A nasogastric tube is inserted to minimize gaseous distension of 
the bowel. Assisted ventilation is preferably administered via an endotracheal tube, 
because handbagging the patient with a mask will aggravate respiratory distress due 
to increasing abdominal distension.171~ 
In tc'le past, emergency surgical repair was the cornerstone of therapy. In the past 
few decades, however, one has gradually become aware that congenital 
diaphragmatic hernia is not an acute event, but rather an anomaly developing early 
in fetal life. The major cause of death is related to abnormal lung development. 
The clinical picture shows respiratory distress as a consequence of lung 
hypoplasia, and persistent pulmonary hypertension with right-to-left shunting as a 
consequence of the abnormal vascular bed. 
After Cartlidge observed that preoperative stabilization might improve the 
outlook, several groups have adopted the delayed surgical approach as a better 
treatment option." This concept has led to ventilation of patients under muscular 
paralysis and sedation. The stomach and the bowel are decompressed by continuous 
suction using a nasogastric tube with a double lumen. Adjustment of ventilatory 
settings including high respiratory rates (60-150 I min) is meant to avoid risk factors 
for persistent pulmonary hypertension. Therefore the objectives are: arterial pH 
values of 7.50 or higher, a PaCO, between 25 and 30 mmHg, and a PaO, between 
100 and 150 mmHg."" Metabolic acidosis is treated vigorously with sodium 
bicarbonate, and further alkalinization is aimed at pH values of 7.50-7.55. Circulatory 
stability may be achieved by administration of vasoactive drugs such as dobutamine 
and dopamine. Monitoring of pre- and postductal arterial blood gas values with 
indwelling catheters or transcutaneous PO, monitors is essential to establish 
persistent fetal circulation. In spite of all these efforts, delayed surgery has not 
brought the expected significant decrease in mortality."·"" 
The recognition of persistent pulmonary hypertension as a major factor 
contributing to death in these patients coincided with the application of ECMO in 
neonatal respiratory failure. In most cases of persistent pulmonary hypertension, the 
infant can be successfully treated by aggressive ventilation with high inspiratory 
pressures, high percentages of oxygen, and induced alkalosis by means of 
hyperventilation."' For those in whom conventional therapies fail, ECMO has 
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provided new chances of survivaL ECMO is the temporary use of an artificial lung 
and provides "lung rest" together with the possibility to overcome episodes of 
persistent pulmonary hypertension in the honeymoon period. 
Many authors have proposed special techniques for postoperative management, 
such as balanced thoracic drainage and reconstruction of the dome of the diaphragm 
with a prosthetic patch to prevent enlargement of the hemithorax, with 
overexpansion of the hypoplastic lung. They all report higher survival rates.""'" 
Others have tried to define accurate predictors of mortality based on pH, PCO, 
(A-a)DO, or best preductal or postductal PO,."·'"' Bohn used ventilatory parameters 
by plotting PCO, versus ventilation index (respiratory rate x mean airway 
pressure)." This method was reliable in the pre-ECMO period when patients who 
deteriorated after a stable interval or who never stabilized at all, usually died. The 
introduction of ECMO complicated this predictive modeL 
Wilson and coworkers examined the severity-of-illness parameters in 59 patients. 
They confirmed earlier observations that the best postductal PO, is an accurate 
predictor of mortality with values < 100 mmHg associated with death: depending, 
however, on the degree of ventilation and alkalosis. They introduced the 
oxygenation/ventilation index [(PO,/mean airway pressure x respiratory rate) x 100] 
and found this a reliable, objective predictor of mortality."'' 
1 .8 Follow-up 
There is increasing awareness that long-term morbidity in congenital diaphragmatic 
hernia survivors is related to the aggressive mode of treatment. The interaction 
between positive pressure ventilation with high percentages of oxygen and the 
hypoplastic and dysplastic lung may cause iatrogenic lung injury. Lung development 
may consequently be disturbed and its function may remain compromised in 
adulthood. Several observations support this hypothesis. The vulnerability of the 
hypoplastic lung in the direct postoperative period was already noticed in an animal 
model developed by DeLuca and coworkers.'" Thurlbeck described a boy, who, 
when a newborn, had undergone an operation for left-sided congenital 
diaphragmatic hernia, but died because of an accident at the age of five. The study 
showed normal histology in the right lung, but parts of destructive emphysema in 
the left lung.'"" 
Long-term function studies show that although these patients are doing well and 
are functioning normally, the majority show a 20 to 30% reduction of normal lung 
function.'" Falconer reported on 19 survivors operated on during the late 1970s, and 
found an increasing incidence of chest symptoms, subjective exercise intolerance and 
expiratory wheeze. Median values for maximum expiratory flow-volume curves were 
lower compared to controls. Radiographic left lung volumes suggested 
overdistension and nuclide scans revealed perfusion of the ipsilateral lung. Highly 
abnormal results were found in the patients who had been ventilated for four days 
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or more.'" Although a morphometrical analysis of a large number of congenital 
diaphragmatic hernia lungs is lacking, several authors report the existence of hyaline 
membranes and thickened alveolar and intra-alveolar walls. 
In other words, the usually term congenital diaphragmatic hernia lung reacts 
similar to artificial ventilation as the lung of the premature infant."·'" Nowadays 
infants with even more severe hypoplastic lungs reach the specialized center, where 
they are subjected to aggressive treatment. From this point of view, it is noteworthy 
that Northway observed that most adolescents who had bronchopulmonary 
dysplasia in infancy have some degree of pulmonary dysfunction, consisting of 
airway obstruction, airway hyperreactivity, and hyperinflation.'" What this 
observation means for the congenital diaphragmatic hernia survivor with hypoplastic 
lungs, having survived either with or without ECMO, is not clear at the moment. 
Another aspect of long term morbidity in congenital diaphragmatic hernia 
survivors is the presence of gastro-esophageal reflux. It has already been noted that 
some fetuses with congenital diaphragmatic hernia develop polyhydramnios and that 
this is associated with poor prognosis." Stolar reported a massive esophageal 
dilatation in congenital diaphragmatic hernia survivors and related this to the 
possibility of a kinked gastro-esophageal junction; this could explain fetal 
swallowing dysfunction leading to polyhydramnios."0 In another study Stolar 
demonstrated symptomatic gastro-esophageal reflux in 69% of tested congenital 
diaphragmatic hernia survivors; all but one patients were manageable with 
conservative therapy without needing anti-reflux surgery.'" 
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2.1 Summary 
ETIOLOGICAL ASPECTS OF 
CONGENITAL DIAPHRAGMATIC HERNIA: 
RESULTS OF A CASE COMPARISON STUDY 
Congenital diaphragmatic hernia is a serious mal£ormation with an unknown 
etiology. The present study was aimed at the identification of possible risk factors 
such as occupational or environmental exposure to chemicals and herbicides as well 
as the use of medications during pregnancy. One of such herbicides is Nitrofen, a 
compound with a strong teratogenic potential that interferes with lung development 
in rats and greatly resembles thyroid hormone. A parental questionnaire about 
teratogenic risk factors and maternal thyroid dysfunction during pregnancy was 
completed by 33 parents whose baby had congenital diaphragmatic hernia, and by 
43 couples whose baby had esophageal atresia. No association with the studied 
teratogens nor with maternal thyroid dysfunction was found in either group. The 
resemblance of Nitrofen with thyroid hormone, a well-known growth factor for the 
developing lung, is of particular interest from a pathogenetic point of view in the 
development of CDH. Whether lung hypoplasia is the result of the diaphragmatic 
defect or primarily the cause of failure of the diaphragm to close, remains to be 
elucidated. The inability to identify teratogenic factors causing CDH still is of value 
in counseling the parents. 
2.2 Introduction 
Congenital diaphragmatic hernia (CDH) is a serious malformation characterized by a 
diaphragmatic defect and bilateral lung hypoplasia.' In the Netherlands its incidence 
is estimated one in 3000 liveborns, which implies that yearly circa 70 newborns will 
present with this defect. Its mortality rate amounts to 40%. Recent changes in 
therapeutic approach, such as delayed postnatal surgery after stabilization, and 
extracorporeal membrane oxygenation, have not improved the outlook." 
The etiology of CDH in the human newborn remains largely unknown', but in 
animal models several teratologic processes including exposure to chemicals have 
been found to induce the induction of CDH.5 The present study was undertaken 
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because within a few months an unusual high number of five newborns from a 
circumscript area with heavy industry and intensive agriculture and market-
gardening were admitted with CDH. In these areas fertilizers and herbicides are 
extensively used. Nitrofen (2,4-dichlorophenyl-p-nitrophenyl ether) is a herbicide 
with a strong teratogenic potential that in rats interferes with lung development 
resulting in bilateral lung hypoplasia and induces anatomical malformations 
including diaphragmatic hernias.' 
The stereo-chemical configuration of Nitrofen greatly resembles that of 
triiodothyronine (T,) and thyroxine (T,) (Figure). Application of Nitrofen leads to a 
decrease in thyroid stimulating hormone (TSH) and T, of the pregnant rat as well as 
a decrease in T, and increase in T3 in the rat fetus.' Thyroid hormone is a well-
known trophic factor for normal lung development and alveolar cell differentiation. 
Moreover, maternal hypothyroidism has been associated with an increased risk for a 
variety of birth defects in offspring', but information on its role in CDH is lacking. 
In this study we report the results of a parental questionnaire concerning 
possible etiological and teratologic factors in the development of CDH. The 
questions inquired after the use of medications during pregnancy, exposure to 
occupational and environmental chemicals (Addendum I and II) and the history of 
maternal thyroid disease. In addition we studied the presence of antibodies against 
thyroid microsomes and thyroglobulin in mothers that had given birth to babies 
with CDH. 
23 Patients and Methods 
The Sophia Children's Hospital is a tertiary referral hospital with a 13-bed Pediatric 
Surgical Intensive Care Unit (PS!CU). The hospital serves a region with a population 
of ± 3 million inhabitants, and an annual birth rate of approximately 35.000 new-
borns. All live-born neonates with structural life-threatening congenital anomalies are 
admitted to this PSICU. We approached all parents of children with a posterolateral 
CDH admitted from 1984 to 1990; stillborns were excluded. We decided to take 
patients with an esophageal atresia (EA) admitted in the same period as a control 
group, since EA has a similar distribution of referral in the area. ln the study 
period 48 patients with a diaphragmatic defect and 66 patients with EA were 
admitted. 
All parents were approached by phone to ask their participation in the study and 
after their consent they received a questionnaire, consisting of 72 items. Questions 
were asked related to potential teratologic data: marital status, family planning, 
contraception, treatment for delayed fertility, complications and illnesses during 
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gestation, way of delivery, occupation and social class, drug abuse, alcohol abuse, 
smoking, medications, X-rays, and contact with hazardous compounds in home 
environment and occupational environment. Reference lists were included with the 
names of 40 chemicals and 42 commonly prescribed drugs (Addendum I and II). 
All questionnaires were evaluated after completion, by one of us (APB), and 
additional information was obtained by phone when answers were not clear. Sta-
tistical analysis was based on chi-square analysis of contingency tables using the 
StataPC program (Computing Resource Center, Los Angeles, California, USA). Statis-
tical significance was accepted at p<O.OS level. 
Blood was drawn immediately postpartum from nine mothers, chosen at random 
from each group, and maternal antibodies were determined against thyroglobulin 
and thyroid microsomes (Thymune test, Wellcome, United Kingdom), and TSH 
receptors (TRAK assay, Henning, Berlin). 
2.4 Results 
Questionnaire 
The final study group consisted of 33 couples (response rate 68%) whose baby had 
CDH, and 43 couples whose baby had EA (response rate 65%). The results are given 
in table 1 and 2. The data show that mothers with a newborn with EA usually 
underwent prenatal sonography, probably because of polyhydramnios, and were 
given specialized obstetrical care in a hospital. The incidence of ovulation induction 
procedures and spontaneous abortions in these mothers was higher than in CDH 
mothers. The number of prescribed medications during pregnancy was higher in fat-
hers and mothers (in the first month of pregnancy only) of CDH newborns. The 
type of drugs taken ranged widely and no specific association was found to be 
significant. 
None of the mothers from either group, suffered clinically from chronic thyroid 
dysfunction. 
Thyroid antibodies 
Antibodies against thyroglobulin and TSH receptors were negative in all tested 
mothers of both groups. Antibodies against microsomes were also negative in all but 
one mother of a patient with a diaphragmatic defect. 
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Table1. Differences between potential risk factors 
in CDH and EA patients 
Before pregnancy p 
Marital status 0.5 
Consanguinity 0.3 
Incidence of illness 0.6 
Induction of ovulation O.D7 
Contraception, type of 0.8 
Delayed conception 0.1 
Pregnancy 
Obstetrical care EA> CDH 0.03• 
Polyhydramnios EA> CDH 0.001• 
Ultrasound EA> CDH 0.003• 
Admission to hospital EA> CDH 0.05• 
Hospital delivery EA> CDH 0.09 
Dietary prescriptions 0.6 
Illnesses 
Ru, febrile disease 0.7 
Cystitis 0.1 
'Fainting' EA>CDH 0.04 
Diabetes gravidarum 0.8 
Emesis 0.5 
Ruxus 0.4 
Fever EA> CDH 0.04 
Hypertension 0.7 
Excessive weight gain 0.6 
•p < 0.05 
2.5 Discussion 
CDH is associated with a number of chromosomal, genetic, and nongenetic patterns 
of malformation and it seems likely that CDH is a non-specific consequence of 
several teratological processes-' 
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Table 2. Differences between teratologic data 
in CDH and EA patients 
Mother 
Alcohol 
Smoking 
Prescribed medications 
(first 4 wks of pregnancy) 
Father 
Alcohol 
Smoking 
Prescribed medications 
Residential area 
Polluted area 
Degree of industrialization 
Contact with herbicides 
Isolation of housing 
Occupational area 
Polluted area 
Industrialization 
Contact with herbicides 
Working with monitor-screens 
•p < 0.05 
CDH>EA 
CDH>EA 
p 
0.4 
0.7 
0.05 
0.2 
0.1 
O.D15• 
0.7 
0.2 
0.7 
0.5 
0.4 
0.6 
0.6 
0.8 
Chemically-induced birth defects account for only 5 % of birth defects observed 
in the population." It remains worthwhile to identify potentially hazardous 
chemicals in the environment in order to minimize the risk of congenital malfor-
mations. In this era of heavy industrialization and pollution the number of environ-
mental factors interfering with the developing fetus in early gestation, may have 
increased. A short report on the incidence of CDH in Avon (UK) suggests an increa-
sing frequency of this defect." 
The herbicide Nitrofen is a potent teratogenic agent in rodent species. Although 
Nitrofen has been withdrawn from the Dutch market in 1984 because of its 
teratogenic properties, it is still used in other parts of the world. Exposure to 
Nitrofen leads to cardiac and kidney malformations as well as diaphragmatic defects 
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O~CHz-CH-COOH O~N~ -I ~-
1 NH2 
3, 5. 3', 5'-tetraiodolhyronine 
(T4) 
3, 5, 3'-triiiodothyronine 
(T3) 
2, 4-dichloro-4'-nitro-diphenyl ether 
(nitrofen) 
4 hydroxy-2,5-dichloro 4'-amino-
diphenyl ether (met#1) 
Figure. Stereochemical structures of thyroid honnones, Nitrofen, and metabolite #1. From 
Manson (1984), with permission. 
in the offspring of pregnant rats.' Nitrofen affects the cellular and structural 
development of the fetal lung resulting in bilateral lung hypoplasia.''-" The exact 
mechanism of teratogenesis is not known but evidence is accumulating that the 
teratogenic effects are mediated via alterations in thyroid hormone status. In vitro 
binding studies show that Nitrofen competes with and replaces T, from its nuclear 
receptor (Brandsma et al, unpublished observations). After in utero exposure 
Nitrofen may interact with the embryonic nuclear receptors for thyroid hormone 
because it resembles .thyroid hormone in structure (Figure). The interaction could 
interfere with lung differentiation and lung growth, and cause pulmonary 
hypoplasia in the fetus.' 
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This hypothesis links pulmonary hypoplasia and CDH with thyroid hormone 
status, and consequently, congenital defects with maternal thyroid disease. Maternal 
thyroid disease has been associated with an increased risk of birth defects, but 
reports on the subject are rather controversial." A large population-based, case-
control study over a 12 year period showed that there was no relationship between 
the risk of birth defects and history of maternal hypothyroidism. In babies with 
multiple congenital anomalies a two-fold increased risk with hypothyroidism was 
found, but no discernible pattern of defects.' It is also known that an intact thyroid 
gland is essential for normal lung development during gestation.'' Increased levels 
of thyroglobulin antibodies and thyroid microsomal antibodies were associated with 
pregnancies affected with Down's syndrome." In this study, neither an increased 
incidence of thyroid dysfunction was found, nor were antibodies detected against 
thyroglobulin, microsomes, and TSH-receptors in mothers of CDH patients. These 
findings do not support the hypothesis that maternal hypothyroidism is a risk factor 
for the development of lung hypoplasia or CDH. 
During pregnancy, the EA group showed a higher incidence of polyhydramnios 
and subsequently more ultrasound examinations, hospital admissions, hospital 
deliveries, and care by a gynecologist. This is especially relevant to the current 
study because, in the Netherlands, 40% of deliveries takes place at home supervised 
by a midwife or a general practitioner, unless gestation is complicated by e.g. 
polyhydramnios. No teratologic differences between the groups were shown other 
than the incidence of prescribed medications to CDH parents during the first 4 
weeks of gestation. Etiological studies in Hungary on isolated EA compared to 
normal controls also failed to show an association with studied teratogens." 
To enable further research into the etiology of CDH, the actual moment of 
maldevelopment should be defined first: absent closure of the diaphragm and 
subsequent pulmonary hypoplasia, or an alternate pathogenetic mechanism with 
primary poor development of the lung bud and subsequent delay of closure of the 
pleuroperitonea! membrane, as has been suggested by lritani." The role of thyroid 
hormone status and that of thyroid hormone receptors in lung tissue and their 
relation with the development of lung hypoplasia in fetuses with CDH remains to 
be elucidated. 
In conclusion, no etiological factors could be identified that are associated with 
either the development of CDH or EA. The birth of an infant with a congenital 
malformation will present the parents with complex emotional reactions", such as 
reproach and lack of understanding. The fact that etiological relationships were not 
identified still can be of value in counseling the parents. 
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Addendum I 
List of drugs 
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Agre-gola~ 
Algesal~ 
AntrenylK 
APCK 
Ascal' 
AugrnentinK 
BactrimelR 
BroxilK 
BuscopanK 
Canesten~ 
Clamoxyl11 
Coldrex11 
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Glifanan~< 
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Hedex~< 
MetamudlK 
Mogadon11 
Nizoral11 
Noctamid11 
NormisonK 
Seresta11 
Valdisperf 
ValiumK 
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Semen Plantaginis Ovatae, 
Fructus Cassiae 
Cetylpyridinium Chloride, 
Diethylarninesalicylate 
Oxyphenonium Bromide 
Acetylsalicylic Acid, 
Caffeine, Paracetamol 
Carbasalate Calcium 
Amoxycillin. Clavulanic 
Acid 
Trimethoprim, 
Co-trimoxazole 
Phenetidllin 
Hyoscine Butylbromide 
Clotrimazole 
Amoxycillin 
Acetylsalicylic acid, 
Phenylephrine , Ascorbic Acid 
Miconazole 
Vitamin A-B-E 
Acetylsalicylic Acid, 
Caffeine, Codeine 
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Lactulose 
Ferrous sulfate 
Ferrous sulfate 
Ferrous fumarate 
Paracetamol, Caffeine 
Metronidazole 
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Sodium hydrogenocarbonate 
Glafenine 
Miconazole 
Paracetamol 
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Diazepam 
Addendum II 
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Act:i.l11 
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MesuroJK 
Nitrofen~< 
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RidomilR 
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lMTD' 
TopsinK 
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Trimaton11 
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Paraquat-diquat 
Ioxynil 
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Bitertanol 
Chlorfenvinphos 
Sulfotep 
Carbofuram 
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Methomyl 
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Dinitrophenyl ether 
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Pirirnicarb 
Metalaxyl 
Propetamphos 
Methamidophos 
1,3-dichlorpropene 
Sulphur 
Th.iram 
Thiophanate-methyl 
Fenbutatinoxide 
Metam-sodium 
Copperoxychloride 
Dinoseb 
Formothion 
Endosulfan 
Phosphamidon 
Zineb 
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ANGIOTENSIN-CONVERTING EN2YME ACTIVITY IS 
INCREASED IN LUNGS OF RATS WITH PULMONARY 
HYPOPLASIA AND CONGENITAL DIAPHRAGMATIC HERNIA 
3.1.1 Summary 
Lung hypoplasia and pulmonary hypertension are responsible for the high mortality 
rate in congenital diaphragmatic hernia patients. Angiotensin-converting enzyme 
plays a role in the regulation of pulmonary vascular resistance in the postnatal 
period and might be involved in the development of pulmonary hypertension of the 
newborn. We studied the development of angiotensin-converting enzyme activity 
spectrophotometrically in a rat model of congenital diaphragmatic hernia. In this 
model, it was previously shown that the lungs are hypoplastic and the musculariza-
tion of the pulmonary vascular bed is increased. Congenital diaphragmatic hernia 
was induced in fetal rats by oral administration of 115 mg/kg Nitrofen to the 
mother on day 10.5 of pregnancy. Fetuses were delivered by hysterotomy on day 19, 
20, 21 and 22. We found a 1.5 fold higher activity in Nitrofen-exposed rats com-
pared to controls. Angiotensin-converting enzyme converts angiotensin I to the 
vasoconstrictor angiotensin II, and it inactivates the vasodilator bradykinin. Increased 
angiotensin-converting enzyme activity may therefore contribute to pulmonary 
hypertension. Whether angiotensin-converting enzyme and angiotensin ll levels are 
increased in human newborns with a diaphragmatic defect and whether they 
contribute to the development of persistent pulmonary hypertension, has not been 
studied up till now. 
3.1.2 Introduction 
Pulmonary hypoplasia has been described in various disease syndromes of newborn 
infants, such as Potter's syndrome (kidney agenesis or dysplasia), obstructive 
anomalies of the lower urinary tract or premature rupture of membranes.' 
Congenital diaphragmatic hernia (CDH) is a congenital anomaly that is often 
associated with hypoplasia of one or both lungs. CDH has a high mortality rate of 
over 40 %. The outcome depends either on the severity of pulmonary hypoplasia or 
on the combination of pulmonary hypoplasia with persistent pulmonary 
hypertension (PPH)Y Aggressive artificial ventilation with high percentages of 
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oxygen and high inspiratory peak pressures is often needed. Not only the lung 
parenchyma but also the pulmonary vascular system shows well-defined 
abnormalities consisting of decreased size of the pulmonary vascular bed, increased 
thickness of the pulmonary arterial muscle coat, and a decrease in the number of 
vessels per unit of lung.' These abnormalities may interfere with the normal drop in 
pulmonary vascular resistance postnatally, leading to PPH and persistent fetal 
circulation with right-to-left shunting. 
Angiotensin-converting enzyme and many other vasoactive compounds have been 
associated with the regulation of pulmonary vascular tone in the postnatal period.' 
Angiotensin-converting enzyme is an enzyme located in the endothelial cells of the 
pulmonary vascular bed. It has two effects: (a) it converts angiotensin I to the 
potent vasoconstrictor angiotensin II and (b) it inactivates bradykinin, a vasodilator.' 
In this study we investigated the activity of angiotensin-converting enzyme in an 
animal model of pulmonary hypoplasia and CDH.7 
3.1.3 Materials and methods 
Animal model 
CDH was induced in fetal Sprague-Dawley rats by oral administration of 115 mg 
Nitrofen/kg body wt to the mother at day 10.5 of pregnancy as described 
previously." In this model animals with a diaphragmatic defect show bilateral lung 
hypoplasia (LH) and smaller lung/body weight ratios compared to controls.' There 
are no significant intragroup differences in degree of LH. About 40% of the fetuses 
do not develop CDH, but solely LH. The distinction between animals with CDH 
(group:LH-CDH) and without CDH (group:LH) can only be made after autopsy. 
Fetuses of pregnant rats who were not given Nitrofen served as normal controls 
(group:control). 
Fetuses were delivered by hysterotomy at day 19, 20, 21 or 22 (full term) of 
gestation. After determination of body weight the fetuses were killed by 
intraperitoneal injection of an overdose of pentobarbital (Nembutal; Sanofi, 
Tinderberg, The Netherlands). The presence of a diaphragmatic defect was evaluated 
by autopsy, after which the heart and lungs were removed en bloc, and the lungs 
were perfused with ice-cold 1/15 mol/L phosphate buffer (PBS; pH 7.8) via the 
pulmonary artery under constant pressure to remove the blood from the circulation. 
During perfusion the colour of the lungs changed to pale white. If part of the lungs 
remained pink, which indicated incomplete perfusion, the organs were discarded. 
The perfused lungs were then dissected, stripped of nonpulmonary tissue, weighed, 
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frozen with liquid nitrogen and then stored at -70'C until angiotensin-converting 
enzyme activity was determined. 
Biochemical analyses 
All biochemical analyses were performed on separate fetal lungs. After thawing, the 
lungs were diluted 1:15 (w /v) in ice-cold PBS, and homogenized with a Brinkmann 
Polytron (Brinkmann Instruments, Westbury, NY) for 15 sec at maximum speed. 
Next, the lung suspension was sonicated for 10 sec on ice. In this crude suspension 
concentrations of protein were estimated by Lowry's method using bovine serum 
albumin as a reference." To determine angiotensin-converting enzyme activity the 
crude suspensions were centrifuged at 20 000 x g for 30 min, and the pellets 
discarded." 
Activity of angiotensin-converting enzyme in the lung supernatants was 
determined by the assay described by Neels et aL" In short, 11-fold diluted 
supernatant in buffered substrate solution consisting of 50 mmoi/L HEPES, 300 
mmoi/L NaCI, 400 mmoi/L Na,SO., 30 mmoi/L hippuryl-glycyl-glycine and 2.5 
rnl/L saturated NaOH, pH 8.15, was incubated for 30 min at 37°C in the presence 
(control) or absence of 0.1 rnM EDTA. After a Folin-Wu deproteinization, the 
liberated glycyl-glycine was derivatized with trinitrobenzenesulfonate (1.67 mmoi/L) 
in borate buffer (55.6 mmoi/L, pH 9.3) to form trinitrophenyl-glycylglycine. The 
absorbance was read at 420 nm vs the controL The resulting enzymic activity 
amounted to about ninefold that of the spectrophotometric assay of Cushman & 
Cheung" as modified by Lieberman." One unit (U) of angiotensin-converting 
Table 1. Developmental changes in lung weight of normal fetal rats and of fetal 
rats exposed to Nitrolen with and without a diaphragmatic defect· 
GA n 
Lung weight (mg)a 
(d) control LH LH-CDH 
19 6 42.7 ( 7.8) 39.3 ( 3.5) 35.6 ( 6.2) 
20 4 74.3 ( 8.5) 46.3 (15.5)b 47.4 (11.1)b 
21 4 126.3(11.9) 13.5 ( 9.3) 95.0 (10.1)b 
22 6 151.8( 8.1) 114.5 ( 8.3)b 52.5 ( 7.7)b 
• Data are means ± SO; GA. gestational age 
a) Total lung weight (mg) of normal rats (control), and of rats exposed 
to Nitrofen without (LH) or with diaphragmatic defect (LH-CDH) 
b) Significantly different from the control group,_p<0.01 
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enzyme activity was defined as the amount of enzyme required to release 1 pmol of 
hippuric acid per min at 37"C. To facilitate comparison and exclude differences 
merely based upon differences in lung weight the angiotensin-converting enzyme 
activities were all expressed as units per mg lung protein. 
Statistical analysis 
In this study lungs of 5-6 rat fetuses in each group were analyzed at day 19,20,21 
and 22. The data are presented as the mean with one standard deviation (SD). 
Treatment effects were evaluated by analysis of variances or regression analysis." If 
a significant F-value in the analysis of variances was found, Bonferroni' s correction 
method for multiple comparisons was used to identify differences among the 
groups. A difference was considered statistically significant when the P-value was 
0.05 or less. 
3 .1.4 Results 
Lung develapment during gestation 
Total lung weight of normal fetal rats and of rats exposed to Nitrofen with or 
without a diaphragmatic defect (group LH-CDH and LH, respectively) increased 
during gestation in a similar fashion as found previously'', (Table 1). The time-
dependent increase in lung weight of LH-CDH and LH rats was significantly less 
than that of control rats (P < 0.001 for group-dependent effect of time). 
Table 2. Developmental changes in lung/body weight ratio of normal fetal rats of 
fetal rats exposed to Nitrofen with and without a diaphragmatic defect 
GA Lung/body weight (mg/g)a n 
(d) control LH LH-CDH 
19 6 29.8 (4.2) 25.0 (0.8) 24.2 (2.0)b 
20 4 32.6 (1.3) 22.8 (2.9)b 24.5 (3.7)b 
21 4 32.6 (1.2) 29.9 (2.3) 26.7 (2.8)b 
22 6 28.1 (2.6) 23.7 (1.1)b 10.9 (1.6)b 
• Data are means ± SD; GA, gestational age 
a) Lung/body weight ratio (mg/g) of normal rats (control), and of rats exposed to 
Nitrofen without (LH) or with diaphragmatic defect (LH-CDH) 
b) Significantly different from the control group p<0.01 
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Table 3. Developmental changes in lung protein of normal fetal rats and of • 
fetal rats exposed to Nitrofen with and without a diaphragmatic defect 
GA Lung protein (~g/mg lung weight)a n (d) control LH LH-CDH 
19 6 71.8 (4.7) 74.7 (4.9) 75.6 (6.4) 
20 4 72.4 (6.2) 68.4 (8.1) 63.6 (9.3) 
21 4 59.5 (0.7) 56.0 (3.4) 62.3 (0.5) 
22 6 60.2 (5.0) 61.4 (3.1) 87.4 (4.2)b 
• Data are means ± SD; GA. gestational age 
a) Lung protein (~g) per mg lung weight of normal rats (control), and of rats 
exposed to Nitrofen without (LH) or with diaphragmatic defect (LH-CDH) 
b) Significantly different from the control group and LH group at the same 
gestational age, P<0.01 
Exposure of the mother led to severe lung hypoplasia in the offspring as reflected 
by lung/body weight ratios, which were 15% lower than the controls, irrespective of 
the presence or absence of a diaphragmatic defect (group LH-CDH and LH, 
respectively), (Table 2). Lung protein content did not change significantly during 
gestation, and did not differ between the three treatment groups, except for day 22 
at which the protein content of LH-CDH rat lungs was significantly higher than of 
normal and LH rat lungs (P < 0.001). (Table 3). 
Angiotensin-converting enzyme activities during gestation 
The angiotensin-converting enzyme activities during gestation are presented in Fig.l. 
Except for day 21. the angiotensin-converting enzyme activity in the lungs of rats 
exposed to Nitrofen was about 1.5 fold higher than in the normal controls. The 
Nitrofen-treated groups did not differ significantly in angiotensin-converting enzyme 
activity during gestation. Regression analysis showed that between day 19 of 
gestation and birth the angiotensin-converting enzyme activity in the normal fetal 
lung steadily increased about 17 fold to 53.04 ± 7.5 mU/mg prot (P < 0.001 for time 
dependency). In the lungs of LH-CDH and LH rats, angiotensin-converting enzyme 
activity increased significantly during gestation as well (P < 0.001 for time-
dependent effect in both groups). Furthermore, the increase in lu..-,g angiotensin-
converting enzyme activity during gestation differed significantly between normal 
rats and rats exposed to Nitrofen (P < 0.001), but not between rats exposed to 
Nitrofen with or without a diaphragmatic defect (P= 0.24). 
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Develapmental changes in angiotensin-converting enzyme activity (mU/mg prot) in 
the lung of normal rats ( ), and of rats with lung hypoplasia without a 
diaphragmatic defect (LH, ) or with a diaphragmatic defect (LH-CDH, ). Each 
point represents the mean ± 1 SD of 5-6 animals. 
3 .1.5 Discussion 
Lung hypoplasia can be induced in fetal rats after maternal exposure to Nitrofen 
(2,4-dichlorophenyl-p-nitrophenyl ether), a herbicide with a strong teratogenic 
potential. Nitrofen affects the cellular and structural development of the fetal lung 
which results in lower lung weight/body weight ratios and lower radial saccular 
counts.7 The lungs of treated rats also show increased muscularization of the 
pulmonary bed as in newborns with CDH.' At day 11 of gestation, the process of 
diaphragmatic closure has proved to be highly sensitive to the teratogenic action of 
Nitrofen resulting in a concomitant diaphragmatic defect. In this study Nitrofen-
treated rats showed a lower increase in lung weight during gestation but a similar 
protein content per unit of lung weight. The angiotensin-converting enzyme content 
in Nitrofen-treated rats was about 1.5-fold higher than in normal controls. The 
developmental pattern of angiotensin-converting enzyme activity in the normal fetal 
rat lung was similar to the pattern shown previously by Wallace et a!." 
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Many factors are thought to regulate the pulmonary vascular tone in the 
postnatal period. The increase in pulmonary blood flow after birth could reflect a 
major shift from active vasoconstriction to active vasodilation. These changes are the 
result of a complex interaction between 0, and vasoactive substances such as 
bradykinin, angiotensin II and the eicosanoids.5 The pulmonary arterial endothelial 
cells play a key role in this process. Endothelial cells release substances that affect 
adjacent smooth muscle cells or stimulate other endothelial cells downstream to 
paracrine activity." Angiotensin-converting enzyme is an enzyme that is located in 
the endothelial cells of the lung, near the luminal surface. It is responsible for the 
activation of angiotensin I to angiotensin ll and the degradation of bradykinin in 
smaller inactive fragments.' Chronic pulmonary hypertension in adult rats is 
associated with decreased levels of angiotensin-converting enzyme."·" Decreased 
angiotensin-converting enzyme activity would lead to a reduction of the 
vasoconstrictor angiotensin II and an increase in the amount of the vasodilator 
bradykinin that stimulates the production of the even more potent vasodilator 
prostacyclin and endothelium-derived relaxing factor." In this way decreased 
angiotensin-converting enzyme activity serves as a protective mechanism. 
In contrast, increased angiotensin-converting enzyme levels would lead to an 
increased production of angiotensin II and an increased degradation of bradykinin. 
We speculate that the normal postnatal drop in pulmonary vascular resistance could 
be easily disturbed in the presence of increased angiotensin-converting enzyme 
activity together with an abnormally muscularized pulmonary vascular bed. 
Another intriguing observation against the background of abnormal 
muscularization of the pulmonary vascular bed is the identification of angiotensin II 
itself as an endothelial growth factor for cell proliferation in the vessel wall." In this 
concept of understanding systemic hypertension, vascular hypertrophy may be an 
adaptive process that normalizes vessel-wall stress in response to elevated arterial 
pressure, according to Laplace's law.11 
In CDH patients the number of vessels per em' lung tissue amounts to only one 
third of normal controls." Pulmonary vascular resistance can be evaluated basically 
from the Poiseuille's equation modified to take into account the numbers of lung 
vessels: Rp=(S/n)(l/kr')l], where I is the length of the vessels, k is the number of 
vessels, r is the radius, and l] is the viscosity of the blood. As a consequence, a 
reduction in the number of vessels to one third would mean a three-fold increase in 
vascular resistance. This phenomenon could play a key role in the development of 
PPH and in this concept increased angiotensin-converting enzyme activity is rather a 
consequence than a cause of PPH. 
The observation that maternal exposure to Nitrofen leads to lung hypoplasia, a 
reduction of the number of blood vessels in the lung and the development of a 
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diaphragmatic defect in the offspring, needs further clarification.'·'-" A possible clue 
could be that Nitrofen resembles thyroid hormone in chemical structure" and 
competes for binding to the nuclear T3 receptor (Brandsma et a!, in press). 
This is the first report of angiotensin-converting enzyme activity in a 
reproducible animal model for CDH characterized by bilateral lung hypoplasia. We 
found an increase in angiotensin-converting enzyme activity in fetal rats exposed to 
Nitrofen. Whether angiotensin-converting enzyme levels are increased in the lungs 
of human newborns with CDH and contribute to the development of PPH remains 
to be elucidated. 
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CONGENITAL DIAPHRAGMATIC HERNIA: 
IMPACT OF PROSTANOIDS IN THE PERIOPERATIVE PERIOD 
32.1 Summary 
A prospective study of 10 neonates with congenital diaphragmatic hernia and five 
controls to determine the importance of prostanoid concentrations perioperatively 
and the relation with persistent pulmonary hypertension (PPH) is reported. In 
neonates with congenital diaphragmatic hernia postoperative concentrations of the 
vasoconstrictor thromboxane B, rose significantly and were higher during episodes 
of PPH; this rise may provoke PPH and subsequent right to left shunting. 
3.2.2 Introduction 
The outcome in patients with congenital diaphragmatic hernia depends either on the 
gravity of pulmonary hypoplasia or on the combination of pulmonary hypoplasia 
with persistent pulmonary hypertension (PPH).' 
Degradation products of arachidonic acid such as the leukotrienes' and the 
prostaglandins and thromboxanes (the so called prostanoids) have been associated 
with the generation of PPH in neonates.' 
The purpose of this prospective study was to determine the importance of 
prostanoid concentrations and ventilatory variables in patients with congenital 
diaphragmatic hernia with and without PPH in the perioperative period. 
3.2.3 Patients and Methods 
During the study period, December 1987 to February 1989, 10 consecutive neonates 
with congenital diaphragmatic hernia (mean gestational age 37.6 weeks, birth weight 
3050 g) were admitted to the pediatric surgical intensive care unit, because of severe 
respiratory insufficiency within six hours after birth. During the same study period 
five patients with oesophageal atresia (mean gestational age 36 weeks, birth weight 
2645 g) served as a control group and they followed the same protocol. 
Registration of ventilatory variables was carried out on admission, one hour 
before surgery, and one and six hours after surgery. These variables included the 
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alveolar-arterial oxygen differences {(A-a)DO,}, mean airway pressure, oxygenation 
index, and ventilation index.' 
Determination of thromboxane B, a stable metabolite of the vasoconstrictor 
thromboxane A2, and 6-keto-prostaglandin F,. (PgF), a stable metabolite of the 
vasodilator prostacyclin, were analyzed by radioimmunoassay. 
The diagnosis of PPH was confirmed with the following diagnostic procedures: 
(i) hyperoxic hyperventilation test in which the arterial oxygen pressure (PaO,) 
increased to > 13.3 kPa after hyperventilation with 100% oxygen; (ii) preductal and 
postductal PaO, differential of >2.7 kPa considered evidence of a transductal shunt; 
and (iii) positive contrast echocardiography showing right to left shunting.' As the 
distributions of most variables were highly skewed the median and range were used 
as descriptive statistics in the statistical analysis. 
32.4 Results 
Ten patients with congenital diaphragmatic hernia and five controls were examined. 
Two of the patients had a right sided defect and eight had a left sided defect, two 
had never had surgery because their condition deteriorated rapidly. These two 
patients died at 15 and 25 hours after admission and necropsy confirmed severe 
lung hypoplasia. A third patient did not undergo surgery because he had an 
isoelectric electroencephalogram after a prolonged period of hypoxia immediately 
after birth. One of the seven patients who underwent surgery had trisomy 18 and 
died. All five control patients were operated on. One prematurely born infant died 
after severe intracranial hemorrhage. 
In patients with congenital diaphragmatic hernia median concentration of 
thromboxane B, rose significantly from 250 (range 81-703) pmol/ml preoperatively to 
740 (range 443-1030) pmol/ml postoperatively (signed rank test, p=0.018). In the 
control group concentrations of thromboxane B, were 376 (range 250-497) pmol/ml 
preoperatively and 185 (range 50-1010) pmol/ml postoperatively (p=0.7). Plasma 
concentrations of PgF, increased from 260 (range 140-8835) to 2460 (range 1709-4150) 
pmol/ml in patients with congenital diaphragmatic hernia and from 455 (range 30-
986) to 1145 (range 180-3682) pmol/ml in control patients; this was not significant. 
The increased concentrations of thromboxane B, at one hour postoperatively dropped 
to preoperative concentrations in all but two patients with congenital diaphragmatic 
hernia (Figure p.62). 
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Figure. Concentrations of thromboxane B, before, immediately after, and six hours after 
surgery in seven patients with congenital diaphragmatic hernia. Patient (+) died. 
One of these patients died with high concentrations and the clinical picture of 
PPH. 
In five patients with congenital diaphragmatic hernia at least one episode of PPH 
was diagnosed. The average values of the ventilatory variables and prostanoid 
concentrations are presented in the table, and compared with the values in patients 
without episodes of PPH. In patients with right to left shunting (A-a)DO,, 
oxygenation index, and thromboxane B2 concentrations were significantly higher than 
in those without right to left shunting. 
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Table 1. Median (range) ventilatory variables and prostanoid concentrations in patients with 
CDH with and without PPH 
CDH without PPH COH with PPH pvalue 
(A-a)D02 201 (127-385) 559 (318-623) O.Q16 
Mean airway pressure 11 (8-15) 9 (8-15) 0.9 
Oxygenation index 4(2-10) 21 (8-30) 0.016 
Ventilation index 630 (330-1296) 542 (497-1138) 0.8 
Thromboxane 82 (pmol/ml) 312 (262-656) 774 (477-3699) 0.03 
PgF (pmol/ml) 726 (562-1056) 938 (55-2713) 0.3 
3.2 .5 Discussion 
Oxygenation of neonates with congenital diaphragmatic hernia in the perioperative 
period remains a challenging problem because of the combination of pulmonary 
hypoplasia and PPH. 
Recently Hammerman and coworkers correlated the presence of PPH in neonates 
to increased concentrations of thromboxane B,.' The pulmonary vascular system of 
the patient with congenital diaphragmatic hernia differs from that of normal 
newborns and may overreact to different stimuli.' In patients with congenital 
diaphragmatic hernia plasma concentrations of the vasoconstrictive metabolite 
thromboxane B, increased significantly during the surgical and anaesthetic 
procedure. If the pulmonary vascular system is still susceptible to vasoconstriction, it 
is obvious that in these cases pulmonary artery pressure may rise and right to left 
shunting may occur. In five out of seven patients thromboxane B2 concentrations 
turned to baseline values at six hours postoperatively, showing that the rise of 
thromboxane B, is related to the operation. 
In other words, the surgical procedure may provoke PPH in a 'susceptible' 
pulmonary vascular system. Ventilatory variables have proved their use in 
prediction of survival in patients with congenital diaphragmatic hernia.' The 
(A-a)D02 and the oxygenation index values are significantly higher in patients who 
have PPH. In these patients, concentrations of thromboxane B, have increased and 
might reflect an imbalance between vasodilation and vasoconstriction, dipping to 
vasoconstriction. 
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In conclusion: we have shown that during surgery there is activation of the 
arachidonic prostanoid cascade leading to a rise in thromboxane B, concentrations in 
patients with congenital diaphragmatic hernia. This may be an additional risk factor 
for right to left shunting postoperatively and it may be an argument for delayed 
surgery till the moment when the pulmonary vascular system has become 'stable'. 
The work was supported in part by a grant from Upjohn Medical Sciences Liaison Division. 
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PERSISTENT PULMONARY HYPERTENSION IN HIGH-RISK 
CONGENITAL DIAPHRAGMATIC HERNIA PATIENTS: 
INCIDENCE AND VASODILATOR THERAPY 
33.1 Summary 
Survival of congenital diaphragmatic hernia patients depends on the gravity of 
pulmonary hypoplasia and persistent pulmonary hypertension (PPH). Many 
vasoactive drugs have been used in the treatment of PPH, but often they also lower 
peripheral resistance, leading to a significant drop in arterial blood pressure. The 
incidence of PPH in 52 high-risk diaphragmatic hernia patients and the results of 
treatment with tolazoline and prostacyclin were evaluated in a study lasting 52 
months and involving 52 patients. High risk patients require ventilatory support 
within six hours after birth. Study parameters were alveolar-arteriar oxygenation 
difference {(A-a)DO,L oxygenation index (OJ), and mean arterial blood pressure 
(MABP), measured at set times before and after administration of tolazoline or 
prostacyclin. Twenty-one patients had documented episodes of PPH (46%), and 18 of 
them died. Tolazoline did not lower (A-a)DO, and 01 values, but MABP dropped 
significantly. Prostacyclin caused a significant decrease of (A-a)DO, and 01 values 
without an effect on MABP. We concluded: (1) PPH presented in 46 % of our 
patients, associated with a high mortality rate; (2) tolazoline is not an effective 
dilator of the pulmonary vascular bed and lowers MABP; (3) prostacyclin is an 
effective pulmonary vasodilator as reflected by ventilation parameters without 
systemic side effects; it does not affect overall outcome but can used as a "bridge " 
to ECMO. 
3.3.2 Introduction 
Newborn infants with congenital diaphragmatic hernia (CDH) presenting with 
respiratory distress within six hours after birth, still have a mortality rate of 
approximately 40 %-'" 
The diaphragmatic defect is already present very early in gestation and leads to 
impaired branching of the bronchial tree and subsequent uni- or bilateral lung 
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hypoplasia.' In addition, the muscularization of intra-acinar arteries is increased, and 
the external diameter of arteries is decreased.' These structural abnormalities may 
result in increased. pulmonary vascular resistance and the clinical picture of 
persistent fetal circulation with right-to-left shunting through the ductus arteriosus 
and the foramen ovale.5 A vicious circle of hypoxia, hypercarbia and acidosis, -well 
known risk factors for increased pulmonary vascular tone-, often leads to the death 
of the newborn with CDH due to therapy resistent pulmonary hypertension. 
Pharmacologic intervention to reduce pulmonary vascular resistance is often 
complicated by a concomitant decrease in peripheral resistance and a subsequent 
decrease in systemic blood pressure.' 
ln this study we report the incidence of persistent pulmonary hypertension (PPH) 
in newborns with CDH and the results of treatment with tolazoline and 
prostacyclin. 
3.33 Patients and methods 
The study was conducted as a retrospective study from January 1986 until May 1989 
and continued prospectively until May 1991. In the whole study period 52 newborns 
(29 boys and 23 girls) with CDH were admitted to the Pediatric Surgical Intensive 
Care Unit of the Sophia Children's Hospital in Rotterdam. All were so-called high 
risk patients requiring ventilatory support within six hours after birth and all were 
so-called primary referrals. Six patients were excluded because of missing data, so 
the study group consisted of 46 patients. Eleven patients had a right-sided defect 
and 35 had a left-sided defect. 
All patients were stabilized preoperatively and treated according to the "delayed 
surgery" protocol, as described previously'. In short the infants were paralyzed, 
sedated, and mechanically ventilated with frequencies of 60 to 100/min. Ventilatory 
support was aimed at pH values of 7.45 or higher, PaO, > 100 mmHg, and PCO, 
between 25 and 30 mmHg. The stomach and bowel were decompressed by 
continuous suction using a nasogastric tube with a double lUL'llen. Circulatory failure 
was treated with plasma, dobutamine (7 to 15 pg/kg/min) together with low dose 
dopamine (3 pg/kg/min). Oxygenation was monitored using either preductal and 
postductal indwelling catheters, or two transcutaneous saturation monitors. 
The diagnosis of PPH was confirmed with the following diagnostic procedures: 
(1) hyperoxic hyperventilation test in which the arterial PaO, increased to > 100 
mmHg after hyperventilation with 100% oxygen; (2) preductal and postductal PaO, 
differential of > 20 mm Hg considered evidence of a transductal shunt; (3) positive 
contrast echocardiography showing right to left shunting'. 
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Table 1. Characteristics of patients with(+) and without(-) PPH* 
Number of patients 
Gestational age.(wk) 
Birth weight {g) 
Side of defect - R 
number of deaths 
-L 
number of deaths 
Total number of deaths 
PPH+ 
21 
38 ± 2.5 
2923 ± 647 
10 
9 
11 
9 
18 
• Data are means ± SD; •p < 0.01 
PPH-
25 
38.5 ± 2.5 
2847±886 
1• 
1• 
24 
4 
total 
46 
11 
10 
35 
13 
23 
In the first part of the study period tolazoline (1 to 2 mg/kg/rnin) was the drug 
of choice to lower pulmonary vascular resistance, in the prospective part 
prostacyclin (FlolanR, Wellcome) was the drug of first choice (5-20 nanog/kg/rnin). 
Registration of ventilatory and circulatory parameters was carried out shortly before, 
one hour after, and at 3-hour intervals after administration of vasoactive drugs. The 
variables were the alveolar-arterial oxygen difference {(A-a)D02}, oxygenation index 
(OJ) and mean arterial blood pressure (MABP). The unpaired Student's t test was 
used to compare data between treatment groups. Statistical significance was accepted 
at p< 0.05 leveL 
3 3.4 Results 
Twenty-one patients had documented episodes of PPH and 25 did not. Patients are 
divided according to the presence or absence of PPH; patient presenting 
characteristics are shown in Table 1. There were no significant differences between 
groups in terms of gestational age or birth weight. All patients without PPH were 
operated, except one .with trisomy 18, one severely asphyxiated patient with an iso-
electric EEG and a third with extreme lung hypoplasia. The incidence of PPH and 
the mortality rate was significantly higher in patients with a right--sided defect 
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Table 2. (A-a)D02. 01, and MABP before and alter treatment 
in 21 patients with PPH* 
Tolazoline (n=12) Prostacyclin (n=9) 
pre post pre post 
(A-a)D02 605 587 598 487• 
SEM ±7 ±16 ±16 ±48 
01 27 34 29 21 
SEM ±3 ±6 ±5 ±6 
MABP 41 29• 41 42 
SEM ±3 ±3 ±2 ±3 
*Data are means ± SEM; •p < 0.05 
(p=0.002 and p=0.009 respectively). Ten of 21 patients had severe PPH 
preoperatively and were allowed to die without surgery, in the period before ECMO 
was available. Seven of them also had severe pulmonary hypoplasia as reflected by 
a highest pO, < 80 mmHg. In five of these seven patients autopsy was obtained, 
which confirmed lung hypoplasia showing lung body weight indices less than 
0.0129• Table 2 contains the (A-a)DO, 0!, and MABP values before and after 
treatment with tolazoline or prostacyclin. Tolazoline did not lower (A-a)D02 and Ol 
values, but MABP dropped significantly (p=0.009). After administration of 
prostacyc!in a significant decrease of mean (A-a)DO, values was seen (p=0.04), the 
decrease of Ol values did not reach significance (p=0.3). There was no effect on 
MABP. The (A-a)DO, values in the individual patients after administration of 
prostacyclin are shown in Figure 1. All non-responders died. Patient 1 showed an 
initial drop of (A-a)DO, and 0! but deteriorated later despite maximal treatment 
and died without the availability of ECMO. Patient 2 and 3 could be transferred for 
ECMO treatment and both could be weaned from ECMO. Patient 2 survived, but 
patient 3 died two weeks later with relapsing therapy-resistent episodes of PPH. 
Patient 4 remained stable under continuous administration of prostacyclin during 6 
days and survived. 
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3.3.5 Discussion 
Newborns with CDH leading to respiratory insufficiency within 6 hours after birth 
have a poor outlook. Lung hypoplasia and (PPH) are the main causes of death. In a 
prospective study in 66 CDH patients Bohn et al. assessed the predictive value of 
preoperative PaCO,, ventilatory measurements, in combination with morphometric 
analysis of the lungs of non-survivors. Their findings suggest that the degree of 
pulmonary hypoplasia rather than the pulmonary vascular abnormality determines 
survival." Our data show an incidence of PPH of 46 % associated with the death of 
18 of 23 non- survivors. 
The pulmonary vascular bed is abnormal in CDH patients and is characterized 
by decreased total size of the pulmonary vascular bed, increased pulmonary arterial 
muscle and decreased number of vessels per unit of lung."'"'1u2 The normal resetting 
of pulmonary vascular tone in the postnatal period is a complex interaction between 
0, and several vasoactive compounds such as bradykinin, prostaglandins, and 
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thromboxanes.'3 This process is disturbed in many CDH patients and the pulmonary 
vessels are excessively reactive to physiological stimuli, for example hypoxia and 
acidosis, resulting in vasoconstriction and subsequent right-to-left shunting." 
Mediators for this process of vasoconstriction probably are the prostanoids, because 
high levels of the vasoconstrictor thromboxane B, have been identified during right-
to-left shunting in newborns with a diaphragmatic defect." During surgery the 
arachidonic cascade is activated, leading to a rise in thromboxane B, levels 
postoperatively, at a time when the pulmonary vascular bed has not "stabilized" 
yet.1t-
The ideal treatment for PPH would be selective pulmonary vasodilation without 
side effects on the systemic circulation.17 For many years Tolazoline was the drug of 
choice in newborns with PPH.'' But this drug has a long half-life, lowers systemic 
blood pressure in human newborns", decreases cerebral blood flow in newborn 
dogs" and does not improve survival. In this study we found no positive effect on 
oxygenation and a significant decrease in MABP leading to a deterioration in almost 
all patients. 
Prostacyclin is an arachidonic acid metabolite with strong vasodilative properties 
and a short half-life (1 to 2 min) that reduces resting pulmonary vascular tone and 
hypoxic pulmonary vasoconstriction." In children with PPH secondary to congenital 
heart disease, prostacyc!in turned out to be a powerful but not selective pulmonary 
vasodilator." Animal studies showed that unwanted side effects on the systemic 
circulation occurred at doses above 20 nanog/kg/min." Clinical experiences in 
neonates are scarce and not consistent, but showed a beneficial effect on 
oxygenation in a number of cases.".25 We found a significant decrease of (A-a)DO, 
values after treatment with prostacyclin, without effects on MABP. Overall outcome 
did not improve but one patient benefitted from prolonged prostacyclin 
administration, and in three other patients time was gained to institute other forms 
of treatment such as ECMO. No side effects were noted. 
In conclusion, PPH is a major problem in CDH which occurs in almost half of 
the patients and contributes to the high mortality rate. Vasodilator therapy with 
Tolazoline was not successful and led to systemic hypotension in almost all patients. 
Administration of prostacyclin did not influence overall outcome but, in responders, 
time was gained to make other forms of treatment possible. In other words 
prostacyclin is a valuable alternative in the treatment of PPH in newborns with a 
diaphragmatic defect. Prostacyclin can be of use as a "bridge" to ECMO. 
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NITROFEN INDUCED DIAPHRAGMATIC HERNIAS IN RATS: 
PULMONARY ANTIOXIDANT ENZYME ACTIVITIES 
4.1.1 Summary 
We developed an experimental rat model of congenital diaphragmatic hernia (CDH) 
to elucidate the etiology and pathogenesis of this serious congenital anomaly in 
humans, and in particular to study the effects of a short period of artificial 
ventilation on the CDH lung in relation to antioxidant defense mechanisms. CDH 
was induced in about 60% of the offspring by maternal exposure to 2,4-
dichlorophenyl-p-nitrophenylether (Nitrofen) during pregnancy. This herbicide 
resembles thyroid hormone in chemical structure. The lungs of fetal rats (day 19, 20, 
21, and 22) were examined for protein and DNA content, and activity of superoxide 
dismutase (SOD), catalase and glutathione peroxidase (GPX). The same parameters 
were assessed in tracheotomized newborn rats after pressure-controlled artificial 
ventilation with either room air or pure oxygen during a short period of 5 hours. 
Both in CDH-rats and controls wet lung weight increased during gestation. At 
term CDH-rats had significantly lower mean lung weights than controls. Both 
groups did not differ in protein and DNA content per mg lw.-,g, and SOD, catalase 
and GPX activity before and at birth. 
After artificial ventilation of neonates with air and pure oxygen SOD activity 
tended to decrease, whereas catalase activity remained virtually unchanged in the 
CDH lung. However, GPX activity in the CDH lung was reduced to 80% of initial 
activity at term after ventilation with air and to 70% with pure oxygen. Literature 
supports that tissues can tolerate loss of catalase activity during oxidative stress, but 
no loss of GPX activity. In fact, this enzyme is one of the last remedies a cell has to 
repair free-radical induced lipid peroxidation of its membranes and prevent lethal 
damage. The present finding of a decline in GPX activity in this animal model after 
a short period of artificial ventilation may indicate that the CDH rat neonate is at 
risk to develop oxygen-related lung damage. 
4.1.2 Introduction 
Congenital diaphragmatic hernia (CDH) is a serious congenital anomaly with 
unknown etiology which occurs in approximately one in 2000 to 5000 newborns. In 
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contrast to other congenital abnormalities the mortality rate of CDH has not 
dropped since the introduction of neonatal intensive care and artificial ventilation.' 
Mortality still remains 50% due to pulmonary hypoplasia with or without persistent 
pulmonary hypertension.' Those infants with severe respiratory compromise need 
maximal ventilatory support, and are often subjected to high inflation pressures and 
high percentages of oxygen. The side-effects of respiratory treatment are well 
known' and the clinical picture of bronchopulmonary dysplasia (BPD) has become 
one of the major sequelae of neonatal intensive care.' Only few reports describe 
defense mechanisms against oxidative stress in the human neonatal lung.' Most 
experimental studies on the development of antioxidant enzyme activity (AOA) have 
been done in small rodents.'·' The effect of artificial ventilation on the lung has been 
studied only in larger animals such as the baboon.' 
We described a model in which CDH was induced in fetal Sprague-Dawley rats 
by maternal exposure to a single dose of 2,4-dichlorophenyl-p-nitrophenyl ether 
(Nitrofen) during pregnancy.'·" The incidence of CDH in the treatment group was 
up to 60%. The diaphragmatic defect was mainly right-sided with severe hypoplasia 
of the lung as reflected by decreased lung weight/body weight ratios. No 
correlation was found between the size of the defect and the ipsilateral and 
contralateral lung weights.' Without artificial ventilation more than 80% of the CDH 
animals died within 2 hr after birth due to severe respiratory insufficiency. 
In the present study we report (a) the activities of superoxide dismutase 
(CuZnSOD) (EC.l.lS.l.l), catalase (EC 1.11.1.6) and glutathione peroxidase (GPX) 
(EC.l.l1.1.9) just before and at birth in the diaphragmatic hernia lung, and (b) the 
effect of a short period of artificial ventilation on the activity of these antioxidant 
enzymes. 
4.1.3 Materials and Methods 
Animal model 
CDH was induced in fetal Sprague-Dawley rats by oral administration of 115 mg 
Nitrofen/kg body wt to the mother at day 10.5 of pregnancy as described 
previously.'·" Animals with a diaphragmatic defect showed a bilateral lung 
hypoplasia and smaller lung/body weight ratios compared to controls. There were 
no significant intragroup differences in degree of lung hypoplasia. About 40% of the 
fetuses did not develop CDH. The distinction between animals with CDH 
(group:CDH) and without CDH (group:NDH) could only be made after autopsy. 
Fetuses of pregnant rats who were not given Nitrofen served as normal controls 
(group:control). 
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Fetuses were delivered by hysterotomy at day 19, 20, 21 and 22 (full term) of 
gestation. After determination of body weight the fetuses were killed by 
intraperitoneal injection of an overdose of pentobarbital (Nembutal; Sanofi, 
Tinderberg, The Netherlands). The presence of a diaphragmatic defect was evaluated 
by autopsy, after which the heart and lungs were removed en bloc, and the lungs 
were perfused with ice-cold 1/15 moi/L phosphate buffer (PBS; pH 7.8) via the 
pulmonary artery under constant pressure to remove the blood from the circulation. 
During perfusion the color of the lungs changed to pale white. If part of the lungs 
remained pink, which indicated incomplete perfusion, the organs were discarded. 
The perfused lungs were then dissected, stripped of nonpulmonary tissue, weighed, 
frozen with liquid nitrogen and then stored at -7{J"C until antioxidant activity was 
determined. 
The effect of a short period (for practical reasons) of artificial ventilation with air 
or pure oxygen on pulmonary AOA was investigated in spontaneously delivered 
newborn rats. The presence of CDH could be suspected in Nitrofen-treated rats by 
observing a high ventilatory rate and persistent cyanosis with the inability to suck 
spontaneously.' Artificial ventilation was performed using the technique described 
by Lachmann.11 In short, the newborn rats underwent tracheostomy under 
pentobarbital anaesthesia (35 rng/kg body wt/ 4 hr) to allow insertion of a small 
canula into the trachea. After muscle relaxation by administration of 
pancuroniumbromide (0.1 mg/kg body wt/hr) the animals were transferred to a 
multichambered heated body plethysmograph, which was connected to a modified 
Servo 900 B ventilator system (Siemens, Elema, Sweden) designed for parallel 
ventilation. Pressure-controlled ventilation was performed with inspiratory peak 
pressures of 17 ern H20 and 2 em H,O of PEEP, respiratory rate 40/min, I:E ratio 
1:2 according to the original reports by Lachmann et a!." on artificial ventilation in 
premature delivered rabbit pups. We did not increase the respiratory rate further, 
because the rat pups showed normal thoracic excursions and remained pink. 
Artificial ventilation was limited to five hours, since CDH-rats did not survive 
artificial ventilation with room air for longer periods. After this period the animals 
were killed by an overdose of pentobarbital, after which the diaphragmatic defect in 
the treatment group was evaluated by autopsy. Then, the lungs were processed for 
AOA assay as described above. After ventilation, the lungs of control rats were 
processed in the same way as of rats exposed to Nitrofen. 
Biochemical analyses 
All biochemical analyses were performed on separate fetal lungs. After thawing, the 
lungs were diluted 1:15 (w /v) in ice-cold PBS, and homogenized with a Brinkmann 
Polytron (Brinkmann Instruments, Westbury, NY) for 15 sec on maximum speed 
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according to Yarn et al." Next, the lung suspension was sonicated for 10 sec on ice. 
In this crude suspension concentrations of protein and DNA were estimated 
respectively by Lowry's method", using bovine serum albumin as a reference, and 
by a sensitive fluorimetric assay." To determine AOA the crude suspensions were 
centrifuged at 20 000 x g for 30 min, and the pellets discarded. The activity of the 
most prevailing superoxide dismutase isoenzyme in the lung, i.e., the copper-zinc 
SOD (CuZnSOD)", was assayed in the supernatants by the inhibition of the xanthine 
(0.1 rnM) xanthine-oxidase(0.025 U /ml)-catalyzed reduction of ferricytochrome c at 
pH 10.2 in the presence of 0.1 rnM EDTA to chelate free copper."·" Under those 
conditions no spontaneous reduction of ferricytoch.rome c occurred in the presence 
of the supernatants under investigation. After initiating the reaction by adding 
xanthine oxidase, the rate of increase in absorbance at 550 nm was recorded. 
Various volumes of each sample were used to determine the 50% inhibition point. 
Only linear reaction rates were taken into account to eliminate interference of 
cytochrome oxidase or peroxidase with the assay. In lysates of rat erythrocytes we 
found the CuZnSOD to be 9.7 times more active at pH 10.2 than at pH 7.8, which 
is in accordance with earlier reports." Since the manganese SOD has the same 
apparent activity at pH 10.2 and pH 7.8", and the results of a pilot study indicated 
that this isoenzyme contributes to maximally 20% of total SOD activity (data not 
shown) confirming earlier observations", the SOD assay at pH 10.2 is useful to 
determine changes in CuZnSOD activity. One unit of SOD activity was defined 
according to Fridovich" as the amount of enzyme needed for a 50% inhibition of 
the reduction of ferricytochrome c in the xanthine-xanthine oxidase system at pH 7.8 
using the aforementioned conversion factor of 9.7. Catalase was measured according 
to Bergmeyer"·19, one enzyme unit (IU) was defined as the amount of enzyme that 
will decompose 1 pmol of H,O, in 1 min at 25°C at pH 7.0, when the initial 
concentration of peroxide, which has a molar extinction coefficient of 41/ em at 240 
nm, is 10.5 mmoi/L. Glutathione peroxidase (GPX) activity was determined as 
previously described by Paglia and Valentine"20, who defined one unit of GPX as 
the amount of enzyme that convert one pmol of NADPH/min using a molar 
extinction coefficient of 6.22 x 103 / ern at 340 nm." To facilitate comparison and 
exclude differences merely based upon differences in lung weight, the activities of 
SOD, catalase and GPX were all expressed as units per mg lung DNA. 
Statistical analysis 
In this study lungs of 4-10 rat fetuses in each group were analyzed. The data are 
presented as the mean with one standard deviation (SD). After rank transformation 
treatment effects were evaluated by analysis of variances." If a significant F-value 
was found, Bonferroni' s correction method for multiple comparisons was used to 
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identify differences among the groups." A difference was considered statistically 
significant when the P-value was 0.05 or less. 
4.1.4 Results 
Lung development during gestation 
Wet lung weight of normal controls increased with gestational age between day 19 
up to birth to 136.4 ± 21.5 mg (for time dependency, P < 0.001); that of CDH-rats 
increased during gestation as well (P = 0.007), but the mean lung weight amounting 
to 62.9 ± 10.3 mg at birth was significantly (0.01 < P < 0.05) lower compared to the 
control and the NDH group (Table 1). The mean lung weight in the CDH and NDH 
rats was lower at birth than at day 21 of gestation and also the large SD found in 
the control rat neonates at birth is obvious. No statistical significant differences in 
body weight were found between the groups during gestation (Table 1). As 
expressed by the significantly lower lung/body weight ratios the CDH-rats 
apparently developed severe lung hypoplasia in utero (Table 1), which affected both 
lungs as shown by Tenbrinck et al.' During gestation lung protein content and DNA 
Table 1. Developmental changes in lung weight. body weight; and lung/body weight ratios of control rats and rats 
exposed to Nitrofen with and without diaphragmatic defect• 
Gestational age (d) 
Group CD n 19 20 21 Birth 
Lung weight (mg) c 10 43.0 ± 7.1 89.6± 5.2 121.6 ± 7.8 136.4 ± 21.5 
NDH 7 40.8 ± 3.7 65.8 ± 30.1 137.0 ± 12.4@ 109.7 ± 8.9@ 
CDH 6 35.2± 5.6@ 47.6 ± 18.2ill 99.5 ± 17.1""" 62.9 ± 10.3 OX!l 
Body weight (g) c 10 1.5 ± 0.2 2.7± 0.3 3.9± 0.1 5.4 ± 0.3 
NDH 7 1.6±0.1 2.6± 1.0 4.5± 0.4 4.8 ± 0.2 
CDH 6 1.5 ± 0.1 2.0 ± 0.8 4.2± 0.7 5.0 ± 0.4 
Lung wt/body wt ratio (mg/g) c 10 28.2± 2.4 33.8± 1.7 33.5± 0.9 28.1 ± 2.6 
NDH 7 25.8 ± 1.6 27.1 ± 2.7 30.9± 1.1 22.6± 1.2" 
CDH 6 24.1 ± 1.8il> 26.6± 2.7" 24.8± 5.1 Cllil> 12.2 ± 2.1 ""' 
·oata are means± SO. 
CD C. control group; NOH. rats exposed to Nitrofen without diaphragmatic defect; COH, rats exposed to Nitrofen 
with diaphragmatic defect 
G!l Significantly different from control, 0.01 < p < 0.05. 
a> Significantly different from control, p < 0.01. 
®Significantly different from NOH group, p < 0.01. 
ill Significantly different from NDH group. < 0.01 < p < 0.05. 
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content expressed per mg lung weight remained virtually unchanged in all groups 
(Table 2); this was reflected in the protein/DNA ratio which did not differ with 
time and amounted to a mean value of about 7 (Table 2). The apparent increase in 
lung DNA and protein within the three groups between day 21 of gestation and at 
birth indicates that a loss of amniotic fluid from the lungs could explain the 
decrease in lung weight at birth. 
Antioxidant enzyme activities during gestation 
Between day 19 of gestation up to birth the level of SOD activity remained fairly 
constant within the three groups (Fig.l, p. 80). Catalase activity showed a significant 
increase in activity between day 21 of gestation and birth in each group (control: P 
= 0.007; NDH: P < 0.001; CDH: 0.05 > P > 0.01, respectively); however, there was 
no significant difference between the groups (Fig.2, p. 80). GPX activity steadily 
increased in each group with age amounting at birth to 174%, 162% and 184%, 
respectively for the control, NDH and CDH groups, of the initial GPX activity at 
day 19 of gestation (for time dependency in each group, P < 0.001; Fig.3, p. 81). 
Table 2. Developmental changes in lung protein and protein/DNA ratio of control rats and rats exposed to Nitrofen 
with and without diaphragmatic defect* 
Gestational age (d) 
Group <D n 19 20 21 Birth 
Protein (~g/mg lung wt) c 10 71.5 ± 4.3 71.1 ±4.7 62.8 ± 3.9 64.1 ± 7.8 
NOH 6 72.7 ± 4.3 61.7 ± 6.3 59.8± 6.3 65.0 ± 6.8 
COH 6 76.9 ± 3.7 65.2 ± 6.7 63.5 ± 3.5 86.9 ± 7.1 
DNA (~g/mg lung wt) c 10 10.4 ± 0.7 8.2± 1.5 9.6 ± 0.7 10.3±1.1 
NDH 6 11.0 ± 0.5 8.9 ± 1.4 7.5± 1.2 8.8±0.5 
CDH 6 11.2±1.0 9.7± 1.1 9.2± 0.8 12.1 ±1.6 
Protein/DNA ratio c 10 6.9±0.1 9.0 ± 1.8 6.6 ± 0.7 6.3 ±0.5 
NOH 6 6.6±0.1 7.2 ± 0.8 8.3± 2.0 7.4 ± 0.8 
CDH 6 6.7 ± 0.1 6.7±0.1 7.0 ± 0.9 6.6 ± 0.7 
*Data are means ±SO. 
<DC, control group; NOH, rats exposed to Nitrofen without diaphragmatic defect; CDH, rats exposed to Nitrofen 
with diaphragmatic defect 
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Fig.1. CuZn-superoxide dismutase activity before and at birth expressed per mg lung DNA. 
Each point represents the mean + 1 standard deviation of four to 10 lungs of normal control 
fetuses (c), and of fetuses exposed to Nitrofen without a diaphragmatic defect ( ll), and 
fetuses with CDH ( o). 
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Fig.2. Catalase activity before and at birth expressed per mg lung DNA. Each point repre-
sents the mean + 1 standard deviation of four to 10 lungs of control fetuses ( o), and of 
fetuses exposed to Nitrofen without a diaphragmatic defect ( t:.), and fetuses with CDH (c) 
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Fig3. Glutathione peroxidase activity before and at birth expressed per mg lung DNA. Each 
point represents the mean + 1 standard deviation of four to 10 lungs of normal control 
fetuses ( o), and of fetuses exposed to Nitrofen without a diaphragmatic defect ( t.), and 
fetuses with CDH (c). 
Effect of a short period of artificial ventilation on AOA 
In the control group and the NDH group subjected to a 5-hr period of ventilation 
with room air or pure oxygen immediately after birth SOD, catalase and GPX 
activity remained at about the initial level (Table 3, p. 82). Without ventilation none 
of the CDH animals survived the 5 hr. Under both ventilatory conditions SOD in 
CDH-rats showed a tendency to decrease to about 85% of the initial activity at birth 
(Table 3), which did not reach statistical significance (P = 0.12, and P = 0.18, for the 
difference between initial activity and activity after ventilation with room air and 
with pure oxygen, respectively). Catalase activity remained under both ventilatory 
conditions at the level reached at birth and resembled normal controls and NDH 
rats (Table 3). After ventilation with room air GPX activity in the CDH lung 
decreased to about 80% and after ventilation with pure oxygen to almost 70% of 
initial activity at birth (P = 0.05, and P = 0.01, respectively) (Table 3); compared to 
the normal neonatal rat lung the CDH lung shows 20% less activity under the latter 
condition (P = 0.05; Table 3). 
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Table 3. Effect of short period of artificial ventilation on pulmonary SOD, Catalase. 
and GPX activities of control rats and rats exposed to Nitrolen with and 
without diaphragmatic defect• 
SOD Catalase GPX 
GroupiD Ventilation® n (U/mg DNA) (IU/mg DNA) (mU/mg DNA) 
c Birth 10 22.1 ± 2.2 142.1 ±27.6 276.9 ±40.5 
Air 7 20.9 ± 3.5 136.5 ±22.7 275.8 ± 18.7 
Oxygen 8 22.8 ± 4.5 125.5 ± 13.7 271.9 ±41.2 
NOH Birth 5 19.4 ± 4.4 146.5 ±30.5 283.9 ±43.6 
Air 7 20.9 ± 3.5 116.9 ± 12.4 264.1 ± 13.8 
Oxygen 9 24.6 ± 5.1 144.8 ±31.1 255.4 ±40.7 
CDH Birth 7 20.7 ± 4.7 124.3 ±30.9 315.4 ±46.4 
Air 4 17.5± 0.2 119.8 ± 10.1 247.9 ±14.9@ 
Oxygen 6 17.9 ± 1.9 134.0 ±40.1 216.3 ±54.2 @@ 
·oata are means± SO. 
1D C. control group; NOH, rats exposed to Nitrofen without diaphragmatic defect; 
CDH, rats exposed to Nitrofen with diaphragmatic defect. 
®Neonatal rats were artificially ventilated for 5 h with air or pure oxygen. 
For comparison, birth values are given, because unventilated CDH neonates 
did not suNive the first hour of life. 
®Significantly different from the same group at birth, p = 0.05. 
®Significantly different from the same group at birth, p = 0.01. 
Ill Significantly different from the control group under the same ventilatory 
condition, p = 0.05. 
4.1.5 Discussion 
The present study showed that before and at birth the level of SOD, catalase and 
GPX activities in the lungs of CDH and normal rats were similar. Since lung weight 
was significantly lower in the CDH group, total AOA, however, was reduced. This 
indicates that the CDH lung does not differ qualitatively from the normally 
developed rat lung, but only quantitatively. Furthermore, upon a short period of 
artificial ventilation with pure oxygen only the CDH lung showed a small but 
significant decline in GPX activity. 
Several studies focussed on the prenatal development of pulmonary antioxidant 
enzymes in the rat showed that the activities of total SOD, catalase, and GPX were 
low early in gestation and increased during fetal life.'·' The activity of at least one 
of those antioxidant enzymes is also affected by the amount of trace metals present 
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in the food." Gerdin et al.25 were the first to establish that the three antioxidant 
enzymes in the lung, i.e., SOD, catalase and GPX, developed in different ways. GPX 
in the lung shows a remarkable increase during the last 3 days prior to birth, and 
catalase is doubled in 2 days after birth. The SOD activity, on the other hand, 
increases slowly with time, with less age-related variation than catalase and GPX. In 
the present study we focussed on the late gestational profiles (from day 19 onward) 
to establish whether CDH fetuses differ in antioxidant enzyme activities from 
normal rats. The results show that this was not the case. Within our observation 
period the developmental profiles of SOD, catalase and GPX were fairly comparable 
to those reported by Gerdin et aL" 
In normal newborn rats the effect of normobaric hyperoxia on the pulmonary 
antioxidant enzyme system has been extensively investigated.""~" We are, however, 
not aware of any study on the effect of artificial ventilation on the neonatal rat 
antioxidant enzyme system. To explore this aspect, we subjected spontaneously 
delivered newborn rats immediately after birth to a short period (for practical 
reasons) of artificial ventilation with room air or pure oxygen. The results of this 
study showed that under both ventilatory conditions GPX activity decreased 
significantly in the CDH lung, but not in the controls. SOD activity tended to 
decrease in these CDH-rats as well, whereas catalase activity remained at about the 
initial leveL We do not know what caused the decrease in SOD and GPX activity of 
the CDH lung. At birth the pO, of room air to which the neonate is exposed, is 
about five-fold higher than the pO, in utero.' Under such conditions of 
reoxygenation incompletely reduced forms of oxygen, i.e., oxygen-derived free 
radicals, become abundant. It is well known that SOD can be inactivated by 
hydrogen peroxide29.3<> and GPX is highly susceptible to inactivation by superoxide, 
hydroxyl radicals, and hypochlorous acid.30-32 If the rate of degradation of these 
enzymes during artificial ventilation is not compensated by an increased rate of 
synthesis, a decline in enzyme activity can be expected. 
The maturation of the pulmonary antioxidant enzyme system is under hormonal 
controL'~" Thyroid hormone stimulates metabolism generally causing an increased 
oxygen consumption, stimulates tissue maturation, but is shown to depress the 
development of antioxidant enzymes if administered at pharmacological doses 
leading to a markedly poorer survival of preterm rats during the first hr of life.35 It 
is not known whether decreased enzyme synthesis, increased enzyme inactivation, or 
increased enzyme turnover rate is underlying the depressed increase in antioxidant 
enzyme activity during gestation. Furthermore, it has been shown that in rats 
rendered hyperthyroid the heart showed decreased GPX activity and increased lipid 
peroxidation."' Earlier studies have revealed that Nitrofen, which resembles thyroid 
hormone in chemical structure, is able to cross the placenta" and appears to have 
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thyrornimetic activity affecting the heart, the diaphragm""', and the lungs9'*"2 From 
the low lung/body weight ratio and the reduced alveolar space as found in an 
earlier study' it can be concluded that the CDH lung in our animal model is indeed 
hypoplastic. At the dose of Nitrofen administered apparently subtle differences in 
the exposure to this drug may exist among individual fetuses in utero, since about 
40% of them did not develop diaphragmatic hernia. However, with respect to lung 
weight and lung/body weight ratio (Table I) and maybe to the GPX response under 
artificial ventilation as well (Table 3), those rats could be considered as intermediate 
between control and CDH. This led us to propose that Nitrofen due to its 
thyrornimetic activity has stimulated the differentiation of the CDH neonatal lung 
resembling the normal adult lung in its inability to respond to oxidative stress by 
an increase in antioxidant enzyme activity. Further investigations are necessary to 
assess the validity of this hypothesis. 
Under normal steady-state conditions antioxidant enzymes afford effective 
protection to tissue damage by reducing the concentration of reactive oxygen species 
in the lung. Superoxide is converted by SOD to hydrogen peroxide. Both catalase 
and GPX can effectively detoxify hydrogen peroxide, but only GPX can reduce toxic 
lipid hydroperoxides formed by free radical attack in the cell membrane to the less 
toxic hydroxy fatty acids, and is therefore directly involved in the repair of the cell 
membrane." If, however, the oxygen concentration is suddenly increased, e.g., 
during birth or artificial ventilation, the formation of reactive oxygen species may 
overwhelm the pulmonary antioxidant enzyme system. A pivotal role of GPX in 
protection against oxidant injury is supported by the finding that tissues can tolerate 
loss of catalase activity during oxidative stress, but no loss of GPX activity.~·'' In 
that respect the present finding of a decrease in pulmonary GPX activity after 
artificial ventilation may indicate that the CDH rat neonate is at risk to develop 
oxygen-related lung damage. 
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RADIOGRAPHIC EVIDENCE OF BRONCHOPULMONARY 
DYSPLASIA IN HIGH-RISK CONGENITAL DIAPHRAGMATIC 
HERNIA SURVIVORS 
42.1 Summary 
Congenital diaphragmatic hernia is a congenital malformation associated with 
pulmonary hypoplasia which often leads to respiratory failure requiring artificial 
ventilation with high inflation pressures and high percentages of oxygen. 
Radiographic evidence of bronchopulmonary dysplasia in survivors, who presented 
with respiratory distress within 6 hours after birth so-called high-risk patients was 
evaluated by a radiographic scoring system measuring the severity of 
bronchopulmonary dysplasia (Toce score) and the degree of pulmonary hypoplasia 
(Touloukian score). Fifteen of 45 survivors (33%) had clinical and nidiological lung 
disease resembling bronchopulmonary dysplasia. As a group they had significantly 
higher Touloukian and Toce scores than survivors without bronchopulmonary 
dysplasia. Morbidity expressed as duration of artificial ventilation, supplemental 
oxygen, and hospital stay was much higher in the bronchopulmonary dysplasia 
group. The hypoplastic lung in infants with congenital diaphragmatic hernia appears 
to be as susceptible to barotrauma and pulmonary oxygen toxicity as the lungs of 
prematurely born infants. To what extent bronchopulmonary dysplasia in congenital 
diaphragmatic hernia survivors might influence future development of lung function 
is not known yet. 
4.2.2 Introduction 
Congenital diaphragmatic hernia (CDH) is a congenital malformation with an 
unchanging high mortality rate from respiratory failure caused by pulmonary 
hypoplasia and persistent pulmonary hypertension.' Its incidence is approximately 
1:3000 live births and this exceeds the incidence of cystic fibrosis (1:3500), the most 
common genetic disorder in The Netherlands. Recent developments in obstetric care, 
such as prenatal ultrasound study, may result in early detection of the fetus with a 
diaphragmatic defect leading to increased maternal transport and planned delivery.' 
As a consequence, many more patients, including those with severe pulmonary 
hypoplasia reach the specialized center. 
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These patients often require artificial ventilation with high inflation pressures and 
high percentages of oxygen to provide adequate oxygenation. Bronchopulmonary 
dysplasia (BPD) is a chronic pulmonary disease mainly presenting in premature 
infants who have been mechanically ventilated with high concentrations of inspired 
oxygen for respiratory distress syndrome.' The pathogenesis of BPD is believed to 
be multifactorial with pulmonary oxygen toxicity and barotrauma having important 
roles:I-
Few reports describe the effect of artificial ventilation on the hypoplastic CDH-
Iung, indicating an increased sensitivity to barotrauma.' To test the hypothesis that 
the incidence of chronic lung disease, resembling BPD in these patients might be 
increased, we reviewed all high-risk CDH-survivors. After repair of the 
diaphragmatic defect we scored radiographic and clinical evidence of BPD and 
related morbidity expressed as duration of artificial ventilation, supplemental 
oxygen, and hospital stay. The preoperative chest X-ray was evaluated in order to 
determine whether it might predict pulmonary hypoplasia and subsequent 
development of BPD. Furthermore, we assessed the severity of the BPD and we 
tried to correlate BPD with the degree of lung hypoplasia as measured by the 
Touloukian score. 
423 Patients and Methods 
A total number of 74 high-risk CDH patients were treated at the Sophia Children's 
Hospital from January 1981 through December 1990. Infants were included in the 
high-risk group if they presented with respiratory distress within the first 6 hours of 
life. All patients had been treated according to a protocol described previously.' In 
brief, patients were ventilated under sedation and muscle paralysis using time-cycled 
pressure-controlled ventilators (Amsterdam Infant Ventilator Mk IllS or Servo 
Siemens 900 C) with a respiratory rate of 60-120 breaths per minute. The goals of 
ventilatory support were PaO, > 100 mmHg, PaCO, < 30mmHg, and pH > 7.40. 
Forty-six patients (62 %) survived. Twenty-eight patients died pre-operatively or in 
the direct postoperative period, either due to lung hypoplasia (maximal PaO, < 80 
mmHg, n=12) or due to therapy resistent persistent pulmonary hypertension (n=16). 
One of the survivors was not enrolled in the study group because of missing X-rays 
and thus the study group consisted of 45 patients. The medical records of these 
patients were reviewed for gestational age, birth weight, gender, side of defect, 
duration of artificial ventilation, duration of supplemental oxygen, and duration of 
hospital stay. In addition ventilation indices, and preoperative and postoperative (A-
a)DO, and P,CO, values were scored. Clinically, BPD was defined according to 
Bancalari as a dependency on oxygen for more than 28 days following mechanical 
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Fig. 1 Typical chest X-ray of a patient after surgical repair of a left-sided diaphragmatic 
defect, compatible with BPD. There is slight cardiomegaly (score, 1 point). Right 
hemidiaphragm projects at ninth posterior and ninth anterior rib (rib count of 18; score, 2 
points). Multiple tiny bubbles of emphysema are apparent especially on the left side (score, 1 
point). Interstitial markings are abnormally prominent (score, 1 point). Patient appears 
moderately diseased (score, 1 point). Overall score is thereby 6 points. 
ventilation during the first week of life.' The chest X-rays were scored by two 
experienced pediatric radiologists in a blinded fashion as follows: the first X-ray for 
risk assessment of pulmonary hypoplasia according to Touloukian', and the X-ray on 
day 28 for BPD-assessment according to Toce.' The Touloukian score included: (1) 
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side of the diaphragmatic defect, (2) location of the stomach, (3) presence of an 
ipsilateral or contralateral pneumothorax, (4) degree of the mediastinal shift, (5) 
amount of visceral distension, (6) relative volume of aerated ipsilateral, and (7) 
contralateral lung. Each roentgen finding was graded on a sliding scale from 0 to 2 
with the higher grades assigned to the less favorable findings. The maximal score 
was 14 points. The Toce score is largely based on four of the most prominent 
roentgenographic abnormalities in BPD: overall lung expansion, interstitial densities, 
focal emphysema,and cardiovascular abnormalities (Fig.1). These factors were scored 
on a scale from 0 to 2 to indicate increasing severity. A fifth factor, scored likewise, 
is the roentgenographic impression of the overall severity of disease. The range of 
scores is thus 0 to 10, with 10 being the most severe. Statistical analysis for 
differences of means was done with the unpaired t-test. Results are given as mean ± 
standard error. The relationship between Touloukian and Toce scores was evaluated 
by linear regression analysis. Significance was accepted at the p<0.05 leveL 
42.4 Results 
Twelve patients had already been discharged or were without supplemental oxygen 
on day 28, and consequently did not have BPD.' Radiologic evaluation of chest X-
rays taken on day 28 or later was possible in 33 patients. Fifteen of them had chest 
X-rays showing BPD at day 28 of life, and 18 did not. The 15 BPD-patients were 
compared with the 30 patients that did not have clinical BPD (Table !, p. 92). The 
group with BPD had a shorter gestational age and a lower birth weight, but the 
difference did not reach a significant leveL Side of defect and male:female ratio did 
not differ between groups. The Touloukian scores and the Toce scores were 
significantly higher in the BPD group. The Touloukian score was not correlated with 
the Toce score in the individual patient (r=0.15, p=0.62). Ventilation indices, and 
preoperative and postoperative (A-a)DO, and P,,CO, values were higher in BPD-
patients, however, without reaching statistical significance. As expected, patients 
with BPD required prolonged artificial ventilation, prolonged administration of 
supplemental oxygen, and had a much longer hospital stay. 
42.5 Discussion 
The radiologic score of BPD developed by Toce confirmed the clinical diagnosis in 
15 out of 45 surviving high-risk patients. Preoperative risk assessment aimed at 
establishing the degree of pulmonary hypoplasia showed higher mean Touloukian 
scores in the BPD group; so this scoring system may help identify patients at risk 
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Table1. Profiles of survivors of CDH with and without BPD* 
BPD non-BPD 
Clinical data (n = 15) (n = 30) 
gestational age (wk) 37.7 ± 0.5 39.1 ± 0.5 
birthweight (kg) 2.93± 0.14 3.1 ± 0.13 
Touloukian-score 10.3 ± 0.2 9.0± 0.3• 
Toes-score 3.9 ± 0.6 0.7 ± 0.2• 
hospital stay (days) 126 ± 20 46 ± 8• 
artificial ventilation (days) 38 ± 10 12 ± 2• 
supplemental oxygen (days) 45 ± 11 14 ± 2• 
Ventilation parameters (n = 12) (n = 25) 
Ventilation index 793 ±421 569 ±51 
(A-a) 002 preop 176 ±103 150 ± 78 
postop 237 ±186 162 ±83 
PaC02 preop 37.3 ± 6 33.6± 7 
postop 36.5 ± 4.8 35.9± 6.6 
• Data are means ± SEM;• P< 0.05 
Ventilation index: Mean Airway Pressure x Respiratory Rate 
for BPD. No correlation with the Toce score was found in the individual patient. 
Morbidity is very high in these patients, as is reflected by long-term artificial 
ventilation, administration of supplemental oxygen, and hospital stay. 
One of the characteristics of CDH is a variable degree of hypoplasia of the ipsi-
and contralateral lung. The maturation of alveolar structures is delayed. The number 
of alveoli and the number of generations of the bronchial tree is reduced."·" 
Consequently respiratory failure immediately after birth is common in these patients 
and may be due primarily to lung hypoplasia. Oxygen toxicity and barotrauma may 
then lead to further damage of the lung and further need for ventilatory support. 
There is evidence that the CDH-lung is anatomically and biochemically immature. 
Hisanaga et a!. have shown that the amniotic fluid of infants with CDH has lower 
lecithin/sphingomyelin ratios." Animal experiments showed that antioxidant enzyme 
activity in the lungs of neonatal rats with a diaphragmatic defect and lung 
hypoplasia is decreased when exposed to artificial ventilation with 100% oxygen. 
Normal controls were able to produce normal lung antioxidant enzyme activity."·H If 
this finding is applicable to the human infant with a diaphragmatic defect the 
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Fig. 2 Incidence of BPD related to birth weight in premature infants (data from Bancalari ' 
(with permission), and CDH survivors). 
vulnerability of the CDH-lung to hyperoxia might be explained. Artificial ventilation 
with high percentages of oxygen and high inflation pressures may then lead to lung 
damage, even at full term. 
The pathogenesis of BPD has been thought to be multifactorial and is related to 
tissue damage by hyperoxia and barotrauma.' BPD is one of the major sequelae of 
mechanical ventilation in the neonatal period.' lt affects in particular prematurely 
born infants with a low birth weight.' 
Patients with CDH have hypoplastic lungs that are often immature and 
functionally resemble the lungs of the premature infant." The risk for barotrauma in 
CDH patients might be even increased, because the asymmetry of the lungs results 
in areas of differential compliance and subsequent risk for hyperinflation16 and 
overexpansion of alveoli." Sakai and co-workers found that respiratory system 
compliance values dropped after surgical repair, due to the tight closure of the 
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diaphragm, the relocated abdominal viscera, and particularly hyperinflation, resulting 
in barotrauma of the contralateral lung." This probably explains the relatively high 
incidence of BPD despite normal birthweight (fig 2, p.93). 
There are few reports in which pulmonary function after repair of CDH is 
evaluated. Pulmonary function tests within 30 days after surgical repair of CDH 
revealed a decrease in forced vital capacity and respiratory system compliance to 
half the values in normal newborn infants. In addition, airway reactivity was a 
prominent feature in CDH survivors, with the site of the reactivity probably located 
in the periphery of the lungs.19 In long-term survivors reduced perfusion and 
ventilation of the ipsilateral lung in combination with airway obstruction has been 
reported." In one report destructive emphysema of the hernia-side lung was 
evident.21 Since the introduction of prenatal ultrasound study and maternal transport, 
many more neonates with severe pulmonary hypoplasia will be able to reach the 
specialized center and will receive artificial ventilation. On the one hand, 
preoperative stabilization before surgical repair has been proven beneficial in CDH 
patients resulting in a nearly twofold increase in respiratory system compliance and 
subsequently in better chances of survival." The application of extracorporeal 
membrane oxygenation (ECMO) also contributes to initial survival of the so-called 
high-risk patients in the neonatal period. On the other hand, a recent analysis of 
ECMO treatment showed a considerable number of deaths in these patients within a 
few months. Most of them still needed artificial ventilation after coming off ECMO 
and died of BPD. This is why the mortality rate remains 40%.23 
In conclusion: CDH is a serious congenital malformation with a high mortality 
rate and a high morbidity. This is the first documented report on the incidence of 
chronic lung disease, resembling BPD in high-risk CDH survivors, showing an 
increased incidence despite term gestation and mean birth weights around 3000 g. 
These patients require long-term artificial ventilation and hospital stay following 
surgical correction. 
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"DELAYED" AND "ACQUIRED" PRESENTATION 
5.1.1 Summary 
A case of late presentation of left congenital diaphragmatic hernia (CDH) in a boy 
of 9 months is reported. A chest X-ray taken after (premature) birth gave normal 
results; hence this type of CDH is called "acquired". Not being associated with 
pulmonary hypoplasia, this condition is difficult to diagnose. The patient presented 
as an emergency and the initial diagnosis was tension pneumothorax. This resulted 
in the insertion of a chest tube, fortunately without damage to the herniated 
stomach and spleen. Doubling upward of the tip of the nasogastric tube led to the 
correct diagnosis. After successful repair of the diaphragm the child made a full 
recovery. 
5.1.2 Case History 
A boy of 9 months was found early one morning in his crib with respiratory arrest. 
Mouth-to-mouth respiration was applied successfully by the father and the child 
was rushed to the hospital. It appeared that he had been suffering from an upper 
respiratory tract infection for several days with increasing dyspnoea. He had been 
born prematurely at 35 weeks gestation with hydrops fetalis due to rhesus 
antagonism, which necessitated exchange transfusions. Mild respiratory distress 
symptoms in the neonatal period were diagnosed as ''wet lung", and treated with 
continuous positive airway pressure (CPAP) and additional oxygen. A chest X-ray 
taken at the time gave normal results. 
On admission, the boy was found to be dyspnoeic and cyanotic. His body 
temperature was 38.5°C, pulse rate 160/min, respirations 40/min. No breath sounds 
were heard on auscultation of the left chest. A chest X-ray (Fig.1) demonstrated air 
in the left pleural cavity with a mediastinal shift to the right, which was interpreted 
initially as left-sided tension pneumothorax. Laboratory findings were: White blood 
count 18.7 x 109 /1; Capillary blood gas analysis: Ph 7.03; pCO, 8.3 kPa; Base 
excess -14,4; 0,-saturation 46%. A drain was inserted in the left pleural cavity but 
the left lung did not expand. It was then noted that the nasogastric tube curled 
upward, suggesting that the stomach was in the left pleural cavity. Contrast 
administration through the nasogastric tube confirmed this, leading to a provisional 
diagnosis of left diaphragmatic hernia (Fig.2, p. 100). 
Subsequent laparotomy demonstrated a Bochdalek congenital diaphragmatic 
hernia on the left side, through which stomach and spleen were herniated. There 
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Fig. 1 Chest X-ray made on admission at 9 months 
was no hernial sac. The organs were intact and could be reduced without difficulty. 
A normal left lung was seen to expand. The diaphragm was then repaired. 
The post-operative course was complicated by recurrent atelectasis of the right 
upper lobe, which necessitated prolonged artificial ventilation and repeated 
bronchoscopy. After successful weaning from the ventilator on the seventh post-
operative day, the child developed an intestinal obstruction. Laparotomy revealed 
ileo-ileal intussusception, which was reduced without resection. One month after the 
hernia repair the infant left the hospital in good condition. 
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Fig. 2 Radiograph after administration of gastrografin via nasogastric tube, revealing the 
stomach in the left pleural cavity 
DELAYED PRESEl\.'TATION 
____________________________________ _JQl 
5 .1.3 Discussion 
Wiseman and McPherson' differentiated between four types of congenital diaphrag-
matic hernia (CDH). In type 1 herniation occurs early in the course of bronchial 
branching, resulting in fatal bilateral pulmonary hypoplasia. In type 2 there is 
herniation at the stage of distal bronchial branching, resulting in unilateral 
hypoplasia with some chances of survival. In type 3 there is herniation at a late 
stage of gestation with little or no lung changes. Type 4 CDH presents some lime 
after birth in children who are free from symptoms initially while this type is not 
associated with pulmonary hypoplasia. Therefore, the prognosis is very good. 
In all 17 type 4 cases reported by Wiseman and McPherson', results of the initial 
chest X-ray had been normal. Consequently, they speak of acquired CDH. In their 
series herniation symptoms occurred between 12 h and 5 years after birth, but in 
several cases it took days to months to reach the proper diagnosis. Left- or right-
sided CDH occurred with equal frequency and there was a male predominance. 
Presenting symptoms of type 4 CDH are either pulmonary (pneumonia, 
dyspnoea, cyanosis) or gastrointestinal (obstruction).' Bowel sounds may be heard on 
auscultation of the chest. According to Wiseman and McPherson herniation in type 
4 CDH takes place most often in the neonatal period because physiological events at 
that time favour a visceral shift from abdomen to chest. 
In our patient normal results of a chest X-ray in the neonatal period 
demonstrated no CDH, therefore he can be classified as acquired or type 4 CDH. It 
is uncertain when and how herniation occurred, but it appears plausible that his 
upper respiratory tract infection with dyspnoea may have led to aerophagy with 
increasing distention of the stomach. This resulted in a mediastinal shift and 
circulatory problems. Mouth-to-mouth respiration forced more air into the stomach, 
leading to the clinical and radiological picture of tension pneumothorax. In 
retrospect, insertion of a chest tube was a risky procedure in view of the presence 
of stomach and spleen in the chest. Fortunately, the correct diagnosis was reached 
soon afterwards and surgical correction posed no problems. 
Awareness of the possibility of late presentation of CDH will lead to a proper 
diagnosis and prevent hazardous insertion of a chest tube under the mistaken 
diagnosis of pneumothorax. 
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5.2.1 Summary 
PRE-OPERATIVE STABILIZATION 
WITH DELAYED REP AIR IN 
CONGENITAL DIAPHRAGMATIC HERNIA 
Congenital diaphragmatic hernia (CDH) remains one of the major challenges for 
pediatric surgeons and pediatric intensive-care specialists. Death in patients with 
CDH is 30-60% worldwide due to severe pulmonary hypoplasia or pulmonary 
hypoplasia associated with persistent pulmonary hypertension, secondary to hypoxia, 
metabolic acidosis or myocard insufficiency. Pre-operative stabilization of CDH 
patients might reduce the risks of these complications. In a two-year period 16 high-
risk patients with CDH (respiratory insufficiency < 6 hrs after birth) underwent 
delayed surgery following a stabilization period (mean 14 hrs). Continuous 
suctioning on a nasogastric tube resulted in total resolution of the mediastinal shift 
on repeat x-rays. The use of the ventilation parameters arterial alveolar oxygen 
gradient (A-A)DO, oxygenation index (01) and mean airway pressure (MAP) 
revealed three different groups of patients: I consisting of 6 survivors, II two 
preventable deaths and Ill eight non-survivors. 
In this way selection of patients with CDH is possible. In patients who do not 
improve during the stabilization period alternative ways of treatment have to be 
evaluated such as extracorporeal membrane oxygenation (ECMO), high frequency 
oscillation (HFO) or high frequency jet ventilation (HFJV). Application of the 
ventilation parameters in prospective trials of patients with CDH enables comparison 
between different ways of treatment in the future. 
5.2.2 Introduction 
The mortality rate for patients with congenital diaphragmatic hernia (CDH) varies 
form 30-60%.'2 " Patients admitted within 6 hours of birth generally constitute a high 
risk group. Death in patients with CDH is due to severe pulmonary hypoplasia' or 
to less severe pulmonary hypoplasia associated with persistent pulmonary 
hypertension. Attempts to decrease the high pulmonary arterial pressure by means 
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of vasoactive drugs is not always successful.' In many cases high pulmonary arterial 
pressure is secondary to hypoxia, metabolic acidosis or electrolyte disturbances.'·'•-9 
Pre-operative stabilization of CDH patients might reduce the risk of these 
complications. In patients treated in this way new questions arise about the 
indication and timing of the operation. Ventilation parameters collected during the 
stabilization period can be evaluated as predictors for survival. 
5.23 Patients and Methods 
In a two year period from January 1986 to December 1987 16 patients (8 males and 
8 females) with CDH were admitted within 6 hours after birth to the pediatric 
surgical intensive-care unit of the Sophia Children's Hospital in Rotterdam. The 
mean birth weight was 2900 grams (1885-3700 g), mean gestational age 38 weeks 
(32-42 wk). Two children were born preterm. 
Overall mortality was 10 out of 16 (61 %). The diaphragmatic defect was 
predominantly !eft-sided involving 10 patients versus 6 with a right-sided defect. 
Four patients had concomitant congenital anomalies, consisting of hypoplastic left 
ventricle, aortic coarctation, trisomy 21, and cheiloschisis. In the patient with aortic 
coarctation hypertension of the upper part of the body was diagnosed only two 
months after birth and successfully repaired by resection of the coarctation. All 
patients suffered from respiratory insufficiency within 0-3 hours after birth, requiring 
endotracheal intubation and artificial ventilation. 
In one patient bilateral pneumothorax was drained successfully in the referral 
hospital, while in another patient pneumothorax was diagnosed on arrival at the 
surgical intensive-care unit and drained. All patients were ventilated by a time-
cycled volume-controlled ventilator (Siemens Servo 900C) with frequencies between 
60-80 per minute under general muscular paralysis (Pavu!onR) and sedation 
(DiazepamR). 
Adjustment of ventilatory settings was always aimed at arterial pH values 
between 7.45 and 7.50, PaCO, between 25 and 30 mmHg and Pa02 between 100 and 
150 mmHg. The ventilatory requirement was based on arterial blood gas analysis 
using pre- and postductal indwelling catheters that enabled continuous monitoring 
of the systemic blood pressure as welL In case one of the arterial catheters could 
not be placed, pre- and postductal transcutaneous PO, measurements were done in 
addition. 
All patients underwent cardiac evaluation at least once preoperatively to exclude 
structural cardiac anomalies as well as evaluation of myocardial contractility. 
Hypoxic cardiomyopathy was suspected in many patients secondary to postnatal 
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asphyxia. If required, the systemic blood pressure was supported by dopamine or 
dobutamine (2-10 11g/kg/min), in a few cases in combination with isoprenaline (3-10 
l'g/kg/hr). In case of hypoxic cardiomyopathy sodium-nitroprusside or nitroglycerin 
was administered for afterload reduction in a dosage ranging from 0.5-10 
l'g/kg/min. 
Metabolic acidosis was treated by vigorously by sodium bicarbonate or TRI5-
buffer until the arterial pH had risen above 7.40. A nasogastric tube was inserted in 
all patients enabling continuous suctioning of 5 ern of water to reduce the shift of 
the mediastinum which was always present. Repeat thoracic X-rays 6-12 hrs after 
admission served to assess any decrease in mediastinal shift as well as the amount 
of air in the digestive tract. 
Twelve of our 16 patients were operated upon through a subcostal abdominal 
incision enabling reduction of the abdominal organs from the thoracic cavity and 
closure of the defect in the diaphragm. The mean duration of the stabilization 
period was 14 hours (range 2-33 hrs). Primary repair was possible in three patients, 
all others required a durapatch. Prior to the diaphragmatic closure, a chest tube was 
placed in the pleural space without suctioning and kept in place for at least 3-5 
days. 
Autopsy was performed in 8 of the 10 patients who died. The diagnosis of 
pulmonary hypoplasia was based on a Jung-bodyweight index Jess than 0.012 as 
described by Askenazi et al (1979).10 In all patients the ventilation parameters were 
determined at six-hour intervals using the following formulas: 
Arterial alveolar oxygen-gradient " 
(A-a) DO, = FiO, (Pb-47) - PaO,-PaCO, (FiO, + 1 - FiO,/ R) 
Mean airway pressure ' 
MAP = 2/Jt(lt x TRC) x (PIP-PEEP) + PEEP 
Oxygenation index " 
01 = FiO, x 100 x MAP 
PaO, 
FiO, = inspired oxygen concentration 
Pb = atmospheric pressure 
PaO, = arterial pO, 
pACO,= alveolar pCO,, 
assumed is paCO, (arterial pCO,) 
R = respiratory quotient, assumed to be 0.8 
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It = 
TRC = 
PIP = 
PEEP= 
inspiratory time 
total respiratory cycle 
peak inspiratory pressure 
positive end-expiratory pressure 
52.4 Results 
Ten of our 16 patients died, amounting to an overall mortality of 61%. This 
included all six patients with a right-sided defect but only four of ten patients with 
a left-sided defect, a comparative mortality of 100% versus 40%. 
For two patients death was not directly related to the diaphragmatic defect. One 
of them contracted a pulmonary infection following successful surgical repair 
requiring increased oxygenation. The occurring persistent foetal circulation did not 
respond to vasoactive drugs and Pseudomonas aeruginosa were isolated from 
tracheal cultures. At the age of seven days this patient died. 
Table 1. (A-a)D02, 01 and MAP values measured at admission, after 12 and 24 hours• 
n 0 hrs 12 hrs 24 hrs 
(A-a)D02 
Survivors 6 321 ± 269 147± 105 189 ± 105 
Prevent death 2 198 -289 192 - 172 562 - 198 
Non-survivors 8 607 ± 12 606 ± 39• (n = 7)+ 565 - 176 (n = 2)+ 
01 
Survivors 6 16 ± 20 5 ±1 5 ± 2 
Prevent death 2 6.7 - 5.2 3.1 - 7.3 3.8- 2.1 
Non-survivors 8 27 ± 24 95 ±78"(n=7)+ 67.5-186 (n = 2)+ 
MAP 
Survivors 6 13 ±5 3 ± 1 13 ± 5 
Prevent. death 2 9 - 9.4 9.7 - 9.9 9.4 - 9.9 
Non-survivors 8 14 ±5 23 ± 5" (n = 7)+ 19.6 - 33.6 (n = 2)+ 
• Data are means ± So;+ Number decreased by deaths; • p<0.05 
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Fig. 1 (A-a)DO, in survivors (a) and nonsurvivors (b) including preventable deaths. Broken 
line indicates more than 80% mortality rate. Hr: hours after arrival at ICU. 
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The other patient returned to the ICU with persistent foetal circulation which did 
not respond to ventilatory assistance or vasoactive drugs and was subsequently 
found to have developed pneumothorax at surgery that had remained undetected. It 
was felt that these two deaths might have been prevented and these two non-
survivors were therefore classified separately. Consequently, the assessment of 
results concerned three groups of patients: I consisting of six survivors, II two 
"preventable deaths", and III eight non-survivors. For all patients, regardless of 
survival or mortality, pre-operative stabilization successfully reduced the mediastinal 
shift as shown by the repeat thoracic x-rays taken before surgery. 
Table 1 (p. 106) gives the values determined for the ventilation parameters at 
different intervals per group of patients, showing a decrease in numbers for the 
non-survivors. Figure 1 (p. 108) gives the values of the arterial alveolar oxygen 
gradient in relation to time as well as the moment of operative repair. For eight 
patients these values amounted to <: 600 with minor changes in time; all these 
patients died. Two other patients with an (A-a)DO, > 600 on arrival had a rapid 
decrease of this gradient and both patients survived. In contrast, two of the 
remaining six patients with low (A-a)DO, values on arrival showed a significant 
increase within the first 24 hours after admission and died (preventable deaths). 
Figures 2 and 3 shows that both the OI and MAP at 12 hours after arrival in 
survivors and non-survivors differ significantly with exception of the two patients 
whose deaths were considered preventable (p. 110 & 111) Figure 4 (p. 112) gives the 
relationship between FiO, and preductal arterial PaO, at 12 hours after arrival. A 
preductal PaO, above 100-150 was achieved in all surviving patients, while in all 
non-surviv.ors the preductal paO, was below 60 mm Hg even with a FiO, of 1,0. 
The two patients with preventable death clearly showed an intermediate pattern. 
Four patients were never operated upon because of persistent arterial hypoxemia 
(PaO, < 60 rnm Hg). Lung hypoplasia (lung-bodyweight index < 0.012) was 
diagnosed postrnortally in all eight non-survivors for whom permission for autopsy 
was granted, including two patients who never underwent surgery. 
5.2.5 Discussion 
Congenital diaphragmatic hernia is generally considered to be a surgical emergency. 
The bowel loops that protrude into the thoracic cavity during the foetal period have 
to be removed as soon as possible. 
In our series of 16 CDH patients primary non-operative treatment revealed two 
divergent patterns. In the first group of six patients no pathological values of the 
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Fig. 4 Relationship between Fi02 and the preductal Pa02 at 12 hours after arrival at the 
ICU. 
arterial alveolar oxygen gradient, oxygenation index and low mean airway pressures 
were observed. These infants had an excellent prognosis and survival should have 
been 100%. Unfortunately two patients did die, but their death was clearly not 
directly related to the CDH and could have been prevented. 
The second group of patients, 10 out of 16, had pathological values of (A-a)D02 
on arrival. In two cases in which pathological values were noted (>80% predicted 
mortality)" on arrival at the !CU pre-operative stabilization resulted in a rapid 
normalization of the (A-a)D02 and to a lesser extent of the 01 and MAP and these 
patients survived as well. In the remaining eight patients adjustment of ventilatory 
settings in combination with medication to improve cardiac output did not lead to 
improvement of arterial blood gas values. These patients showed no response to 
treatment and died within 4-32 hours after admission. 
Many patients with CDH pass a period of asphyxia following birth leading to 
hypoxic cardiomyopathy and persistent R-L shunt due to persistent pulmonary 
hypertension. For this reason other authors'·" have advocated delayed repair of 
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CDH. Cartlidge et a! described 17 patients with CDH who developed severe 
respiratory insufficiency within one hour after birth." Their survival rate increased 
from 12% in patients, who underwent emergency repair to 53% following delayed 
repair. Bohn reported the use of the ventilation index as predictor of survival in 36 
patients with CDH who underwent delayed repair.' The same group demonstrated 
that lung compliance may decrease significantly following surgical repair." 
Other ways of ventilation have been suggested as a way to improve survival of 
patients with congenital diaphragmatic hernia such as high frequency oscillation or 
ECMO. ECMO may be considered for patients who survive the operation by at least 
8 hours and meet the criteria of Bartlett." A prospective randomized trial using 
ECMO and other forms of ventilatory support (high frequency jet ventilation or 
oscillation) has not yet been performed. In contrast to the investigations of Raphaely 
and Downes" who attributed a significant decrease of the (A-a)D02 in surviving 
patients with CDH to surgical correction we have shown that this value decrease 
regardless whether the patients are operated upon or not.. 
In other words, the improvement of the (A-a)DO, cannot be considered as a 
result of the surgical correction. lt can be achieved by optimal artificial ventilation 
and the use of vasoactive drugs alone. In all our patients nearly complete resolution 
of the mediastinal shift took place by continuous suction of the stomach. Repeat x-
rays revealed that the deviation of the mediastinum had disappeared. In our opinion 
this phenomenon plays a significant role in the improvement of the arterial blood 
gas values observed in a number of patients during the preoperative period. This 
dismisses a persistent shift of the mediastinum and compression of the contralateral 
side as an argument for emergency operation. Although our approach did not lead 
to a significant decrease of the mortality rate it does enable selection of patients. In 
patients who do not improve alternative ways of treatment have to be evaluated. 
The great number of right-sided diaphragmatic hernias in our group might have 
contributed significantly to the total mortality." 
In conclusion: (A-a)D02, Ol and MAP values obtained during the preoperative 
stabilization period in CDH patients have a predictive value for survival. In case no 
significant improvement of the values under study is observed during the 
stabilization period, surgical repair does nog change the ultimate prognosis for these 
patients. 
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SURFACTANT REPLACEMENT THERAPY IN 
HIGH-RISK CONGENITAL DIAPHRAGMATIC HERNIA 
5.3.1 Letter 
SIR,- Clinical trials of surfactant replacement therapy have shown a reduction in the 
frequency and severity of respiratory distress syndrome (RDS) in premature 
newborn babies,' and first clinical trials in adults have also shown the beneficial 
effects of this therapy." 
Does surfactant have a role in the treatment of more mature infants with pneumonia 
and meconium aspiration syndrome, or in infants with hypoplastic lungs, as seen in 
congenital diaphragmatic hernia? Congenital diaphragmatic hernia present in 1 in 
3000 liveborn babies. Although new treatments, such as delayed surgery and 
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extracorporeal membrane oxygenation (ECMO), have been advocated, the case 
fatality rate for this malformation still remains 30-50% worldwide because of 
pulmonary hypoplasia and persistent pulmonary hypertension.' The hypoplastic lung 
in these patients is probably biochemically immature, and low 
lecithin/sphingomyelin ratios in amniotic fluid have been recorded.' We investigated 
the effect of surfactant replacement therapy in 4 newborn babies with a congenital 
diaphragmatic defect. Their mean gestational age was 37 (range 36-40) weeks and 
their mean birthweight 2880 g (range 2560-3400). All 4 patients had respiratory 
insufficiency within 6 h after birth. They were ventilated with a time-cycled pressure 
controlled ventilator ("Servo 900C", Siemens Elema, Sweden) with high inflation 
pressures and 100 % 0,. We did not use surfactant prophylactically, but as rescue 
therapy within 24h of birth to improve oxygenation and to diminish further damage 
to the hypoplastic lung. The surfactant used was a natural substance isolated from 
minced bovine lungs. It consists of about 83% phospholipids, I% hydrophobic 
proteins (SP-B and SP-C), and other lipids such as cholesterol, glyceride, and free 
fatty acids, but does not contain SP-A. The freeze-dried preparation was 
resuspended in a 0.9% NaCl solution resulting in a total concentration of 40 mg 
phospholipids per mi. We gave 150 mg/kg of the surfactant extract endotracheally, 
and recorded the alveolar-arterial oxygen tension difference (A-a)D02, which 
indicates gas exchange by the lungs, immediately before and after administration 
and after 6 h. In patients 1 and 2 (figure),(A-a)DO, fell strikingly and led to a 
decrease in FiO, and inspiratory peak pressures. The effect was most pronounced 
immediately after administration. Repeated doses had only a short-term effect. The 
diaphragmatic defect was closed afterwards and both patients survived. In the other 
two patients no effect was noted; both had had ECMO treatment. Patient 3 died on 
ECMO with uncorrectable coagulation disorders and a massive intracranial 
hemorrhage. 
After being weaned from ECMO successfully at age 12 days, patient 4 died at six 
weeks because of relapsing episodes of persistent pulmonary hypertension. 
Our preliminary conclusion is that in some newborn infants with congenital 
diaphragmatic hernia, surfactant therapy may induce a transient but important 
improvement of oxygenation. Tiris improvement may lead, especially when used as 
a prophylactic measure, to a reduction of barotrauma to the hypoplastic lung and a 
reduction of risk factors for persistent pulmonary hypertension (ie, hypoxia) as well 
as to the possibility of gaining time to introduce other treatments such as ECMO. 
The best dosing schedule and the optimum preparation of surfactant for these 
patients needs to be established. We have lately treated a fifth baby born at term 
(patient 5 in figure) with congenital cystic adenomatoid malformation of the lung 
who responded well to treatment and who survived without chronic lung disease. 
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CHANGING CONCEPTS 
During the past few decades we have seen a changing approach to the treatment of 
newborns with congenital diaphragmatic hernia presenting with symptoms soon 
after birth. The original report by Ladd and Gross published in 1940, advocated 
emergency surgery.' The significance of the degree of pulmonary hypoplasia and the 
pathophysiological role of the abnormal pulmonary vascular bed have been 
recognized since then: they contribute to patterns of mortality and morbidity and 
limit the extent of successful treatment. Despite highly-skilled care by neonatologists 
and pediatric surgeons, and despite antenatal diagnosis by means of sonography, the 
mortality rate has remained unchanged at approximately 40 to 50%. 
It was common experience that aggressive artificial ventilation, using high 
inspiratory peak pressures and high percentages of oxygen, was needed to achieve 
adequate gas exchange and reduction of risk factors for persistent pulmonary 
hypertension. In other words, a regimen destructive to the hypoplastic lung, which 
often resulted in early onset of bronchopulmonary dysplasia. Therefore, several 
attempts have been made to improve the outlooks. 
1). The effect of DELAYED suRGERY on survival was first reported by Cartlidge'. 
Different groups around the world have reported their experiences with this 
approach using a standardized protocoL'" The concept of delayed surgery is based 
on several premises: (a) surgical repair of the diaphragmatic defect is not an 
emergency, except in case of bowel strangulation; (b) risk factors for persistent 
pulmonary hypertension such as hypoxia, acidosis, hypothermia, and low systemic 
blood pressure can be treated'; (c) lung compliance decreases significantly following 
surgical repair6; and (d) patients with pulmonary hypoplasia incompatible with life 
can be recognized.' Prospective clinical studies have shown that the operative 
procedure itself has a major impact on circulatory vasoconstrictive agents.' 
The delayed surgery approach has become standard procedure around the world; 
however, evaluation of the patients treated this way, did not show a reduction of 
mortality. Nevertheless it allowed for a far better pathophysiological understanding 
of the adaptation of the pulmonary vascular bed after birth and of the intrathoracic 
pressure relationships before and after closure of the diaphragm. An unsolved 
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question is the duration of the stabilization period: what criteria should be used to 
determine the optimal moment of surgical intervention? If the long-term outcome in 
larger series should still be disappointing, the use of this treatment modality will 
have to be re-evaluated. However, a certain period of stabilization provides the 
possibility to institute other forms of treatment that may contribute to better chances 
of survival. 
2). If conventional artificial ventilation should not result in adequate gas 
exchange, with acceptable oxygenation and elimination of CO, thereby reducing the 
risk factors for persistent pulmonary hypertension, some children will benefit from 
new ventilatory strategies using high-frequency jet ventilators and high-frequency 
OScillatorS. HIGH FREQUENCY OSCILLATION VENTILATION has been SUCCesSfully USed in a 
number of neonates.3'9'10.1 1'12 One of its advantages is that it enables C02 removal with 
lower mean airway pressures, minimizing the risk for persistent pulmonary 
hypertension and barotrauma and subsequent development of bronchopulmonary 
dysplasia in case the patient survives. 
3). In some centers patients are given a trial of high frequency ventilation before 
EXTRACORPOREAL MEMBRANE OXYGENATION (£CM0) is instituted as rescue therapy for 
persistent pulmonary hypertension." ECMO provides lung rest together with the 
opportunity to overcome episodes of persistent pulmonary hypertension. 
Historically, at least a single measurement of PaO, > 80 mmHg was needed to 
prove the presence of the absolute minimum number of alveoli to guarantee 
survival after corning off ECMO. The first reports on survival rates in congenital 
diaphragmatic hernia patients treated with ECMO were encouraging. 
Heaton reported a survival rate of 73% in 30 patients." 
Stolar treated only patients with a best preductal PO, > 100 mmHg and PCO, < 
50 mmHg to avoid treatment of overwhelming pulmonary hypoplasia, and found 
a survival of 68% in 27 patients." 
Langham reported 41 survivors in 93 patients (42%) in a study from the ECMO 
Central Registry, and suggested that these children would not have survived 
without ECMO." 
Redmond found a survival rate of 73% in a 3-year period (30 patients) and a 
strong indication that the maximum postoperative mean-airway-pressure value 
accurately predicts survival." 
Heiss even reported a survival rate as high as 87% and stated "the reversal of 
mortality with ECMO" has started." 
The initial optimism waned when it was observed that results of ECMO in 
congenital diaphragmatic hernia patients did not parallel the results in other patient 
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groups, for instance in those suffering from the meconium aspiration syndrome."20 
According to O'Rourke and coworkers, the mortality rate did not decrease after the 
introduction of ECMO. They distinguished different hospital courses: (1) survival 
with conventional therapy; (2) survival with ECMO; (3) early ECMO death (direct 
ECMO complications and absence of improvement in lung function); and (4) late 
ECMO deaths: patients who were weaned from ECMO, but died secondarily to 
complications from chronic lung disease."-" The early ECMO death group may have 
such severe lung hypoplasia that ECMO only postponed death. Recognition of this 
group is difficult in the immediate postnatal period, and conventional ECMO entry 
criteria may not be applicable for the congenital diaphragmatic hernia patient. The 
late ECMO death patients deteriorated on conventional mechanical ventilation and 
probably represent a group of patients with a combination of moderate lung 
hypoplasia and iatrogenic lung injury. O'Rourke's group also compared the results 
of immediate repair with those of delayed repair using ECMO when necessary. 
They reported survival rates of 43% versus 45%. The best postductal PO, proved to 
be an accurate predictor of outcome in these patients. 
ECMO certainly supports some congenital diaphragmatic hernia patients and 
prevents progressive pulmonary destruction and early onset of bronchopulmonary 
dysplasia. Therefore, others advocated ECMO for all congenital diaphragmatic hernia 
patients regardless of entry criteria based on gas exchange values and regardless of 
predictors of mortality." 
4). In our institution we observed that some congenital diaphragmatic hernia 
patients benefit from early application of suRFACTANT." The hypoplastic lung is 
anatomically immature, but there is direct and indirect proof that production of 
surfactant is also diminished.""' If the hypoplastic lung really is unable to produce 
sufficient amounts of surfactant, replacement therapy can be of value to reduce 
ventilator settings and subsequent development of bronchopulmonary dysplasia. The 
patients could be selected when predetermined ventilator settings are reached, and 
analysis of bronchoalveolar fluid lavage, as described by Stenmark, has been 
obtained."" 
5). Persistent pulmonary hypertension is one of the determining factors of the 
outcome in patients with congenital diaphragmatic hernia. Numerous VASO-ACTIVE 
AGENTS have been advocated as the ultimate solution to modulate pulmonary vascular 
tone, but a selective vasodilator of the pulmonary vascular bed is still not available. 
Tolazoline has been advocated, but it may have deleterious side-effects on the 
systemic circulation."'"' Elevated levels of the vasoconstrictor thromboxane have been 
reported in congenital diaphragmatic hernia patients during persistent pulmonary 
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hypertension."" Promising results have been reported concerning the application of 
prostacyclin after cardiac surgery in children and in persistent pulmonary 
hypertension in neonates."-"' Ford and coworkers reported elegant studies in a lamb 
model of congenital diaphragmatic hernia and investigated the effectiveness of 
several vasodilators. They concluded· that prostaglandin D2 came closest to the ideal 
vasodilator, with isoprenaline as second best." More recent reports suggested 
magnesium sulfate as a promising alternative." New data on the cell-biological 
aspects of vascular tone regulation mediated by endothelium-derived relaxing factor, 
stimulated the use of nitric oxide as a local intratracheal drug." 
6). FETAL SURGERY is an approach developed by Harrison and coworkers after 
having defined the pros and cons of prenatal diagnosis by ultrasound.""' They 
found mortality rates exceeding 75% in antenatally diagnosed patients, and 
identified polyhydramnios and timing of the herniation as bad prognostic signs." In 
the concept of fetal surgery catch-up growth of the lung can be achieved by 
antenatal repair of the diaphragm. This concept has been documented in the fetal 
lamb model. Finally they developed techniques for maternal anesthesia, fetal 
monitoring and tocolytic control of preterm labor in a monkey model:"' Clinical 
application remains more or less experimental although this treatment modality is 
proposed to parents of a fetus with congenital diaphragmatic hernia. In 1991 
Harrison reported the initial results of in utero repair: three survivors out of 16 
treated cases." In other words, the risks of prenatal correction have not been 
weighed against the benefits and remain high to both the mother and the fetus. 
7). The concept that lung hypoplasia, and not a closing defect of the diaphragm, 
is the primary event in congenital diaphragmatic hernia is gaining increasing 
popularity. If this hypothesis would prove to be valid, only PRENATAL MODULATION or 
LUNG GROWTH or lung transplantation following birth, may provide ways of survival 
for the most severely affected patients. Fetal lung maturation has been enhanced by 
the combined application of corticosteroids and thyrotropin-releasing hormone, 
agents that both pass the placenta easily." These studies have been confirmed by de 
Zegher and coworkers, who showed a reduction of respiratory distress syndrome in 
prematurely born infants treated this way:'' It seems worthwhile to establish 
whether this approach will be of benefit for the congenital diaphragmatic hernia 
patient. Fetal surgery combined with prenatal modulation of lung growth remains 
another option worthy of investigation. 
8). The ultimate therapy for the congenital diaphragmatic hernia patient with 
extremely hypoplastic lungs might be the option of LUNG. TRANSPLANTATION as early as 
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possible after birth to prevent damage due to barotrauma and hyperoxia. Harrison's 
group performed pulmonary lobar transplantation in pigs with a diaphragmatic 
defect, and found that the graft was well tolerated." In humans, lung transplantation 
has been carried out on ECMO support." Theoretically this would result in a 
congenital diaphragmatic hernia patient who is no longer a patient, but a baby with 
normal lungs, both anatomically and biochemically. At the moment the concept of 
using ECMO as a bridge to lung transplant in newborns with high risk congenital 
diaphragmatic hernia, might still be a bridge too far."' 
In effect, the degree of lung hypoplasia is the limiting factor in survival and 
should be considered the primary defect. 
I hope that this concept is the key to new insights into pathogenesis and 
treatment of the disease. Our ultimate goal could then be prevention of the defect. 
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Chapter 7 
SUMMARY 
This thesis was undertaken in order to investigate selected aspects of the clinical 
picture of congenital diaphragmatic hernia. The estimated incidence of congenital 
diaphragmatic hernia is one in 3000 newborns. It exceeds the incidence of cystic 
fibrosis, the commonest genetic disorder in the Netherlands. Patients presenting with 
symptoms within 6 hours after birth are called high-risk patients. 
Chapter 1 is an outline of the literature on congenital diaphragmatic hernia. It 
describes historical and epidemiological aspects. The clinical picture of the high-risk 
patient is discussed, and it is shown that despite new therapeutic modalities, 
mortality has remained unchanged during the past decades. Developmental aspects 
of the lung in congenital diaphragmatic hernia are discussed against the background 
of normal lung development. 
Two observations prompted us to undertake the study presented in Chapter 2: 
(1) the admittance, within a few months, of a cluster of congenital diaphragmatic 
hernia patients from an area with heavy industrialization and agriculture including 
extensive use of fertilizers and herbicides, and (2) the resemblance of the herbicide 
Nitrofen with thyroid hormone: a well known growth factor of the fetal lung. In 
this study we compared congenital diaphragmatic hernia and esophageal atresia 
patients. A questionnaire inquiring after possible etiological and teratologic factors 
during pregnancy was completed by 33 couples whose baby had congenital 
diaphragmatic hernia, and by 43 couples whose baby had esophageal atresia. 
Specific attention was directed at maternal thyroid dysfunction, and in a number of 
mothers antibodies against thyroglobulin, thyroid microsomes, and TSH receptors 
were determined. This study did not reveal any differences in exposure to well-
known teratogenic agents in the home environment or the occupational environment. 
No specific drug could be identified that is associated with congenital diaphragmatic 
hernia. Nevertheless the fact that etiological relationships were not identified can 
still be of value in counseling the parents, especially against the background that 
over 95% of congenital anomalies have an unknown cause. 
In the next chapter the problems of persistent pulmonary hypertension and 
persistent fetal circulation are discussed. Part 3.1 reports on the development of 
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angiotensin-converting enzyme in the rat model of congenital diaphragmatic hernia. 
The pulmonary vascular bed is abnormal in congenital diaphragmatic hernia patients 
and is characterized by a decreased size of the pulmonary vascular bed, increased 
thickness of the pulmonary arterial muscle coat, and a decrease in the number of 
vessels per unit of lung. Many compounds play a role in regulating pulmonary 
vascular tone in the postnatal period, and angiotensin- converting enzyme is one of 
them. It has two effects: it converts angiotensin l to the potent vasoconstrictor 
angiotensin II, and it inactivates bradykinin, a vasodilator. Angiotensin converting 
enzyme activity in the lungs of rats exposed to Nitrofen was about 1.5 fold higher 
than in normal fetal rat lungs. Increased angiotensin-converting enzyme levels would 
lead to increased production of angiotensin ll and increased degradation of 
bradykinin. The normal postnatal drop in pulmonary vascular resistance could be 
easily disturbed in the presence of increased angiotensin-converting enzyme activity 
together with an abnormally muscularized pulmonary vascular bed. In the human 
newborn with congenital diaphragmatic hernia the number of pulmonary vessels per 
em' lung tissue amounts to only one third of that in normal controls. According to 
Poiseuille' s equation this would mean a three-fold increase in vascular resistance. 
Angiotensin ll is a growth factor for cell proliferation in the vessel wall and 
vascular hypertrophy may be an adaptive process in normalizing vessel-wall stress. 
lncre<:J.sed angiotensin-converting enzyme activity, leading to increased angiotensin ll 
levels, may be rather a. consequence than a cause of persistent pulmonary 
hypertension. 
Part 3.2 describes a prospective study of ten neonates with a diaphragmatic 
defect and five esophageal atresia patients. Ventilatory parameters were registered 
on admission, one hour before surgery, and one and six hours after surgery. 
Determination of thromboxane B,, a stable metabolite of the vasoconstrictor 
thromboxane A,, and 6-keto-prostaglandin Fw a stable metabolite of the vasodilator 
prostacyclin was carried out at the same moments. In patients with congenital 
diaphragmatic hernia the median concentration of thromboxane B, rose significantly 
after surgery and dropped to preoperative values in all but two patients. In patients 
with right-to-left shunting the ventilatory parameters (alveolar-arterial oxygen 
difference, oxygenation index), and thromboxane B, concentrations were significantly 
higher than in those without right-to-left shunting. It is stated that duri.ng surgery 
for congenital diaphragmatic hernia, the arachidonic cascade is activated and leads 
to a rise in the vasoconstrictor thromboxane B,. This may be an additional risk 
factor for the development of persistent pulmonary hypertension at a time when the 
pulmonary vascular bed still is in the perinatal adaptation phase. 
Part 3.3 reports the use of vasodilators to lower pulmonary vascular resistance in 
the clinical situation. In this study the effectiveness of the "historical" vasodilator 
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tolazoline is compared with the newer drug prostacyclin. Ventilatory parameters and 
mean arterial blood pressure were recorded during episodes of right-to-left shunting 
and at set times after the administration of vasoactive drugs. Tolazoline did not 
lower ventilatory parameters, but mean arterial blood pressure dropped significantly. 
After administration of prostacyclin (A-a)D02 values decreased significantly, without 
side effects on mean arterial blood pressure. Theoretically the ideal treatment for 
persistent pulmonary hypertension would be a selective pulmonary vasodilator. 
Indeed, prostacyclin turned out to be an effective pulmonary vasodilator in some 
patients, as is reflected by ventilatory parameters, and can be used as a "bridge" to 
ECMO. 
The following chapter discusses functional properties of the hypoplastic lung 
related to tissue damage by oxygen. Part 4.1 is the report of research into 
antioxidative enzyme activity during gestation and under artificial ventilation with 
hyperoxia in the rat model. Between day 19 of gestation and birth the level of 
superoxide dismutase remained fairly constant in the rats with and without a 
diaphragmatic defect. Catalase showed a significant increase in activity between day 
21 of gestation and birth. Glutathione peroxidase activity steadily increased with age 
in each group. After artificial ventilation with air and pure oxygen, superoxide 
dismutase activity tended to decrease, whereas catalase activity remained unchanged. 
Glutathione-peroxidase activity in the congenital diaphragmatic hernia lung was 
reduced to 70% of initial activity after artificial ventilation with pure oxygen. This 
enzyme is one of the last remedies of a cell to repair free-radical induced lipid 
peroxidation of its membranes and to prevent lethal damage. It is stated that this 
finding may indicate that the newborn rat with a diaphragmatic defect is at risk to 
develop oxygen-related lung damage. 
It is known that the term lung of the congenital diaphragmatic hernia patient 
behaves as the lung of the preterm infant and that it reacts on artificial ventilation 
with the formation of hyaline membranes (Gaillard, unpublished observations). Part 
4.2 confirms the suspicion that as a consequence the incidence of chronic lung 
disease resembling bronchopulmonary dysplasia should be high in congenital 
diaphragmatic hernia su..rvivors despite their term delivery. In this retrospective 
study the preoperative chest X-ray was evaluated in order to determine whether it 
might predict pulmonary hypoplasia and subsequent development of 
bronchopulmonary dysplasia. Furthermore, we assessed the severity of the 
bronchopulmonary dysplasia and tried to correlate bronchopulmonary dysplasia with 
the degree of lung hypoplasia. Thirty-three percent of the survivors had clinical and 
radiological lung disease resembling bronchopulmonary dysplasia. Morbidity 
expressed as duration of artificial ventilation, application of supplemental oxygen, 
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and hospital stay was much higher in this group. After repair of congenital 
diaphragmatic hernia, pulmonary function tests show a decrease in forced vital 
capacity and respiratory system compliance. Reduced perfusion and ventilation of 
the ipsilateral lung and airway obstruction have been reported in long-term 
survivors. lt is stated that a new population of congenital diaphragmatic hernia 
survivors might arise, those who will have compromised lung function in early 
adulthood. 
Chapter 5, Part 5.1 briefly describes the clinical picture of the "delayed" or 
"acquired" presenting congenital diaphragmatic hernia. The main difference with the 
so-called high-risk patient is the lack of pulmonary hypoplasia. Presenting symptoms 
are either pulmonary (pneumonia, dyspnea, cyanosis) or gastrointestinal 
(obstruction). Still these patients may present as an emergency under the initial 
diagnosis tension pneumothorax. It is stated that intended drainage is a hazardous 
procedure in these patients. Part5.2 and Part 5.3 discuss the experiences with the so-
called delayed surgical approach and summarize the preoperative stabilization 
procedure. This concept was developed to minimize risk factors for persistent 
pulmonary hypertension and to select patients with inadequate lung mass who 
would not benefit from surgical repair. The first experiences with surfactant-
replacement therapy are reported; they indicate that the hypoplastic lung is 
biochemically immature indeed and resembles the premature lung in function. 
In conclusion, congenital diaphragmatic hernia remains a continuing challenge for 
pediatric surgeons and neonatologists. Basic questions remain to be answered 
concerning the functional properties of the hypoplastic lung, its reaction to 
treatment, and the consequences for future lung development and function. 
SAMENVATTING 
In dit proefschrift wordt verslag gedaan van een onderzoek naar de pathofysiolo-
gische mechanismen die een rol spelen bij de syrnptomatologie van de congenitale 
hernia diaphragmatica patient. Congenitale hernia diaphragmatica komt voor bij 1 : 
3-5000 pasgeborenen. De incidentie is daarmee hoger dan die van cystic fibrosis, de 
meest voorkomende erfelijke aandoening in Nederland. Patienten die syrnptomen 
van respiratoire insufficientie tonen binnen zes uur na de geboorte, worden high-risk 
patienten genoemd. De mortaliteit in deze groep wordt geschat op 40 tot 50%. 
Hoofdstuk 1 bevat een literatuuroverzicht. De geschiedenis van congenitale her-
nia diaphragmatica wordt behandeld en de veranderende inzichten in tijdstip van 
behandeling worden besproken. Epidemiologische en etiologische studies vermelden 
een vergelijkbare incidentie in verschillende Ianden. Congenitale hernia diaphragma-
tica patienten worden geclassificeerd op grond van de plaats van het defect in het 
middenrif. De posterolaterale hernia met of zonder een breukzak draagt de naam 
van Bochdalek en is het onderwerp van dit proefschrift. Deze vorm komt het meest 
voor; bovendien zijn linkszijdige defecten acht rnaal zo frequent als rechtszijdige 
defecten. Bilaterale defecten zijn zeldzaam en hun incidentie wordt geschat op 3 tot 
5%. Tot de overige gevallen van congenitale hernia diaphragmatica worden de her-
nia's door het foramen van Morgagni, de centrale hernia's en de eventratie van het 
middenrif gerekend. Congenitale hernia diaphragmatica kan ook voorkomen als 
onderdeel van chromosomale en genetisch bepaalde aandoeningen. Wanneer doodge-
boren kinderen in de analyse worden betrokken, is er in 50% van de onderzochte 
gevallen sprake van andere aangeboren afwijkingen. Met name neurale buis defecten 
en hartafwijkingen komen vaak voor. Chromosomale afwijkingen die het meest wor-
den gevonden in geval van congenitale hernia diaphragmatica, zijn trisomie 18 en 
trisomie 21. Defecten van het middenrif kunnen ook onderdeel zijn van omschreven 
syndromen zoals het Fryns' syndroom of het Cornelia de Lange syndroom. Het 
familiair voorkomen van congenitale hernia diaphragmatica is bekend sinds 1916. 
Multifactoriele overerving wordt het meest waarschijnlijk geacht. 
Antenataal kan met behulp van echografie de diagnose worden gesteld, wanneer 
abdominale organen in de foetale borst- holte worden gezien of er een verplaatsing 
van het mediastinum zichtbaar kan worden gemaakt. Vaak is er sprake van een 
polyhydramnion, die zich na de 24e zwangerschapsweek heeft ontwikkeld. Het ont-
staan van een polyhydramnion is niet geheel duidelijk, maar wordt in verband ge-
bracht met functionele obstructie van het maag-darm kanaal. Wanneer de diagnose 
is gesteld, dient antenataal chromosomenonderzoek te worden verricht en dienen 
andere structurele afwijkingen te worden uitgesloten. Ook kan dan intra-uterien 
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transport en een geplande partus met adequate neonatologische opvang worden 
geadviseerd. 
Het klassieke trias symptornen van de congenitale hernia diaphragrnatica patient 
bestaat uit cyanose, dyspnoe en verplaatsing van het hart (rneestal) naar rechts. Bij 
licharnelijk onderzoek valt een vlakke buik op, zacht ademgeruis, en soms de aan-
wezigheid van darmgeruisen bij auscultatie van de thorax. De mortaliteit is het 
hoogst bij patienten die binnen 6 uur na de geboorte symptomen tonen. De prog-
nose is goed, wanneer de symptomen zich voordoen meer dan 24 uur na de geboor-
te. Het klinisch beeld word! gekenmerkt door respiratoire insufficientie en persiste-
rende foetale circulatie, op grond van longhypoplasie en het bestaan van abnormale 
muscularisatie van het pulmonale vaatbed. 
De sluiting van het rniddenrif vindt plaats rond de negende zwangerschapsweek. 
De ontwikkeling van de long tijdens de zwangerschap kent vijf stadia. De eerste 
fase is de embryonale periode. Aan het eind van de tweede fase, de pseudoglandu-
laire fase, die duurt van de 8e tot de 16e zwangerschapsweek, zijn aile luchtwegver-
takkingen voltooid. In de canaliculaire fase vindt differentiatie plaats van type II en 
type I cellen. Daarna vindt de ontwikkeling van sacculi en waarschijnlijk ook alveoli 
plaats tijdens de sacculaire en alveolaire fase. De ontwikkeling van alveoli gaat ook 
na de geboorte nog door tot de leeftijd van ongeveer 5 jaar. Het pulmonale vaatbed 
volgt de vertakkingen van de grote luchtwegen tot de acinus en is eveneens rond 
de 16' zwangerschapsweek voltooid. Verdere uitbreiding binnen de acinus vindt 
daarna plaats. Voor de geboorte is er een sterke muscularisatie van het pulmonale 
vaatbed, leidend tot een hoge longvaatweerstand en een lage pulmonale bloed-
stroom. Na de geboorte dient de pulmonale bloedstroom toe te nemen en daarvoor 
is adaptatie van het vaatbed noodzakelijk. Deze aanpassing vindt grotendeels in de 
eerste uren en dagen na de geboorte plaats. 
Functionele eigenschappen van de long zijn de produktie van surfactant en van 
antioxydatieve enzymen. Surfactant bestaat uit een aantal lipiden en eiwitten. De 
type li cellen zijn vanaf de 24e zwangerschapsweek in staat om in toenernende mate 
surfactant te produceren. Dit proces staat onder invloed van glucocorticoi'den en 
schildklierhormoon. De ontwikkeling van het antioxydatieve systeem vertoont grote 
gelijkenis met die van surfactant. De produktie van superoxide dismutase, catalase, 
en glutathionreductase neemt sterk toe naarmate de zwangerschap vordert. 
De theorieen over het uitblijven van de sluiting van het rniddenrif zijn goed 
samengevat door Kluth. De meest intrigerende theorie is die van lritani, die sugge-
reerde dat longhypoplasie eerder de oorzaak is dan het gevolg van het diaphragrna 
defect. De long van de congenitale hernia diaphragrnatica patient wordt gekenmerkt 
door hypoplasie, uitgedrukt als een verlaging van de long:lichaarnsgewicht ratio, een 
afname in het aantal vertakkingen van de bronchiaalboom, een verrninderde "radial 
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alveolar count", een afname van het DNA-gehalte per hoeveelheid longweefsel, lage-
re phospholipide-concentraties, en de afwezigheid van elastische vezels. Het pulmo-
nale vaatbed is gekenmerkt door een afname van het totale oppervlak, een toename 
van de hoeveelheid spierweefsel in de vaatwand en een afname in het aantal vaten 
per hoeveelheid longweefsel. Functioneel is er sprake van een verminderde surfac-
tantproduktie door de congenitale hernia diaphragmatica Iangen. Over de produktie 
van antioxydatieve enzymen door deze longen is niets bekend. 
Van oorsprong bestond de behandeling van congenitale hernia diaphragmatica uit 
een zo spoedig mogelijke sluiting van het diaphragma defect. Met de vaststelling 
dat longhypoplasie en pulmonale hypertensie de oorzaken zijn van de klinische 
symptomen van congenitale hernia diaphragmatica is er een nieuwe behande-
lingswijze ontstaan. Deze is er op gericht om de patient te stabiliseren en risicomo-
menten voor pulmonale hypertensie zo vee! mogelijk te vermijden. Operatieve cor-
rectie vindt dan in een latere fase plaats, wanneer het pulmonale vaatbed minder 
gevoelig is voor stimuli die pulmonale hypertensie kunnen uitlokken. De mortaliteit 
is door deze behandeling echter niet gedaald, wei zijn de inzichten in de pathofysio-
logie er door verdiept. De toepassing van nieuwe beademingstechnieken, de toepas-
sing van extracorporele membraanoxygenatie, en de ontwikkeling van nieuwe medi-
camenten om de pulmonale vaatweerstand te bemvloeden hebben baat gebracht voor 
een aantal patienten, maar de mortaliteit binnen de groep als geheel is echter niet 
gedaald. Mogelijkerwijs houdt dit verband met het feit dat congenitale hernia dia-
phragmatica steeds vaker wordt gediagnostiseerd v66r de geboorte waardoor oak 
kinderen met ernstige longhypoplasie na intrauterien transport het ziekenhuis kun-
nen bereiken. 
Twee waarnemingen vormden de reden om de studie te ondernemen waarvan in 
hoofdstuk 2 verslag wordt gedaan. Allereerst werd binnen enkele maanden een 
groep patienten opgenomen, die allen afkomstig waren uit een streek met intensieve 
landbouw en zware industrie. Ten tweede vie! de gelijkenis op tussen Nitrofen en 
schildklierhormoon -een bekende groeifactor voor de foetale long. Een vragenlijst 
gericht op mogelijke etiologische en teratologische factoren werd ingevuld door 33 
ouderparen van een kind met congenitale hernia diaphragmatica en door 43 ouder-
paren van een kind met oesophagus atresie. Bovendien werd een aantal vragen 
gesteld, gericht op het v66rkomen van ziekten van de schildklier. Bij een aantal 
moeders werd bloed afgenomen om antistoffen tegen thyroglobuline, schildklier-
microsornen en TSH receptoren te bepalen. Er werden geen verschillen gevonden 
tussen de twee groepen voor wat betreft teratologische invloeden uit de woon- of 
werkorngeving. Er was geen medicijngebruik waarvan bekend is dat het congenitale 
hernia diaphragmatica kan veroorzaken. Het ontbreken van een relatie tussen invloe-
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den uit woon- en werkomgeving heeft zeker waarde in de begeleiding van de ou-
ders van deze patienten. · 
In de volgende hoofdstukken wordt het probleem van de persisterende pulmo-
nale hypertensie besproken. Hoofdstuk 3.1 doet verslag van een prospectieve studie 
bij 10 pasgeborenen met een congenita!e hernia diaphragrnatica en 5 controle patien-
ten met een oesophagus atresie. In deze studie werd een aantal beaderningspara-
meters vastgelegd bij opname, een uur voor chirurgische correctie, en een en zes 
uur na de operatie. Op dezelfde tijdstippen werden spiegels bepaald van het circule-
rende thromboxane B,, een stabiele metaboliet van de vasoconstrictieve stof throm-
boxane A, en 6-keto-prostaglandin F,w een stabiele metaboliet van prostacycline. Bij 
patienten met een congenitale hernia diaphragrnatica steeg de concentratie van 
thromboxane B, onrnidde!lijk na de operatie, maar daalde later terug naar de pre-
operatieve waarde. Bij patienten met een rechts-links shunt werden hogere waarden 
gevonden van de beademingsparameters (A-a)DO, en oxygenation index. Bij deze 
patienten waren de thromboxane B, spiegels significant hoger. Er is dus gedurende 
de operatieve ingreep activatering van de arachidonzuur cascade, waardoor een 
verhoogde uitstort van de vasoconstrictieve stof thromboxane A, plaatsvindt. Met 
name wanneer het pulmonale vaatbed nog in de aanpassingsfase is aan het extraute-
riene Ieven en gevoelig is voor prikkels die pulmonale hypertensie kunnen uit-
lokken, vormt de verhoogde uitstort van thromboxane A2 daarvoor een risico factor. 
Hoofdstuk 3.2 beschrijft de ontwikkeling van angiotensin-converting enzyme 
activiteit in het diermodel dat door TenBrinck en co!!ega's van het Instituut Kinder-
heelkunde werd ontwikkeld in het Laboratorium voor Chirurgie van de Erasmus 
Universiteit Rotterdam. Het pulmonale vaatbed is abnormaal bij congenitale hernia 
diaphragrnatica patienten en wordt onder andere gekenmerkt door een toename van 
de hoeveelheid spierweefsel in de kleinere vertakkingen van de arteria pulmonalis. 
Talrijke stoffen, waaronder angiotensin-converting enzyme, hebben een invloed op 
het dalen van de pulmonale vaatweerstand na de geboorte. Angiotensin-converting 
enzyme heeft twee effecten: het zet angiotensine I om tot de krachtige vasoconstric-
tor angiotensine !! en het inactiveert bradykinine, een vasodilator. Angiotensin-con-
verting enzyme activiteit in de longen van ratten die blootgesteld waren aan het 
herbicide Nitrofen was 1.5 maal hoger dan in controledieren. Een toename van de 
angiotensin-converting enzyme activiteit zal leiden tot een toename van de produktie 
van angiotensine II en een toename van de afbraak van bradykinine. De norma!e 
postnatale daling van pulmonale vaatweerstand zou gemakke!ijk kunnen worden 
verstoord in de aanwezigheid van een toegenomen hoeveelheid angiotensin-conver-
ting enzyme, zeker wanneer ook nog het puh-nonale vaatbed een abnormale struc-
tuur heeft. De hoeveelheid bloedvaten in de longen van een pasgeborene met een 
congenitale hernia diaphragrnatica bedraagt slechts een derde van de hoeveelheid 
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die normaal aanwezig is. Volgens de wet van Poiseuille zou dit een verdrievou-
diging van de vaatweerstand betekenen. Angiotensine heeft naast vasoconstrictieve 
werking ook nog een stimulerend effect op celproliferatie in de vaatwand, en hyper-
trofie van de vaatwand kan een mechanisme zijn om de drukverhoudingen in het 
vat te normaliseren. De verhoging van de angiotensin-converting enzyme activiteit, 
die leidt tot verhoging van de angiotensine II spiegels, zou dan eerder een oorzaak 
dan een gevolg zijn van pulmonale hypertensie. 
Hoofdstuk 3.3 vergelijkt het gebruik van twee vasodilatatoire stoffen in de klini-
sche situatie. Beaderningsparameters en gerniddelde arteriele bloeddruk werden vast-
gelegd tijdens episoden van een rechts-links shunt en op gezette tijden na toedie-
ning van hetzij tolazoline of prostacycline. Tolazoline had geen invloed op de 
beaderningsparameters, maar de gerniddelde arteriele bloeddruk daalde significant. 
Na toediening van prostacycline werd een significante daling van de beadernings-
parameter (A-a)DO, gezien zonder effecten op de gerniddelde arteriele bloeddruk. 
Hoewel in de kleine studiegroep geen verbetering van de prognose werd aan-
getoond, kan prostacycline in ieder geval tijdelijk leiden tot een daling van de 
pulmonale vaatweerstand en daardoor de toepassing van andere behandelingen, 
zoals extracorporele membraan oxygenatie mogelijk maken. 
In het volgende hoofdstuk worden de functionele eigenschappen van de conge-
nitale hernia diaphragmatica longen en het gevolg daarvan voor de prognose 
besproken. Hoofdstuk 4.1 is het verslag van studies in het diermodel die gericht 
waren op de ontwikkeling van de antioxydatieve activiteit tijdens de zwangerschap 
en onder kunstrnatige beaderning met 100% zuurstof. Tussen dag 19 en dag 22 (a 
terme) bleef de enzymactiviteit van superoxide dismutase constant binnen de groe-
pen met of zonder een diaphragma defect. Catalase toonde een sterke stijging in 
activiteit tussen dag 21 en de geboorte. Glutathion-peroxidase toonde een gelijk-
matige stijging naarmate de zwangerschap vorderde. 
Beaderning met zuivere zuurstof leidde tot een daling van de activiteit van 
superoxide dismutase, terwijl de catalase activiteit onveranderd bleef. De glutathion-
peroxidase activiteit nam af tot 70% van de initiele activiteit na beaderning met 
100% zuurstof. Dit enzym is een van de laatste mogelijkheden die de eel heeft om 
beschadiging door vrije zuurstof radicalen te voorkomen. Deze waamerning zou 
kunnen betekenen dat de pasgeboren rat met een congenitale hernia diaphragmatica 
gevoeliger is voor zuurstofschade dan de normale contr6le rat. Wanneer deze bevin-
ding zou worden vertaald naar de situatie bij de mens, zou dat betekenen dat de 
long van de pasgeborene met een congenitale hernia diaphragmatica zich gedraagt 
als de long van een premature pasgeborene. De waarnerning dat de congenitale 
hernia diaphragmatica long reageert op kunstrnatige beaderning met de vorrning van 
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hyaline membranen (Gaillard, niet gepubliceerde observaties) is daarrnee in overeen-
stemrning. 
Hoofdstuk 4.2 bevestigt het verrnoeden dat dienten-gevolge de incidentie van 
longbeschadiging gelijkend op bronchopulmonale dysplasie hoog moet zijn. In deze 
retrospectieve studie werd aangetoond dat bij 33% van de overlevenden sprake was 
van klinische en rontgenologische tekenen van bronchopulrnonale dysplasie. De 
morbiditeit, uitgedrukt als duur van kunstrnatige beaderning, duur van extra zuur-
stofbehoefte, en hospita!isatie, was hoog in deze groep. In dit hoofdstuk komt ter 
sprake dat Iongfunctie-onderzoeken ongeveer een maand na operatie een afname 
van de vitale capaciteit en de compliantie Iaten zien. Longfunctie- onderzoeken na 
langere tijd tonen een verrninderde perfusie en ventilatie, en verhoogde bronchiale 
prikkelbaarheid. Waarschijnlijk is de onderzochte populatie nog maar de voorbode 
van een groep die ondanks een nog ernstiger longhypoplasie kan overleven en 
moge!ijkerwijs nog ernstiger longbeschadiging zal overhouden. 
Hoofdstuk 5 behandelt een aantal klinische aspecten. Hoofdstuk 5.1 beschrijft 
kort de klinische presentatie van de zogenaamde "verworven" congenitale hernia 
diaphragrnatica. De prognose is bij late presentatie goed, maar er bestaat een groep 
patienten die zich alsnog als "acute" patient kan presenteren 6£ met het beeld van 
een spanningspneurnothorax, waarbij de uitgezette maag wordt aangezien voor de 
pneumothorax, 6£ ten gevolge van strangulatie van de darrn door de breukpoort. 
Drainage van de "pneumothorax" is een gevaar!ijke procedure in deze patienten-
groep. Hoofdstuk 5.2 verslaat de ervaringen met de zogenaamde uitgestelde operatie 
na een stabilisatiefase. Dit concept is ontwikkeld om de risicofactoren voor pulmo-
nale hypertensie tot een minimum te beperken en om patienten te selecteren die een 
zodanig ernstige Ionghypoplasie hebben dat een chirurgische sluiting van het 
rniddenrif hun levenskansen niet zou verbeteren. In hoofdstuk 5.3 worden de eerste 
gunstige ervaringen met de toediening van surfactant beschreven bij een aantal 
patienlen. Deze ervaringen vormen een indirect bewijs dat de hypoplastische long 
inderdaad biochernisch onrijp is. 
De hypothese dat congenitale hernia diaphragrnatica meer is dan aileen maar een 
defect van het middenrif en mogelijk onderdeel van een aandoening waarbij hypo-
plasie van de long centraal staat, krijgt meer en meer steun. Deze bewustwording 
heeft geleid tot een andere behandeling van de pasgeborene met een congenilale 
hernia diaphragmatica, en in de afgelopen jaren is een aantal verschillende behande-
lingswijzen ge!ntroduceerd. Anlenatale diagnostiek heeft geleid tot intra-uteriene 
overplaatsing naar centra waar neonatologische opvang en kinderchirurgische 
behandeling na de geboorte mogelijk zijn. Het concept van de uitgestelde chirurgi-
sche correctie is in Europa ontwikkeld, welhaasl tegelijk met de introductie van 
extracorporele membraan oxygenatie in de Verenigde Staten. Verbeterde beadernings-
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strategieen en de ontwikkeling van nieuwe medicamenten om de pulmonale vaat-
weerstand te bei"nvloeden leken aanvankelijk veelbelovend, maar in grotere series 
bleef de mortaliteit onveranderd hoog. Ook foetale chirurgie lijkt niet de ideale 
behandelingsmethode te kunnen worden, omdat de bronchiaalboom zijn definitieve 
vorm al heeft gekregen rond de 16e zwangerschapsweek, lang voordat deze behan-
deling mogelijk is. In hoeverre prenatale modulatie van de longgroei de prognose 
kan verbeteren lijkt de moeite van verder onderzoek waard. De optie om te slreven 
naar longtransplantatie waarbij exlracorporele rnernbraan oxygenatie als overbruggen-
de therapie kan dienst doen, lijkt vooralsnog eerder science fiction dan realiteit. 
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